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1. Summary 
1.1. Summary in English 
During development of vertebrate organisms, precise spatio-temporal 
expression patterns of genes are necessary for the proper growth and tissue 
differentiation in the embryo. Developmental genes are usually controlled by multiple 
elements scattered several hundreds of kilobases up- and downstream of a target gene, 
sometimes embedded in introns of functionally non-related genes. This intricate 
distribution along the chromosome raises the question on the importance of the 
regulatory architecture for the correct gene expression. This is additionally 
emphasized by several genetic disorders, where no mutations in coding regions were 
found. Instead, it seems they are associated with the disruption of the normal structure 
of chromosomal domains. Furthermore, distribution of genes and their regulatory 
elements is mostly conserved across distant species, suggesting they are organized 
following a specific architecture.    
In order to address the role of structural organization of genes and their 
regulatory elements in achieving proper gene expression, we decided to study the 
TLX1-FGF8 interval mapped to human chromosome 10q24. This ~600 kb gene-rich 
region harbors seven functionally and phylogenetically unrelated genes, representing 
a “normal” genomic situation. Gene order of the whole region is extremely conserved 
in tetrapods and to some extent in teleost fish and beyond. In addition, human 
condition split hand-foot malformation type 3 (SHFM3) is caused by 0.5 Mb tandem 
duplication within TLX1-FGF8 locus. It is characterized by the absence of central 
digits on both hand and feet. FGF8 is coding for a signaling molecule involved in 
multiple developmental processes, including limb development. Although FGF8 is 
not within the duplicated interval, the early termination of its expression in the limb 
apical ectodermal ridge (AER) contributes to the phenotype.  
Some attempts to map Fgf8 regulatory elements have already been conducted 
in mice and fish; however, their full scope was not determined. Combining mouse 
transgenesis and chromosomal engineering I narrowed down the region critical for 
proper Fgf8 expression that is spanning ~200 kb downstream of the gene. Within it, I 
characterized individual regulatory elements. Many of them guided the expression of 
LacZ reporter gene in the overlapping domains, suggesting functional redundancy. 
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Also, when tested individually, they express much more regulatory potential than is 
eventually utilized by Fgf8. Additional experiments using bacterial artificial 
chromosomes (BACs) with inserted reporter gene revealed filtering of this potential 
when elements are in their natural genomic environment. Fine-tuning of the 
regulatory potential can be achieved either by negative elements or the structure of the 
locus itself.  
Close proximity of Fgf8 enhancers and promoters of other genes in the region 
raised the question on how do regulatory elements discriminate between the target 
promoter and the promoters of the genes nearby. A series of chromosomal 
rearrangements that reallocate different promoters into Fgf8 regulatory region showed 
that Fgf8 enhancers are intrinsically capable to activate heterologous promoters and 
that enhancer-promoter specificity is not exclusively guided by the sequence of the 
promoter. Rather, the relative position of the two plays a significant role in achieving 
proper activation of the target gene by the set of enhancers.  
Based on the results of our study, we propose a novel concept of gene 
regulation: a holo-enhancer. Within a holo-enhancer, vast regulatory potential of 
multiple enhancers is filtered by the activity of potential other negative regulatory 
elements and their relative position towards the target gene. Also, individual 
enhancers are able to activate heterologous promoters. However, this intrinsic 
promiscuity is refined by the position-dependent activity of the regulatory elements. 
In a complex genomic environment like the one of Fgf8, gene regulation is not 
composed of simple binary interactions between a promoter and single regulatory 
module(s), but is embedded in the structure of the region itself. Once a holo-enhancer 
is divided into individual elements, their full potential is revealed and perturbations of 
the region show the potential of enhancers to act on other promoter sequences. This 
novel concept emphasizes the holistic nature of the interactions of the genes and their 
regulatory elements in achieving gene and tissue specificity, with the overall 
organization of the locus being a key aspect in this process.   
These observations led us to suggest the mechanism leading to SHFM3. 
Duplication breakpoints disrupt the holo-enhancer, reallocating part of the enhancers 
and releasing them from the potential negative elements needed for fine-tuning of 
their activities. In addition, a new position brings them to the appropriate distance to 
the heterologous promoters. Their intrinsic promiscuity and broad regulatory potential 
allows activation of other genes in the region and potentially leads to their up-
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regulation. Moreover, complex interactions within this region could also explain 
conserved gene order in multiple orthologous loci across different organisms. Ancient 
linkage between functionally unrelated genes, as is the case with Fgf8 and Fbxw4, is 
most probably due to the structural constraints of the regulatory scaffold upon which 
genes are transcribed.  
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1.2. Deutsche Zusammenfassung 
Die Entwicklung von Vertebraten benötigt räumlich und zeitlich exakt 
kontrollierte Genexpressionsmuster, die das Wachstum und die korrekte 
Gewebsdifferenzierung gewährleisten. Diese Gene werden meist durch mehrere 
regulative Elemente gesteuert, die über einige hundert Kilobasen um das Zielgen 
verstreut sein und manchmal in Intronen funktional nicht verwandter Gene liegen 
können. Die komplexe und evolutionär konservierte Verteilung der Elemente lässt die 
Frage nach einer spezifischen „regulativen Architektur“ in der Genexpression 
aufkommen. Diese Architektur scheint sehr wichtig für die korrekte Expression vieler 
Gene zu sein, da viele humangenetische Erkrankungen nicht auf Mutationen in 
kodierenden Sequenzen, sondern auf strukturelle Veränderungen chromosomaler 
Domänen zurückzuführen sind.  
Um die Existenz einer möglichen regulativen Architektur in der Verteilung 
von Genen und regulativer Elemente zu klären, haben wir uns entschlossen den auf 
Chromosom 10q24 zu untersuchen. Diese etwa 600 kb große, genreiche Region 
beinhaltet sieben funktional und phylogenetisch nicht verwandte Gene und bietet 
somit eine repräsentative, genomische Umgebung für die Studie. Sie ist zwischen 
Tetrapoden besonders und bis zu Teleostier weitgehend konserviert. Des weiteren ist 
der TLX1-FGF8 Locus relevant für Humangenetiker, da eine 0,5 Mb 
Tandemduplikation in dieser Region ursächlich für die humane Spalthand und -Fuß 
Malformation 3 (SHFM3) ist. FGF8 kodiert ein Signalmolekül, welches an einer 
Vielzahl von entwicklungsbiologischen Prozessen, wie zum Beispiel der 
Extremitätenentwicklung beteiligt ist. Obwohl FGF8 selbst nicht von der Duplikation 
betroffen ist, spielt die vorzeitige Terminierung seiner Expression in der 
Extremitätenknospe bei der Entwicklung des Phänotyps eine wichtige Rolle.  
In den Modellorganismen Maus und Fisch wurden in früheren Studien schon 
einzelne Fgf8 regulierende Elemente entdeckt, aber das gesamte Ausmaß nie 
systematisch untersucht. Mittels Maus Transgenese und Chromosomen Engineering 
konnte ich die zur Fgf8 Expression wichtige Region auf  200 kb unterhalb des Genes 
eingrenzen. Innerhalb dieser Region habe ich regulative Elemente charakterisiert, die 
die Expression eines LacZ Reporter Genes in überlappenden Fgf8 Domänen steuern 
können und die daher funktional redundant zu sein scheinen. Weiterhin zeigten die 
individuellen Elemente ein weit höheres regulatives Potential als die Fgf8 Expression 
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vermuten ließe. Allerdings wird dieses überschüssige Potential entweder durch 
negative Elemente oder die Struktur des Locus in der natürlichen genomischen 
Umgebung unterdrückt, welches ich durch weitere Experimente mit BACs zeigen 
konnte. 
Ein zentraler Punkt in der Forschung von Genregulation ist die Frage, wie 
regulative Elemente zwischen ihrem Zielpromoter und anderen, zum Teil näher 
liegenden  Promotern unterscheiden können. Durch Umgestaltung des Fgf8 Locus 
mittels Chromosomen Engineering konnte ich zeigen, dass Fgf8 Enhancer heterologe 
Promotoren aktivieren können und daher die Enhancer-Promoter Spezifität nicht 
ausschließlich Sequenz-abhängig sein kann. Diese scheint eher von der relativen 
Positionierung zueinander und der Struktur des gesamten Locus abzuhängen.  
Aufgrund der Ergebnisse dieser Studie schlagen wir ein neues Konzept der 
Genregulation vor, in dem ein gesamtes Intervall als „Holoenhancer“ agiert. Innerhalb 
eines Holoenhancers wird das enorme regulative Potential mehrer Elemente über 
andere, negative Elemente und durch ihre relative Position zum Zielgen gefiltert. 
Weiterhin können individuelle Elemente heterologe Promotoren aktivieren, wobei 
allerdings die gegebene Möglichkeit dieser unspezifischen Interaktion durch ihre 
positionsabhängige Aktivität verhindert wird. In einer komplexen genomischen 
Umgebung wird die Genregulation nicht durch einfache Interaktionen von 
Promotoren mit einzelnen regulativen Elementen gesteuert, sondern ist in der 
umliegenen Struktur eingebettet. Dies wird deutlich, wenn der Holoenhancer in die 
einzelnen Elemente aufgeteilt wird und dadurch das volle regulative Potential 
offenkundig wird. Dieses neue Konzept unterstreicht die ganzheitliche Natur der 
Interaktion von Genen mit ihren regulativen Elementen. Diese ist nötig um Gen- und 
Gewebsspezifität zu gewährleisten, wobei der strukturellen Organisation des Locus 
eine Schlüsselrolle zukommt. 
Diese Hypothese kann auch zur Klärung der Entstehung der SHFM3 beim 
Menschen herangezogen werden. Die Bruchpunkte der Duplikation zerstören die 
Integrität des Holoenhancers und verteilen einen Teil der regulativen Elemente um. 
Dadurch werden diese von mutmaßlichen negativen Elementen getrennt und in die 
entsprechende Distanz zu heterologen Promotern gebracht. So könnten andere Gene 
in FGF8 Domänen ektop exprimiert werden und somit den dominant-negativen 
Phänotyp auslösen. Die Notwendigkeit für eine definierte räumliche Struktur 
regulativer Elemente erklärt möglicherweise auch den evolutionären Druck für die 
 15 
sehr alten Kopplungen von funktional unterschiedlichen Genen, die im Falle von Fgf8 
und Fbxw4 bis zu den Weichkorallen konserviert ist.  
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2. Introduction  
Every organism is the final product of expression of multiple genes, combined 
with the influence of the environment. It is clear that the expression of genes has to be 
tightly coordinated and this is particularly important during development when body 
axes are established and organogenesis is taking place. Regulation of gene expression 
is a complex process with several checkpoints on multiple levels, most important 
being transcriptional one. Transcriptional regulation enables proper expression of 
multiple genes in a certain tissue at the specific time point. Several categories of cis-
acting regulatory elements are identified so far to play important roles: promoters, 
enhancers, silencers and insulators.  
While promoters are relatively easy to identify, as they are mainly located in 
the close proximity of transcriptional start site, the rest of the regulatory elements act 
at long distances from the genes, sometimes even a megabase away (Lettice, Heaney 
et al. 2003). They can also be embedded in introns of functionally unrelated genes. 
This possesses a great challenge to identify them throughout the genome as well as to 
assign their target gene(s).  
However, the study of distant cis-regulatory elements has become an 
important field of study for several reasons. First, it has been observed that increased 
genome size in more complex organisms does not correlate with the increase in the 
number of genes. It seems that the morphological evolution was guided by the 
changes in the regulatory sequences, rather than in the genes themselves (Carroll 
2008). Second, there are a growing number of developmental diseases whose causes 
cannot be assigned to the mutations in the coding sequences. Instead, different 
chromosomal rearrangements (duplications, deletions, translocations) as well as the 
mutations in conserved noncoding (potentially regulatory) sequences have been 
attributed as a cause (Kleinjan and van Heyningen 2005). Finally, understanding the 
nature of cis-regulation helps in understanding complex developmental processes.  
 
2.1. Regulation of gene expression 
In eukaryotes, gene expression is a multi-level process that starts with the 
remodeling of the chromatin at sequences that regulate the transcription, followed by 
the transcription itself. Then, RNA is edited and mature mRNA is transported from 
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the nucleus to the cytosol, where translation and post-translational modifications take 
place. Regulation of gene expression occurs at each of these levels. For most of the 
genes however, transcription is a crucial event. Transcription is also regulated at 
multiple steps: preinitiation chromatin remodeling around the promoter and other cis-
acting elements, initiation, elongation and termination. A key event is the assembly of 
RNA polymerase II (RNAPII) complex at the transcriptional start site, favored 
through the activity of multiple cis-regulatory elements. Several types of regulatory 
elements involved in this process are promoters and proximal promoter regions, 
mostly located in the proximity of the genes. Enhancers, insulators and silencers 
usually act from, sometimes great, distances (Figure 1). 
 
 
 
 
Figure 1. Transcriptional unit of higher eukaryotes 
Transcriptional unit comprises of the core promoter associated with transcriptional start site and closely 
positioned upstream promoter elements (UPE). Additionally, enhancers and silencers act on the 
promoter elements from great genomic distances and positively or negatively regulate the transcription. 
Insulators create chromatin barriers and have a function in preventing interference with heterologous 
regulatory elements and / or blocking the influence of the genomic surrounding. 
 
2.1.1. Transcriptional activators 
Promoter 
The promoter of a gene is defined as a region around transcriptional start site 
that comprises of the core promoter and the proximal promoter region. The core 
promoter directly binds protein factors that form basal transcriptional machinery and 
are minimally needed for the transcription in vitro. The first step in this process is the 
assembly of the preinitiation complex (PIC). For the first discovered and mostly 
studied core element so far, TATA box, it requires coordinated binding of 
TFIID/TFIIA, TFIIB, RNAPII/TFIIF, TFIIE and TFIIH in this precise order. Later 
on, other core elements were discovered. These include initiator element (Inr), 
downstream promoter element (DPE) and TFIIB recognition element (BRE) (Smale 
and Kadonaga 2003). Proximal promoter elements are usually 100-500 bp upstream 
Regulatory Regions in DNA: Promoters, Enhancers, Silencers, and Insulators 35
Fig. 3.1. Transcriptional regulatory units in eukaryotes. Schematic overview (a and b not drawn to scale) of the various
elements in the transcriptional units in simple eukaryotes (a, yeast) and higher eukaryotes (b, mammalian) and a detailed
overview (c) of the promoter region in mammals. Exons are shown as gray boxes with dashes lines. a, In yeast, a promoter
region is shown with a TATA box at –70 bp and upstream activating sequences (UASs) around 250 bp upstream from
the transcription start site (TSS). b, the mammalian transcriptional unit is more complex, with a large core promoter
overlapping the first exon and upstream promoter elements (UPE, or proximal promoter elements) further upstream. The
DNA loop shows that enhancers can be brought physically close to either the core promoter or the UPE. c, detailed
architecture of the core promoter. Various elements, many of them optional, are shown roughly to scale. Darker shaded
promoter elements are more frequent. Abbreviations: TATA box (TATA), initiator element (Inr), TFIIB recognition element
(BRE, upstream and downstream), motif t n element (MTE), downstream core lement (DCE, subun t 1, 2, and 3), X cor
promoter element 1 (XCPE1), and the downstream promoter element (DPE). Note that the core promoter can be focused
or dispersed, here shown by one bold TSS and many smaller TSSs, respectively.
2. Regions
Involved in
Transcription and
Transcriptional
Regulation
2.1. The Core
Promoter
The classical, textbook definition of the core promoter is a region
around the TSS (+1) of a gene, which contains several DNA ele-
ments that facilitate the binding of regulatory proteins. Binding
of these proteins is required for the step-wise sequestering and
formation of the PIC (pre-initiation complex). In one promoter
architecture, the TATA box, an AT-rich sequence acts as a binding
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of the core promoter, contain specific transcription factor binding sites and enhance 
binding of RNAPII to the core promoter.  
TATA box consensus sequence TATAA is located 28-32 bp upstream of the 
transcriptional start site and binds TATA box binding protein (TBP) (Sawadogo and 
Roeder 1985). The rest of the pre-initiation complex proteins then assembles and 
activates transcription at a defined distance from TATA box. In this process TFIIB 
plays a crucial role (Li, Flanagan et al. 1994). Although TATA box is often coupled 
with another core promoter initiator element (Inr) and they can work synergistically, 
these two also act independently. Initiator element is located right at the 
transcriptional start site (TSS) that is adenosine preceded by cytosine and surrounded 
by pyrimidine bases (Smale and Baltimore 1989). On the other hand, downstream 
promoter element (DPE) requires the presence of Inr. As the name suggests, DPE lays 
28 to 32 bp downstream of TSS and has a consensus sequence A/G A/T C/T G/A/C 
(Burke and Kadonaga 1996; Burke and Kadonaga 1997). TFIIB recognition element 
(BRE) is of the consensus sequence G/C G/C G/A CGCC and is located upstream of 
TATA box. It binds TFIIB instead of TFIID and can both stimulate and repress basal 
transcription (Lagrange, Kapanidis et al. 1998; Evans, Fairley et al. 2001).   
For a long time it has been assumed that proteins involved in core 
transcription machinery assembly on these elements are invariable in different cell 
types, as is the case with the universal transcription factor, TATA box-binding protein 
(TBP), and that the tissue specificity of the genes is governed by the action of the 
enhancers (see later). However, in the last decade tissue-specific homologues of basal 
transcription factors were identified, namely TBP-associated factors (TAFs) and TBP-
related factors (TRFs). They are members of TFIID complex and mediate promoter 
selectivity of tissue-specific genes (Hochheimer and Tjian 2003). 
Additionally, development of new methods for mapping TSSs genome wide 
(Sandelin, Carninci et al. 2007; Ni, Corcoran et al. 2010) revealed more complex 
nature of the initiation of transcription. It has become obvious that majority of 
mammalian genes does not use single TSS but several closely positioned within 50-
100 bp. According to a newly proposed classification, ‘sharp’ promoters have TSSs in 
a narrow window and are mostly enriched for TATA boxes. These promoters are also 
associated with tissue specific genes. On the other hand, ‘broad’ promoters are 
enriched for another class of promoter elements: CpG islands (Carninci, Sandelin et 
al. 2006). These are stretches of DNA up to 2 kb with higher content of CG 
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dinucleotides. Since the methylation of cytosine can lead to irreversible deamination 
to thymine (Bird 2002), many vertebrate genomes have CpG dinucleotides 
underrepresented. However, there are isolated CpG islands connected to promoters 
(Suzuki, Tsunoda et al. 2001). CpG islands usually lack any of the above mentioned 
promoter elements and have multiple TSSs. They can often be found next to 
ubiquitously expressed genes with the exception of genes specifically expressed in the 
central nervous system. The majority of mammalian promoters fall into the category 
of ‘broad’ promoters (Carninci, Sandelin et al. 2006).    
The need for the tight transcriptional control of tissue-specific genes restricts 
the possibility of viable mutations of TATA box consensus sequence and its distance 
from TSS. This could explain the observation of lower nucleotide substitution rate for 
TATA box containing promoters (Carninci, Sandelin et al. 2006). On the other hand, 
higher flexibility of base substitution in CpG islands is allowed probably due to 
epigenetic control of these promoters.  
Enhancers 
Although sequence of the core promoter is enough for the assembly of 
transcriptional machinery, additional factors are often needed to boost up transcription 
above the basal level. In addition to core promoters, different proximal elements can 
be located nearby. They bind specific transcription factors and enhance the assembly 
of the basal transcriptional machinery at the core promoter. For example, Specificity 
protein 1 (Sp1) binds GC-rich oligonucleotides in promoters of the genes involved in 
cell proliferation, DNA synthesis and nucleotide metabolism (Kadonaga and Tjian 
1986; Safe and Kim 2004), whereas nuclear factor-1 (NF-1) binds CCAAT box 
(Jones, Kadonaga et al. 1987). 
Another class of transcription-boosting elements is enhancers. The first 
described enhancer was identified in SV40 virus: a 72 bp sequence located some 200 
bp from the gene for T-antigen (Banerji, Rusconi et al. 1981). Soon after, the first 
vertebrate enhancer was discovered in mammalian B-lymphocytes (Gillies, Morrison 
et al. 1983). Since then, enhancers have been recognized as an important class of 
regulatory elements. They are defined as cis-acting regulatory elements located both 
up- or downstream from the gene they regulate, sometimes even a megabase away 
(Lettice, Heaney et al. 2003). They can also be inserted in the introns of the gene they 
regulate or of a neighboring gene (Lettice, Heaney et al. 2003) and there are some 
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recent evidences that enhancer activity could be encoded by exons (Tumpel, 
Cambronero et al. 2008). In contrast to proximal promoter elements whose position 
and orientations need to be maintained for their function, enhancers activate the 
transcription in position- and location-independent manner. 
Enhancers are most important for developmental genes whose precise spatio-
temporal expression needs to be tightly regulated. These genes usually have multiple 
enhancers acting in an autonomous and modular manner – each module drives the 
expression of the gene in a specific cell type or a tissue at a discrete time point. 
Classical examples include the enhancers that guide the expression of the even-
skipped (eve) gene in Drosophila (Fujioka, Emi-Sarker et al. 1999) or Myf5 muscle 
enhancers in mouse (Carvajal, Cox et al. 2001). Also, one of the best-studied 
regulatory regions is around chicken Sox2 gene (Uchikawa, Ishida et al. 2003). Five 
enhancers are enough to recapitulate full Sox2 expression pattern in the central 
nervous system (CNS) of the developing chicken embryos, driving the expression in 
discrete domains at different time points. Another study by Visel et al. nicely 
demonstrated autonomous and modular manner of the enhancer activity (Visel, 
Akiyama et al. 2009). They have used the transgenic assay to test the activity of the 
compound transgene composed of previously characterized enhancers. Within the 
complex transgene, individual enhancers acted in the autonomous manner, without 
inhibiting or modulating the activity of the others. Individual modules kept their 
specificity, driving the expression of the reporter gene in multiple discrete non-
overlapping domains in the embryo (Visel, Akiyama et al. 2009). 
Recently, a term ‘shadow’ enhancer has been proposed for redundant function 
of multiple enhancers that ensures precise gene expression and robustness under 
variable environmental factors (Hong, Hendrix et al. 2008; Visel, Akiyama et al. 
2009; Frankel, Davis et al. 2010; Hobert 2010). Under optimal conditions ‘primary’ 
enhancer is enough for the full expression of the gene. When conditions change (for 
example extreme temperatures for Drosophila), ‘secondary’ enhancer is needed to 
maintain the normal expression level (Frankel, Davis et al. 2010). Hong et al. 
proposed this redundancy could be a source of evolutionary novelties (Hong, Hendrix 
et al. 2008). However, as I will demonstrate in this thesis, multiple enhancers driving 
the expression in the overlapping domains need not act redundantly but 
synergistically and they may represent modules active in different time points during 
development. 
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Identification of enhancers 
The apparent random distribution of cis-regulatory elements along the 
chromosomes greatly complicated their identification and mapping of all the 
enhancers of a particular gene. For a long time after their discovery, one way of 
identifying regulatory sequences was to clone the 5’ region of the gene upstream of 
the reporter gene and observe its expression in the transgenic animal (Hough-Evans, 
Franks et al. 1987). This transgenic assay method was often slow and technically 
demanding, and could not reveal the full regulatory repertoire of a gene since many 
enhancers can be located far away from the gene they regulate.  
Later on, multiple whole genome sequencing has enabled whole genome 
alignments between evolutionary distant organisms and revealed conserved regions in 
the genome that do not correlate with the exons. Since evolutionary conservation of 
non-exonic regions of the genome could implicate their regulatory function, these 
conserved noncoding sequences are good candidates for regulatory elements (Muller, 
Blader et al. 2002). And indeed, functional analysis in transgenic assay with reporter 
gene(s) showed that many of them have regulatory potential. However, this approach 
is somehow limited, since not all the regulatory elements need to be evolutionary 
conserved (can be species-specific) nor conserved regulatory functions need to have 
conserved sequences of regulatory elements (Blow, McCulley et al. 2010) 
Additionally, even when conserved sequences show the regulatory potential in the 
reporter gene assay, it is not always possible to assign the target gene just by the 
known position of the conserved element. 
Significant contribution to the enhancer identification genome-wide came 
from the investigation of chromatin modifications. In order to perform their function, 
enhancer sequences need to be accessible for the binding of the transcription factors. 
For that purpose, remodeling of the chromatin at the enhancer positions needs to take 
place. Places in the genome of the relaxed nucleosomal array are exposed to accept 
DNA binding factors and are assumed to play a regulatory role. At the same time, 
these sequences are more sensitive to the digestion by DNase I (Wu, Bingham et al. 
1979). Therefore, mapping of DNase I hypersensitive spots in the genome was one of 
the early methods to investigate potential enhancer sequences throughout the genome. 
Chromatin immunoprecipitation coupled by parallel sequencing (ChIP-seq) 
enabled genome-wide discovery of protein binding sites. The method is based on the 
cross-linking of proteins and DNA, immunoprecipitation of the complexes by the 
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antibodies specific for the protein and sequencing of the DNA fragments (Robertson, 
Hirst et al. 2007). This way sequences that bind protein of interest can be detected 
throughout the genome. When transcription factors that regulate a particular gene are 
known, ChIP-seq can determine candidate enhancers for that gene. However, most of 
the time the situation is not so simple since genes, particularly the ones expressed in 
several tissues, have multiple enhancers that respond to various tissue-specific protein 
factors.  
ChIP-seq genome-wide studies also revealed that enhancers have so-called 
“chromatin signatures” – post-translational modifications of different core histone 
residues. This in turn led to the suggestion of a histone code hypothesis: post-
translational modifications of the histones carry the regulatory information and create 
chromatin environment that influences gene expression (Ruthenburg, Li et al. 2007). 
It has been shown that the monomethylation of lysine 4 in histone H3 (H3K4Me1) 
with the absence of trimetylation (H3K4Me3) is specific for the enhancers, while the 
opposite holds true for the promoters of transcriptionally active genes (Heintzman, 
Stuart et al. 2007). In addition, enhancers have acetylated lysine 27 in histone H3 
(H3K27Ac) (Creyghton, Cheng et al. 2010; Rada-Iglesias, Bajpai et al. 2011). This 
acetylation is done by the activity of acetyltransferase p300, an almost ubiquitously 
expressed transcriptional co-activator (Eckner, Ewen et al. 1994; Yao, Oh et al. 1998). 
Visel et al. performed ChIP-seq on three isolated mouse embryonic tissues (forebrain, 
midbrain and limb) using antibodies for p300 (Visel, Blow et al. 2009) and showed 5 
to 16-fold better prediction of enhancer location as well as the tissues where they are 
active than comparative genomics. 
The advantage of genome-wide identifications of various chromatin marks and 
binding of p300 is that they offer the insight into tissue-specific distribution of the 
active enhancers. However, these marks are dynamic, and consequently change as the 
cells determine their fates. Acetylation of H3K27Ac by p300 marks the transition 
between “poised” enhancers in embryonic stem cells and active ones in particular cell 
lineage (Creyghton, Cheng et al. 2010; Rada-Iglesias, Bajpai et al. 2011). Another 
characteristic of “poised” enhancers is H3K27Me3 that is lost upon this transition.  
These and similar studies highlight the importance of the chromatin structure 
in gene regulation. They also produce a rough estimate of 105-106 enhancers in the 
human genome (Heintzman, Hon et al. 2009). However, this is just a very rough 
estimation, since many more histone modifications are still not investigated and the 
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ones studied so far do not always offer good enrichment. What is more important, 
genome-wide studies do not offer the prediction of the target genes for the enhancers 
nor the correlation of their signatures to the their function in gene regulation.   
Mechanism of enhancer activity 
Enhancers regulate transcription by helping to recruit RNAPII to the promoter 
region (Maston, Evans et al. 2006). Various transcription factors bound to enhancers 
interact with the mediator complex or TFIID. In addition, these transcription factors 
can also recruit chromatin remodeling complexes and enzymes that modify histones 
(Clapier, Langst et al. 2001). This leads to decondensation of the chromatin and easier 
accessibility of other members of active transcription complexes.  
However, the intriguing distribution of enhancers at considerable distances 
from their target genes raises the question of how the regulation is achieved 
physically. Early studies on bacterial and phage repressors Gal, AraC and λ showed 
that they can loop out DNA sequence between two binding sites and led Ptashne to 
propose looping model for the interactions between distally positioned DNA 
sequences (Ptashne 1986). Looping model was for a long time popular hypothesis for 
enhancer-promoter interactions. Still, the distances in phages are in the range of 
several kilobases – much less in comparison to hundreds of kilobases between some 
vertebrate enhancers and their target promoters. The direct proof for physical 
interactions of distal DNA sequences in mammals came relatively recently, from the 
studies on human β-globin locus (Carter, Chakalova et al. 2002; Tolhuis, Palstra et al. 
2002).   
Human β-globin locus comprises of several genes that code for proteins 
expressed in different times during embryonic and postnatal life. ε is an embryonic 
gene followed by fetal Aγ and Gγ, pseudogene ψ and adult genes δ and β. 5’ from ε 
gene is Locus Control Region (LCR) characterized by five erythroid-specific DNase I 
hypersensitive sites H1-H5. LCR has diverse regulatory functions, including enhancer 
and insulator activity, changes of the chromatin structure and positioning within the 
nucleus (Mahajan, Karmakar et al. 2007). This locus was a model region for variety 
of studies for more than half a century and depth of investigation and the intriguing 
organization of genes and various regulatory elements within made it an appropriate 
model for study of gene regulation.  
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Two novel methods, RNA TRAP (Carter, Chakalova et al. 2002) and 
Chromosome Conformation Capture (3C) (Dekker, Rippe et al. 2002), were applied 
for the study of sequence interactions within β-globin locus (Carter, Chakalova et al. 
2002; Tolhuis, Palstra et al. 2002). These experiments showed that regulators within 
LCR physically interact with active β-globin genes and loop out the region in 
between. The whole chromatin structure was named Active Chromatin Hub (ACH) 
(Tolhuis, Palstra et al. 2002) and authors hypothesized that it is needed for 
transcription initiation in the repressive chromatin environment. Crucial role in its 
formation have transcription factors that bind distant regions of DNA. Their knockout 
was shown to abolish transcription of the genes within β-globin locus (Drissen, 
Palstra et al. 2004; Vakoc, Letting et al. 2005). Chromatin loops were shown to 
contribute to enhancer-promoter link as well in other loci; for example combination of 
3C and 3D fluorescent in situ hybridization (FISH) method revealed interaction of 
Shh and its limb enhancer ZRS (Amano, Sagai et al. 2009).  
Additionally, it seems that the whole tridimensional nuclear organization plays 
a significant role in regulation of gene expression. It has been shown that active genes 
mainly occupy central part of the nucleus whereas inactive ones are localized to the 
periphery. Tethering of the reporter gene to the nuclear lamina repressed the 
transcription of the reporter gene (Andrulis, Neiman et al. 1998; Finlan, Sproul et al. 
2008). However, this is not absolutely the case; for example, in yeast active genes are 
found at nuclear pores (Taddei 2007). Also, β-globin locus changes its position within 
the nucleus from the periphery at early maturation stage to more interior location as 
maturation proceeds (Ragoczy, Bender et al. 2006). Furthermore, different 
chromosomes form so called “chromosomal territories” (CT) within the nucleus. 
Individual gene loci can loop out into another CT (Amano, Sagai et al. 2009) or be 
co-localized with other loci in RNAPII factories (Sutherland and Bickmore 2009) or 
other nuclear structures: nucleoli, Cajal bodies, PML bodies and splicing speckles. All 
these structures influence gene expression and enable colocalization and temporal and 
spatial co-expression of similarly regulated genes from different chromosomes 
(Ferrai, de Castro et al. 2010). It is not yet clear however whether this colocalization 
forms transcription factories or are genes actively drawn towards already preformed 
structures (Schoenfelder, Sexton et al. 2010).  
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Also, these observations are not an absolute rule. The studies HoxB and HoxD 
clusters on decondensation and looping out from their respective CTs revealed these 
two processes are present during activation of both clusters (Morey, Da Silva et al. 
2007). However, while HoxB genes both loop out and decondense as their activation 
is initiated in the embryonic tissues, HoxD genes display differences in these 
processes. In the embryonic stem cells looping out precedes decondensation, in the 
tail bud these processes are simultaneous and in the limb buds decondensation takes 
place without the genes moving from their CTs. The alterations in these mechanisms 
may reflect differential recruitment of HoxD genes in developmental processes.  
 
2.1.2. Specificity of enhancer interactions 
Specificity of promoter-enhancer interactions 
Most enhancers activate only one gene, ensuring the specificity of enhancer-
promoter interaction. However, enhancer sharing is not as limited as usually thought. 
For example, all the genes within HoxD cluster are controlled by Global Control 
Region (GCR) located outside the cluster (Spitz, Gonzalez et al. 2003). Similarly, in 
another well-studied gene cluster, human β-globin, Locus Control Region (LCR) 
comprises of several regulatory sequences responsible for isolating genes into the 
loop and activating them sequentially during embryonic, fetal and adult period 
(Tolhuis, Palstra et al. 2002). Additionally, shared enhancers can be promiscuous, 
causing activation of bystander genes, as is the case with Lnp and Evx2 located next 
to HoxD cluster (Spitz, Gonzalez et al. 2003).  
Since multiple enhancers are often interspersed among non-related genes and 
throughout long chromosomal distances, there is a need for mechanism(s) that will 
specify enhancer interaction with the promoter of its cognate gene in a certain subset 
of cells and/or at the appropriate time. Additionally, unwanted interactions with non-
target genes should be prevented as well as ectopic expression of the target gene or its 
repression by spreading of heterochromatin.  
Several mechanisms have been proposed to account for enhancer-promoter 
specificity. For example, enhancers can selectively bind specific DNA elements 
within the core promoter (Juven-Gershon, Hsu et al. 2008). Experiments on 
Drosophila showed differential activation of genes having TATA box or DPE/Inr 
containing promoters. Butler and Kadonaga investigated pairs of Drosophila 
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transgenic lines with GFP reporter gene and TATA box or DPE-containing promoters 
inserted at identical genomic locations and monitored enhancer-driven reporter gene 
expression (Butler and Kadonaga 2001). They observed that different enhancers 
selectively drive the expression of GFP in one or the other construct and concluded 
that core promoters play active role in gene regulation. However, the authors also note 
this is most probably the case only for a limited group of enhancers, since 14 of 18 
tested lines did not show any bias towards TATA box or DPE-containing promoters. 
Juven-Gershon et al. showed that majority of Drosophila hox promoters contain DPE 
instead of TATA box and that Caudal, the main transcriptional activator of these 
genes preferentially binds DPE promoters (Juven-Gershon, Hsu et al. 2008). This 
suggested the important role of promoter elements in achieving specificity of gene 
activation and regulation.  
Another proposed mechanism for the regulation of enhancer-promoter 
interactions is by the action of tethering elements (Calhoun, Stathopoulos et al. 2002). 
In Drosophila Antennapedia complex T1 and AE1 enhancers regulate Sex combs 
reduced (Scr) and fushi tarazu (ftz) genes, respectively. Calhoun et al. discovered a 
tethering element ~100 bp upstream of Scr that recruits T1 enhancer. T1 avoids ftz 
promoter located between T1 and Scr promoter and selectively activates Scr gene. 
However, various enhancers are able to activate non-related promoters when 
taken outside their natural context. Yet another mechanism to prevent these unwanted 
interactions in the genome is by the action of other two types of long-range 
regulators: insulators and silencers. 
Insulators 
Insulators are neutral DNA sequences that prevent enhancer-promoter 
interactions when positioned between the two and/or can prevent spreading of the 
heterochromatin. Therefore, insulator is a term that has two meanings: enhancer 
blocker and chromatin barrier. Several insulators have a dual function, even if they 
can be separated. Two best-studied examples of insulators are gypsy element in 
Drosophila and chicken HS4 element. 
Yellow gene in Drosophila is controlled by an array of enhancers each 
responsible for pigmentation of a particular part of fly or larval body. When inserted 
between an enhancer and a promoter, gypsy insulator element causes mutant 
phenotype in the region of the body for which coloration this particular enhancer is 
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responsible. Enhancer(s) proximal to the promoter are not affected, suggesting that 
insulator does not have stimulatory or silencing effects. Although position-dependent, 
the orientation of gypsy element did not play any role in its activity (Geyer and Corces 
1992). Additionally, it has been shown in the same study that protein Suppressor of 
Hairy Wing (Su(Hw)) binds to gypsy element and is necessary and sufficient for its 
insulating function. 
Importantly, gypsy element can override promoter bias. This was nicely shown 
in the experiments with Drosophila AE1 and IAB5 enhancers (Ohtsuki 1998). Both of 
these enhancers can activate TATA box and DPE containing promoters when 
positioned between the two. However, they preferentially activate TATA box 
containing ones. This biased interaction was blocked when gypsy element was 
positioned between the enhancer and TATA box promoter and the activity of the 
enhancer was transferred to DPE promoter. 
As described earlier, human β-globin locus proved to be a useful model for 
variety of studies, including gene regulation. Early experiments revealed that Locus 
Control Region (LCR) positioned 5’ from epsilon gene behaves in a polar manner: it 
has an ability to cause decondensation of chromatin 200 kb downstream (Elder, 
Forrester et al. 1990) and it only activates the genes on its telomeric and not 
centromeric side (Tanimoto, Liu et al. 1999). On the other hand, upstream region 
stays highly condensated in erythroid cell lines (Stalder, Larsen et al. 1980), 
suggesting the presence of some kind of boundary element. This activity was 
associated with an insulator element embedded in LCR. Studies of HS4, a chicken 
homologue of HS5, showed that this element indeed functions as an insulator, 
blocking the enhancer activity of LCR to the reporter gene when positioned between 
the two. It also prevents LCR from displacing the nucleosomes from the promoter of 
the reporter gene, thus acting as a boundary element for chromatin modifications 
(Chung, Whiteley et al. 1993). Later on, the same group reported the discovery of 
DNase I hypersensitive site 3’ from the gene cluster (Saitoh, Bell et al. 2000). 3’HS 
also acts as the boundary element. This particular function of both HS4 and 3’HS 
seems necessary in vivo, where β-globin gene cluster is positioned between foliate 
receptor and olfactory receptor genes. Since inactivity of these genes in erythroid cell 
lines is ensured by high level of chromatin condensation, HS4 prevents spreading of 
the heterochromatin from 5’ direction. On the other side, 3’HS blocks nucleosome 
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displacement by LCR within foliate receptor genes, preventing their unwanted 
activation.  
The protein responsible for HS4 insulator function is the ubiquitously 
expressed CCCTC-binding factor (CTCF) (Bell, West et al. 1999). It comprises of 
eleven zinc finger domains that bind DNA (Filippova, Fagerlie et al. 1996) and is 
conserved from Drosophila to mammals (Moon, Filippova et al. 2005). Genome-wide 
study on CTCF sites in human genome revealed several interesting features (Kim, 
Abdullaev et al. 2007). First, CTCF binding sites are ubiquitously distributed 
throughout the genome, with majority being far from promoters. Second, the authors 
observed sites of high- and low-density of CTCF binding. High enrichment for CTCF 
sites was noticed in the regions with multiple unrelated genes, whereas low 
enrichment spots are correlated with gene clusters. This evidence supports the 
proposed role of CTCF binding sites as insulators: unrelated genes most probably 
have very different expression patterns and should be protected from accidental 
activation by heteologous enhancers. On the other hand, within clusters genes are 
often expressed coordinately, share similar expression patterns and hence regulatory 
regions that are in most cases located outside the cluster. Third, the majority of CTCF 
binding sites share newly defined consensus motif conserved in all vertebrate 
homologs. However, 25% of in vivo binding sites lack it, suggesting the existence of 
at lease one more distinct motif. Finally, most CTCF binding sites are independent of 
the cell type, making CTCF universal protein factor involved in the insulator function. 
An interesting finding is that cohesin, the protein involved in keeping sister 
chromatides together, overlaps with the binding sites of CTCF in the (Parelho, Hadjur 
et al. 2008; Wendt, Yoshida et al. 2008). It was also shown that cohesin is involved in 
cis-interactions within human apolipoprotein (APO) and cytokine (IFNG) loci 
(Hadjur, Williams et al. 2009; Mishiro, Ishihara et al. 2009). Cohesin role in holding 
two sister chromatides could be utilized for intra- and interchromosomal interactions 
that involve CTCF.  
Silencers 
Yet another class of regulatory elements has been recognized to act in a 
negative manner. First silencer was discovered in yeast cells: in the second mating 
locus inactivity of a and α genes is ensured by four sequences bound by SIR protein. 
These sequences were shown to act to heterologous promoters and in a position- and 
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orientation-independent manner (Brand, Breeden et al. 1985). However, current 
understanding of silencers makes a difference between active and passive 
mechanisms (Ogbourne and Antalis 1998). Therefore, silencer elements refer to 
sequences upstream of the gene they regulate and bind transcription factors (called 
repressors) to actively interfere with the assembly of the basal transcriptional 
machinery and repress the gene expression. Another class called negative regulatory 
elements (NREs) is position-dependent and they interfere with the binding of 
transcription factors to other cis-regulatory elements (enhancers), passively repressing 
gene expression. These elements are located up- and downstream of the genes, but 
also sometimes in introns and exons. 
Like other cis-acting regulatory elements, silencers also bind protein factors 
(called repressors) to mediate their function. Additionally, secondary co-repressors 
can be recruited to transmit a repressor signal and interfere with the transcription 
machinery (eg. N-CoR, (Horlein, Naar et al. 1995)).  
One of the most intensively investigated repressors is vertebrate neuronal 
restricted silencing factor / repressor element RE-1 (NRSF/REST). It was found to 
bind neuronal restricted silencing element (NRSE) and represses neuron-specific 
sodium channel gene (SCG10) in non-neuronal cells (Mori, Schoenherr et al. 1992). 
More genes were later discovered to have NRSE sequences and are silenced by NRSF 
(Schoenherr, Paquette et al. 1996). However, NRSF can also act as a positive 
regulator of neuronal genes, depending on the concentrations of protein in cells and 
promoter context (Bessis, Champtiaux et al. 1997). 
The notion that transcriptional activators may also have repressor roles in 
different cells or even in the same cell, but to another gene casts a new light on 
understanding positive and negative gene regulation. One of the best studied 
transcription factors with such dual role is Yin-Yang 1 (YY1) (Shi, Lee et al. 1997). 
Also, Gli3 has both activator and repressor roles during limb development (see later). 
ChIP-on-chip analysis of Gli3 binding sites revealed complex regulatory network of 
this transcription factor (Vokes, Ji et al. 2008). Some of the cis-regulating regions 
were tested in transgenic mice and revealed dual function of Gli3. It will be exciting 
to discover other protein factors involved in both activating and restricting gene 
expression.    
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2.2. Fibroblast growth factor 8 (Fgf8) 
All the regulatory elements described in the previous section are necessary for 
the expression of protein-coding genes. Among those, developmental genes require 
most elaborated regulation. Proper dosage and timing of activation are essential for 
their function during growth and differentiation. Minor changes during these 
processes could lead to severe physical and mental defects. Also, protein products of 
developmental genes are often used in multiple tissues, leading to complex expression 
patterns. Obviously, developmental genes in the genome can be located within gene 
deserts, clusters or gene-rich regions. The more complex expression pattern of the 
gene and its genomic environment, the more elaborated regulation of their 
transcription is required. At the same time, it is a greater challenge to study such a 
complicate genomic environment and the interactions within. As I will describe in the 
following section, fibroblast growth factor 8 (Fgf8) is a developmental gene located 
within a complex genomic environment. 
 
2.2.1. Fgf gene superfamily 
Fibroblast growth factors are members of an evolutionary conserved 
superfamily of genes coding for signaling polypeptides (Itoh and Ornitz 2004) playing 
multiple developmental and metabolic roles. Functionally, these signaling molecules 
can act within the cell (intracellular Fgfs), to the distant cells in an endocrine manner 
(hormonal Fgfs) or to the cells nearby in a paracrine manner (canonical Fgfs). 
Canonical Fgfs are secreted molecules that bind to the extracellular part of 
tyrosine kinase receptors on cell surface. There are four genes coding for seven 
isoforms of these receptors and they have differential preference towards various Fgfs 
(Johnson, Lu et al. 1991; Zhang, Ibrahimi et al. 2006). After binding, two receptors 
form a homodimer, helped by the heparan sulfate bridge (Mohammadi, Olsen et al. 
2005), and activate kinase activity of the intracellular parts that cross-phosphorylate 
tyrosine residues. This subsequently activates several intracellular signal transduction 
pathways, for example Ras-Raf pathway, phosphoinositide-3 kinase pathway and 
phospholipase Cγ (Thisse and Thisse 2005). 
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2.2.2. Fgf8 is a developmental gene 
Fgf8 is a member of Fgf8/17/18 subfamily and codes for a canonical Fgf – a 
secreted molecule that signals via Fgf tyrosine kinase receptors FGFR1c, 3c and 4 
(Zhang, Ibrahimi et al. 2006). It is mapped to mouse chromosome 19. Seven different 
isoforms are expressed in mouse embryo, due to alternative splicing of five exons 
(Crossley and Martin 1995). Fgf8 is expressed in multiple signaling centers in mouse 
embryo that guide the patterning and development of limbs, MHB and elongation of 
body axis. Additionally, several expression domains were identified (telencephalic 
commisurral plate and pharyngeal arches), suggesting their signaling activity. Indeed, 
later studies showed that Fgf8 plays an important role during development of multiple 
organs by acting as a morphogen or a mitotic signal. 
Fgf8 signal starts to be visible already in the prestreak embryo at embryonic 
day E5.75 and continues to be expressed throughout gastrulation period marked by 
the emergence of the streak at E6.5 (Crossley and Martin 1995). Knockout 
experiments showed that Fgf8 is necessary for the gastrulation. In embryos lacking 
Fgf8 cells undergo epithelial-to-mesenchymal transition but do not migrate outside 
the streak. Due to this, mesoderm- or endoderm-derived tissues cannot develop as 
well as neuroectoderm (Sun, Meyers et al. 1999). Consequently, Fgf8 knockout 
embryos do not survive after E9.5. During this early development Fgf8 is also 
involved in establishing left-right asymmetry of the body being a left determinant 
(Meyers 1999). However, its mode of action seems to vary, depending on the species 
considered (mouse, chick, rabbit). Another crucial component is Shh that prevents 
expression of left determinants at the right side of the body. 
After gastrulation Fgf8 continues to be expressed from various signaling 
centers guiding the development of the surrounding tissues. Organs that require Fgf8 
for proper development are: brain, limb, kidney, heart, face and inner ear.  
As shown in Crossley and Martin, Fgf8 is expressed in pharyngeal region 
starting from day E8.0 (Crossley and Martin 1995). Till day E9.0 the signal gets 
restricted to the lateral ectoderm of pharyngeal pouches and grooves and to region of 
telencephalic commissural plate. During the next day and a half extensive 
morphogenesis is taking place, forming frontal regions of the head. Due to this pattern 
of expression, the authors propose the role of Fgf8 in the development of proximal 
head regions. Indeed, later studies showed that inactivation of Wnt signaling pathway 
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leads to downregulation of Fgf8. Mouse embryos lacking Wnt/Fgf8 show severe 
facial defects (Wang, Song et al. 2011).   
Fgf8 is expressed in the cells of the anterior heart field that migrate from the 
pharyngeal region and eventually contribute to the development of right ventricle and 
the outflow tract (Ilagan, Abu-Issa et al. 2006; Park, Ogden et al. 2006). In Fgf8KO 
mutants these two regions are severely affected while the rest of the heart grows 
normally. Impaired development is due to the lower cell proliferation and increased 
cell death, suggesting the role of Fgf8 in maintaining the cell proliferation.   
Fgf8 expression in the early otic vesicle is necessary for the proper ear 
development in both mouse and chick (Ladher, Wright et al. 2005). Similarly, Fgf8 is 
needed for the development or the pronephros, an embryonic kidney crucial for 
proper growth of the adult kidney. Mice lacking Fgf8 fail to develop kidneys and die 
soon after birth (Perantoni, Timofeeva et al. 2005). 
Because of special relevance for the results presented in this thesis, I will 
describe the role of Fgf8 in brain and limb development in a greater detail.  
 
2.2.3. Role of Fgf8 in brain development 
The vertebrate brain is formed from the anterior part of the neural tube located 
dorsally in the developing embryo. After closure of the neural tube, three vesicles 
mark the future brain: prosenceohalon (forebrain) subdivided into telencephalon and 
diencephalon; mesencephalon (midbrain); and rhombencephalon (hindbrain) that is 
divided into metencephalon and myelencephalon. Multiple experiments in zebrafish, 
chick and mouse embryos identified the presence of two organizing centers in the 
brain: commissural plate in the forebrain (Shanmugalingam, Houart et al. 2000) and 
isthmic organizer located in the constriction of the midbrain (Martinez, Crossley et al. 
1999).  
Fgf8 is first detected at E8.0 at the rostral and caudal ends of the neural plate 
(Crossley and Martin 1995). The rostral end will eventually fold to form commissural 
plate whereas the caudal end will by E9.0 form a sharp line of expression at the 
isthmus marking midbrain-hindbrain boundary. While the crucial role of Fgf8 in the 
patterning of mid- and hindbrain has been established, other members of Fgf family 
most probably accompany Fgf8 influence in the pattering of the forebrain (see later). 
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Signaling from commissural plate and telencephalon patterning 
The forebrain develops from anterior neural plate that will give rise to 
telencephalon and diencephalon. In the mouse embryo of day E8.5, Forkhead 
transcription factor gene Foxg1, the main determinant of ventral telencephalic 
identity, starts to be expressed in telencephalic primordium (Tao and Lai 1992). 
Subsequently, telencephalon gets divided into dorsal and ventral parts, each of which 
is further divided to subregions that will eventually give rise to different parts of the 
adult brain. During these early stages Gli3 acts as a dorsalizing factor and its activity 
is counteracted ventrally by the expression of Shh (Aoto, Nishimura et al. 2002). Gli3 
repressor-blocking activity of Shh allows Fgf8 induction in the cells of ventral region. 
Foxg1 initiates Fgf8 expression and there is some evidence that Fgf8 is needed for 
Foxg1 expression, suggesting the existence of a positive feedback loop between the 
two (Storm, Rubenstein et al. 2003; Martynoga, Morrison et al. 2005). Besides Fgf8, 
other Fgfs are expressed in the developing telencephalon, namely Fgf3, Fgf15, Fgf17 
and Fgf18. It seems that Fgfs act in a dose-dependent manner, since removal of the 
activity of these genes by knock down of Fgf receptors leads to the loss of cells with 
ventral identity. The loss is more prominent when two or all three receptor genes are 
impaired. In addition, a more dorsal structure (the cerebral cortex) is also lost, 
indicating that Fgf8 acts as an organizer molecule in telencephalic development 
(Storm, Rubenstein et al. 2003). 
Signaling from midbrain-hindbrain boundary and midbrain development 
The midbrain is separated from the hindbrain by a constriction named isthmus, 
known for its organizing activity to the surrounding tissue. However, even before the 
constriction is visible, its organizing role is established by the expression of various 
secreted molecules and transcription factors (Figure 2). Early on in development, two 
homeodomain transcription factors, Otx2 and Gbx2, start to be expressed: Otx2 in the 
anterior part to rhombomere 1 and Gbx2 posteriorly (Simeone 2000). Initially they 
overlap in the narrow region, but soon they form a sharp boundary, as Gbx2 restricts 
Otx2 to the anterior region up to rhombomere 1.  
Soon after, still in the presomitic stage, Pax2 starts to be expressed in the 
posterior part of mesencephalon and in rhombomere 1 (around Otx2-Gbx2 boundary), 
followed by En1 and Wnt1 in the Pax2 expressing region and Fgf8 in isthmus and 
rhombomere 1. Wnt1 eventually gets restricted to the caudal part of Otx2 domain 
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(Wilkinson, Bailes et al. 1987) and Fgf8 exclusively to isthmus, adjacent to Wnt1 
region (Crossley and Martin 1995).  
Pax2 is crucial for Fgf8 induction – in Pax2 knockouts there are no detectable 
Fgf8 transcripts (Ye, Bouchard et al. 2001) and midbrain does not develop (Bouchard, 
Pfeffer et al. 2000). Similar phenotypes have been observed for En1 (Wurst, 
Auerbach et al. 1994) and Wnt1 knockouts (McMahon and Bradley 1990), indicating 
their role in establishing and maintaining proper midbrain. Pax5 and En2 genes are 
initiated after Fgf8, in the domain overlapping Otx2-Gbx2 boundary (Asano and 
Gruss 1992). Phenotypes of Pax5 or En2 knockouts are milder that those of Pax2 and 
En1 (Wurst, Auerbach et al. 1994).  
Restriction of Fgf8 expression domain to the isthmus at the border between 
the Otx2 and Gbx2 domains is done by a coordinated action of Lmx1b, Wnt1 and Fgf8 
itself (Adams, Maida et al. 2000; Adams 2000; Matsunaga, Katahira et al. 2002). 
Lmx1b is expressed in the isthmus territory, over the domains of Fgf8 and Wnt1 (Guo, 
Qiu et al. 2007). It can induce Fgf8 indirectly, via induction of Wnt1 that positively 
acts on Fgf8. On the other hand, Gbx2 represses Lmx1b and Wnt1, restricting Fgf8 
expression to caudal part of Gbx2 domain (Matsunaga, Katahira et al. 2002; Liu, Li et 
al. 2003). Additionally, Grg4 expressed in mesencephalon inhibits Pax2 that is crucial 
for Fgf8 expression, having as a consequence precise positioning of Fgf8 expression 
to the isthmus (Ye, Bouchard et al. 2001). 
Crossley et al. showed that Fgf8 alone has a transforming effect to the 
prosencephalon, just like grafting of the isthmus, suggesting it is the main signaling 
molecule of the midbrain-hindbrain boundary (MHB) (Crossley, Martinez et al. 
1996). It has been reported that there are seven splicing forms of Fgf8 in the 
developing mouse embryo (Crossley and Martin 1995). The two predominant 
isoforms represented in the developing brain are Fgf8a and Fgf8b. These two 
isoforms are known to have different activities in terms of receptor activation, Fgf8b 
being 100 times more potent than Fgf8a (Sato, Araki et al. 2001). Interestingly, while 
ectopic midbrain expression of an isoform a caused only overgrowth of the midbrain 
and the caudal part of diencephalon due to extensive proliferation of the cells, the 
same experiment with the isoform b transformed the midbrain and caudal forebrain 
into anterior hindbrain (Lee, Danielian et al. 1997). These results additionally 
confirmed Fgf8b as a main isoform involved in the patterning of the midbrain. 
Opposite set of experiments with conditionally knocked out Fgf8 showed extensive 
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cell death leading to the complete lack of midbrain and anterior hindbrain (Chi, 
Martinez et al. 2003). Besides being a patterning molecule, these experiments 
established that Fgf8 also has an important mitogenic role. 
In addition, two other members of the same Fgf subfamily, Fgf17 and Fgf18 
are expresses in the somehow broader midbrain region (Ohuchi, Kimura et al. 2000; 
Xu, Liu et al. 2000). However, no patterning activity was observed with these two 
genes (Liu, Li et al. 2003). Also, even though four different types of Fgf receptors are 
known, only FgfR1 is expressed in the midbrain region; FgfR2 and FgfR3 are 
inhibited by the activity of Fgf8b (Liu, Li et al. 2003; Trokovic, Trokovic et al. 2003). 
However, since Fgf8R1 conditional knockout in the brain did not show as severe 
phenotype as the loss of Fgf8, there must be additional receptor(s) involved in signal 
transduction (Trokovic, Trokovic et al. 2003). 
As mentioned earlier in the introduction, canonical Fgf8 is a paracrine-
signaling molecule that binds Fgf receptors on the cells in the proximity. FgfRs are 
receptor tyrosine kinases with extracellular domain that binds ligand and intracellular 
domain that gets phosphorylated upon ligand binding and dimerisation with another 
receptor. In the midbrain binding of Fgf8 to FgfR1 activates Ras-ERK signaling 
pathway (Sato, Joyner et al. 2004; Echevarria, Belo et al. 2005). This signaling 
pathway includes cascade phosphotylation downstream of FgfR: Ras, then Raf, MEK 
and ERK. Last two members enter nucleus where they initiate transcription of target 
genes. Since MEK and ERK are dually phosphotylated, the signaling cascade is 
extremely efficient, needing only a small initial amount of Ras phosphotylation 
(Echevarria, Belo et al. 2005). 
Signaling from isthmus by Fgf8 has to be tightly controlled. Therefore, 
multiple negative regulators of Ras-ERK pathway are involved. Fgf8 signaling 
induces Sprouty (Spry2) that intracellularly block signal going through Ras-ERK 
pathway (Yusoff, Lao et al. 2002). Sef (Similar expression to Fgf) is a transmembrane 
protein and expressed in Fgf8 overlapping domains. It seems that it prevents tyrosine 
phosphorylation of FgfR1 (Kovalenko, Yang et al. 2003). Known regulator of ERK2 
is Mkp3 (from MAP dual-specificity phosphatase family). This specific interaction 
causes more than 4000 times increase in dehosphotylation of ERK2. Mkp3 alone is 
not activated via cell-proliferative Ras-ERK pathway, but via phosphoinositol-3 
kinase (PI3K) pathway responsible for cell survival and apoptosis (Echevarria, Belo 
et al. 2005).  
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As mentioned before, at the beginning Fgf8 is expressed in rhombomere 1 in 
addition to isthmus, before it is exclusively restricted to the organizer. Initial strong 
signal in the rhombomere 1 activates Ras-ERK signaling pathway, leading to the 
activation of Irx2 transcription factor important for cerebellar development 
(Matsumoto, Nishihara et al. 2004). On the other hand, weak Fgf8 signal in more 
anterior parts defines tectum. 
 
 
 
Figure 2. Patterning of the midbrain 
Scheme represents 6-8 somite stage in chick and gene expression patterns. Initial broad expression 
domain of Fgf8 is narrowed down by the activity of Otx2 and Gbx2. Strong Fgf8 signal will induce 
development of rhombomere 1 and cerebellum. On the other hand, weak Fgf8 signal induces tectum 
development. Regions of activity of multiple other genes that play role in the brain development are 
indicated. For the details, see text. Taken from (Sato, Joyner et al. 2004). 
 
2.2.4. Fgf8 role in limb development 
Limb development 
Tetrapod limbs start as swellings of lateral plate mesoderm, a tissue positioned 
along rostro-caudal body axis, lateral to somites. Early limb buds comprise of 
morphologically identical cells that eventually give rise to different limb elements. 
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carry out rapid gain-of-function analysis. In this paper,
we summarize recent progress on the function of Fgf
signaling in the isthmus by loss- and gain-of-function
analysis, and discuss how the isthmus instructs the
differentiation of the midbrain and cerebellu .
 
Genetic network upstream and downstream of 
Fgf8
 
Many transcription factors and secreted molecules
are expressed around the isthmus (Fig. 1; reviewed by
Joyner 1996; Simeone 2000; Liu & Joyner 2001a;
Nakamura 2001a,b; Rhinn & Brand 2001; Wurst &
Bally Cuif 2001). Wnt1 is one secreted molecule
expressed anterior to 
 
Fgf8
 
 in the isthmus region. Its
expression is initially observed in the entire mes at
early somite stages, and gradually becomes restricted
to the posterior-most mes and dorsal midline of the
central nervous system (CNS) excluding r1. 
 
Wnt1
 
targeted mutant mice have a deletion of the midbrain
and cerebellum and do not maintain 
 
Fgf8
 
 expression
(McMahon & Bradley 1990; Thomas & Capecchi 1990;
 
Fig. 1.
 
Schematic drawing show-
ing gene expression patterns in
mesencephalon (mes)/rhombo-
mere1 (r1) and how Fgf signals
pattern the region. At the 6–8-
somite stage, 
 
En1
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Pax2
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Wnt1
 
,
 
Lmx1b
 
 and 
 
Grg4
 
 are expressed in
presumptive mes and r1. 
 
Otx2
 
 and
 
Gbx2
 
 are expressed in anterior
and posterior neural tissue,
respectively. 
 
Fgf8
 
 is expressed in
a region overlapping both 
 
Otx2
 
and 
 
Gbx2
 
. Around the 12-somite
stage, 
 
Otx2
 
 and 
 
Gbx2
 
 forms a
sharp border at the isthmus imme-
diately anterior to 
 
Fgf8
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En1/2
 
 and
 
Pax2/5
 
 are expressed in both mes
and r1. 
 
Fgf8
 
 becomes confined to
the isthmus, overlapping with
 
Gbx2
 
 expression. 
 
Wnt
 
 expression
becomes restricted to the post-
erior most mes and dorsal midline.
 
Grg4
 
 is expressed in a gradient
complementary to 
 
En2
 
 in the ant-
erior mes and diencephalon (di).
Around the 5–8-somite stage, the
site where 
 
Fgf8
 
 mRNA is localized
receives the strongest Fgf8 signal
and causes activation of the
Ras-extracellular signal-regulated
kinase (ERK) pathway. This region
then acquires characteristics of r1,
with the cerebellum differentiating
dorsally. In contrast, in the mes,
the Fgf8-Ras-ERK pathway is only
activated weakly and the tectum
differentiates dorsally. Otx2 raises
the threshold for Fgf8b signaling to
induce cerebellar differentiation.
Tel., telencephalon; di, dience-
phalon; mes, mesencephalon;
met, metencephalon; rh, rhomben-
cephalon.
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There are three axes: proximo-distal (P-D; shoulder to fingers), anterior-posterior (A-
P; thumb to little finger) and dorso-ventral one (D-V; back to front). All three axes 
have individual signaling centers responsible for patterning along the axis; however, 
interconnection of these pathways is necessary for the establishment of the proper 
limb morphology (see later).  
Soon after limb bud initiation at E9.0 distal-most ectoderm thickness into a 
structure called Apical Ectodermal Ridge (AER). Surgical removal of AER performed 
decades ago on chick limb buds shortened or completely ablated the limbs, depending 
on the time of the removal (Saunders 1948; Summerbell 1974). This established that 
the signaling from the AER is a key process in the elongation of P-D axis. Based on 
these findings, a progress-zone model of limb development has been proposed: 
mesenchymal cells closest to AER are constantly proliferating under the influence of 
the signals from AER. Their differentiation into various elements of the limb depends 
on when they exit the progress (proliferative) zone (Summerbell, Lewis et al. 1973).    
Proximo-distal patterning and the role of Fgf8 
The signaling molecule expressed in the AER is Fgf8. At E9.0 Fgf10 signal 
from mesenchyme of the limb bud initiates Fgf8 in the ectodermal cells that will form 
thickening of AER (Sekine, Ohuchi et al. 1999). Soon, an epithelial-mesenchymal 
feedback loop between these two signaling molecules is established (Ohuchi, 
Nakagawa et al. 1997). Although other members of Fgf family (Fgf4, Fgf9 and 
Fgf17) are subsequently expressed in the AER, their individual knockout does not 
impair limb development (Mariani, Ahn et al. 2008). On the other hand, conditional 
knockout of Fgf8 in limbs impairs Shh expression leading to undeveloped limbs with 
missing parts of limb skeleton (Lewandoski, Sun et al. 2000). This experiment 
showed that Fgf8 alone is necessary for proper limb outgrowth. However, combined 
inactivation of Fgf8 and Fgf4 results in a more severe phenotype. Complementary, 
Fgf4 and Fgf8 are enough to determine P-D axis (Sun, Mariani et al. 2002). These 
authors’ suggested model implies the role of these two factors in enabling the survival 
of the pool of cells needed to build the future limb. More recently, Lu et al. conducted 
the experiment in which they introduced Fgf4 gain-of-function allele in the wild type 
and limbs lacking Fgf8 (Lu, Minowada et al. 2006). They observed that conditional 
gain-of-function of Fgf4 in both types of limbs causes polysyndactyly. Additionally, 
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the Fgf8 null limb phenotype was rescued by the activity of Fgf4. These results 
suggest similar roles of both ligands during limb patterning. 
Complex interplay between molecules expressed in the developing limb buds 
and observed phenotypes could not be explained by relatively simple progress-zone 
model and has led to the proposal of two alternative ones: two-signal and 
differentiation front model. 
Two-signal model is based on the observation that retinoic acid (RA) signals 
from the proximal part of the limb bud and is being antagonized by Fgf signals from 
the AER (Mercader, Leonardo et al. 2000). Retinoic acid and Fgf8 determine 
proximal and distal cell identities, respectively – RA by inducing Meis1/2 genes, Fgf8 
by inducing Hoxa11 and Hoxa13. Recent comparison of transcriptomes of wild type 
and Shh deficient limbs revealed the expression of RA, among the other proximal 
genes, in the more distal domains in the limbs lacking Shh (Probst, Kraemer et al. 
2011). At the same time, RA inhibitor Cyp26b1 is downregulated in the distal 
domain. Since Fgf signaling from the AER regulates Cyp26b1, its expression is 
increased by the Shh upregulating Fgfs in the AER. Cyp26b1 activity inhibits RA in 
the distal part of the limb bud, restricting it to the more proximal region.  
Differentiation front model postulates that early limb mesenchyme will by 
default give rise to more proximal structures, but they are changed to distal structures 
by AER signals. Fgfs from AER maintain distal cells in the undifferentiated 
proliferative state and as they divide, the differentiation front (the border between 
determined and proliferating cells) moves distally (Tabin and Wolpert 2007). As cells 
move out from the reach of the AER signals they undergo differentiation into 
different limb elements.  
Anterior-posterior patterning and the role of Shh 
Apart from proximo-distal axis, the limb also develops along anterior-
posterior one where digit identities are established. This axis is defined by another 
signaling center: the zone of polarizing activity (ZPA) located in the posterior 
mesenchyme. Grafts of this tissue to the posterior of the limb caused mirror image of 
the digits (Saunders 1948; Tickle 1981). In 1968 Wolpert proposed a model by which 
a morphogen is expressed in ZPA and its gradient in the anterior direction defines the 
identity of limb elements by three thresholds (French-flag model) (Wolpert 1969). 
The main molecule signaling from ZPA is Shh (Riddle, Johnson et al. 1993).   
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In the mesenchyme of the developing limb bud Hand2 (Charite, McFadden et 
al. 2000) and 5’-HoxD genes (Tarchini, Duboule et al. 2006) are expressed and induce 
Shh. Additionally, Gli3 acts as a transcriptional repressor to Hand2 and 5’-HoxD 
genes and therefore restricts Shh activity in anterior part of the limb bud (te Welscher, 
Fernandez-Teran et al. 2002). In turn, Hand2 is needed for restriction of Gli3R 
activity in the posterior part.  
Shh acts as a spatial gradient, but time of the exposure defines the digit 
identity. It has been established that digits 4 and 5 and part of digit 3 are formed from 
the cells that expressed Shh. The longer the expression, the more posterior digits are 
form (Ahn and Joyner 2004; Harfe, Scherz et al. 2004). Digits 2 and anterior part of 
digit 3 depend on paracrine Shh signaling, whereas digit 1 does not require exposure 
to Shh (Kraus, Fraidenraich et al. 2001). 
Interplay between A-P and P-D axes and integrative model of limb development 
As described above, Fgf8 and Shh are two main signaling molecules 
responsible for the development of P-D and A-P axes, respectively. However, the 
molecular events along those two limb axes are interconnected (Figure 3). The cross 
talk between the two axes is explained by self-regulatory Shh-Grem1-Fgf epithelial-
mesenchymal loop (Benazet, Bischofberger et al. 2009). BMP4 suppresses the 
expression of Fgfs in AER, but also initiates the expression of its antagonist Grem1. 
As levels of Grem1 rise, it antagonizes BMP4 activity, allowing Fgf signal from AER 
to act on Shh expression. This in turn induces even higher activation of Grem1, 
leading to increased signaling from AER. Extremely important function of Grem1 is 
to induce a switch from BMP4-Grem1 to Shh-Grem1-Fgf loop. As the number of 
cells in the limb bud mesenchyme rises, Grem1 gets further apart from Shh signaling 
and the feedback loop terminates by itself. Considering the complex interdependent 
nature of signaling within the developing limb bud, recently Zeller et al. proposed a 
model that integrates molecular events in space and time (Zeller, Lopez-Rios et al. 
2009).  
Initially, two signaling centers are established independently. Mesenchymal 
Fgf10 activates Fgf8 in future AER whereas Gli3 restricts activity of Hand2 and 5’-
HoxD genes to the posterior part of the limb bud, defining region of Shh expression. 
Fgf8 and Shh signaling defines two limb axes and Shh-Grem1-FGF e-m feedback 
loop is established. Shh-FGF interaction also influences AER-FGF/CYP26B1/RA 
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module, ensuring restriction of RA signaling to the proximal region of the limb bud 
(Probst, Kraemer et al. 2011). 
Next, in the proliferation, determination and differentiation phase limb grows 
coordinately along both axes. As it elongates along P-D axis, more proximal cells exit 
the influence of AER Fgf signals and start expressing Sox9, which activates 
chondrogenesis (Healy, Uwanogho et al. 1996; Tabin and Wolpert 2007). At the same 
time, elongation of the A-P axis defines first anterior and then more posterior digits. 
Increasing pool of mesenchymal cells eventually terminates Shh-Grem1-FGF e-m 
feedback loop. Termination of the loop up regulates BMP expression. BMP signals 
from the interdigital mesenchyme to the digit primordia at the tip of each forming 
digit, just below AER (Dahn 2000). This signaling differs for each condensing center. 
However, there is still no proof that BMP is directly involved in defining digit 
identities. They can actually be defined by different signaling inputs during outgrowth 
of the limb bud and by the A-P position, rather than specific molecules. Therefore, 
BMPs can actually play a role of a “reminder” for cells about the molecular cues they 
received over certain period of time.  
 
 
 
Figure 3. Phases of limb bud development and interconnection of feedback loops 
a) In the initiation phase BMP4 upregulates GREM1, while Shh expression is activated independently 
of GREM1 and AER-FGFs. 
b) During propagation phase Shh upregulates GREM1 that in turn reinforces AER-FGF and ZPA-Shh. 
E-m feedback loop is established. 
c) Termination phase is characterized by the broadened gap between ZPA-Shh and GREM1 
expression. Combined with AER-FGF inhibition of GREM1, this terminates the feedback loop. 
Taken from (Zeller, Lopez-Rios et al. 2009). 
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Figure 3 | Interlinked feedback loops define a self-regulatory limb signalling system. The mesenchymal bone 
morphogenetic protein (BMP4; light blue), sonic hedgehog (SHH; red), gremlin 1 (GREM1; purple) and apical 
ectodermal ridge-derived fibroblast growth factor (AER-FGF; green) xpression d mains during mouse limb 
organogenesis are indicated schematically. The interlinked signalling feedback loops14 that operate at each stage are 
shown as solid lines. Broken lines indicate inactive loops. a | Initiation phase: BMP4 upregulates Grem1 expression  
in a fast initiator loop (~2 h loop time). Shh expression and signalling are activated independently of GREM1 and 
AER-FGFs. b | Propagation phase: the establishment of loops that control the distal progression of limb bud 
development. SHH predominantly upregulates Grem1 expression. GREM1 reinforces AER-FGF and zone of polarizing 
activity-deriv d SHH (ZPA-SHH) signalling by an epithelial–mesenchymal feedback loop (with a loop time of ~12 h). 
The activity of the fast BMP4–Grem1 initiator module is low. However, this low BMP activity controls the length of the 
AER (not shown). c | Termination phase: the widening gap between ZPA-SHH signalling and the Grem1 expression 
domain, together with the onset of AER-FGF-mediated inhibition of Grem1, terminates the signalling system. As a 
consequence, BMP4 activity is likely to increase again.
and finally it rises again and is likely to participate in 
the determination of digit identities as the system is 
terminated (see below).
An integrative model for limb organogenesis
The studies discussed above reveal the complexity of 
the interactions that link specification of the PD and 
AP limb bud axes with outgrowth, determination 
and chondrogenic differentiation. To make progress 
in the identification and understanding of the systems 
of morphological regulation, it is important to con-
sider AP and PD limb bud axis development together, 
rather than as separate developmental processes, as 
is currently the norm. Here, we set out an integrative 
model that is based on the literature discussed and that 
focuses on the mechanisms and interactions that are 
most likely to be important. In addition to both limb 
bud axes, temporal and spatial aspects of gene function 
must be considered; a gene product might be essential 
at one stage, but later might be dispensable or have a 
different function14 (for example, see BMP4 in FIG. 3). 
In developing our integrative four-step model, we 
have realized that there are still substantial gaps in our 
molecular and cellular understanding of how limb bud 
development is orchestrated. In particular, certain key 
findings are still disputed (for example, the role of RA 
in limb bud initiation, discussed above) or have only 
been evidenced in one particular species (for example, 
the roles of BMPs in the determination of digit iden-
tities, see below). Therefore, this integrative model is 
imperfect, but it should provide an interesting and 
useful framework for developing a holistic approach 
to study the regulatory systems and interactions that 
control limb organogenesis.
Initiation and early specification. During limb bud 
initiation (FIG. 4a), the two main signalling centres are 
established. It is possible that the nascent limb bud mes-
enchyme is initially of proximal and/or anterior char-
acter19,60. The most distal and posterior cell identities 
are likely to be specified first by the onset of FGF8 sig-
nalling in the AER (FIG. 1d) and GLI3-mediated restric-
tion of Hand2 and 5?-Hoxd gene expression. These 
GLI3–HAND2 mediated interactions pre-pattern the 
limb bud along its AP axis and activate SHH signal-
ling at the posterior limb bud margin37. Alternatively, 
AP polarity might be transferred from the embryonic 
body axis (head to tail) to the limb field, as is the case 
for the dorsoventral limb bud axis61,62. To understand 
these initiating events, it will be essential to identify the 
mechanisms that activate and restrict the expression of 
key regulatory genes in the lateral plate and limb field 
mesenchyme (for example, Gli3, Hand2, 5?-Hoxd, Bmp4 
and Fgf10).
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Tetrapod limbs versus fish fins 
Fins and limbs are homologous organs (Tanaka, Munsterberg et al. 2002) and 
a great deal of study has been dedicated to investigate comparative gene expression 
between the two. In zebrafish, stickleback and other studied fish species, two 
orthologues of Fgf8 genes are found: fgf8a and fgf8b. This is due to whole-genome 
duplication in the teleost fish lineage some 400 million years ago (Amores 1998). 
Jovelin and collaborators showed by in situ hybridization that two co-orthologues 
share some domains of expression, but have unique ones as well (Jovelin, He et al. 
2007). They also noticed that in the developing fin bud only fgf8a is expressed. This 
expression however, starts only after the fin bud is formed and it remains in the distal 
margin of the fin bud but not in AER. They hypothesized that the function of fgf8 in 
the fin is not as conserved among vertebrates as postulated before. Peculiar spatial 
and temporal expression of fgf8a suggests that orthologous genes do not necessarily 
need to have strictly orthologous functions in different organisms. Other 
investigations revealed that Fgf8 mutation in zebrafish affects brain development 
(acerebellar (ace) mutants), but fins develop properly (Reifers, Bohli et al. 1998). 
Also, Fischer et al. showed crucial role of fgf24 upstream of fgf10 in zebrafish fin bud 
development (Fischer 2003). fgf16 that acts downstream of fgf10 and is expressed in 
the AER, is needed for the induction of fgf4 and fgf8a (Nomura, Kamei et al. 2006). 
Unlike the situation in chick or mouse limb buds, where Fgf8 signaling from the AER 
and Shh from posterior mesenchyme form a feedback loop needed for the limb 
outgrowth, in fish fin buds fgf16 is a signal from AER that responds to fgf10 signaling 
and forms a feedback loop with shh (Nomura, Kamei et al. 2006).  All the mentioned 
studies indicate that, contrary to the earlier assumptions tetrapod limbs and fish fins 
do not employ strictly conserved strategies of development. In a more general way, 
they call to caution when studies of the roles of orthologous proteins in developmental 
processes are conducted on limited number of model species. 
 
2.3. Limb malformations 
As described in the previous section, proper limb development requires 
precisely orchestrated action of multiple genes over defined period of time and at the 
certain positions in the limb bud. Clearly, minor changes in the gene expression can 
lead to severe malformations in the limbs. Therefore, it is not surprising that limb 
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malformations are among the most common congenital human malformations, present 
in as many as 1 in 500 births. These include different levels of arm truncation to 
impaired number and / or finger morphology. Genetic causes are often mutations in 
key genes controlling limb development. However, in the last decade it is becoming 
more and more obvious that the whole variety of developmental defects, including 
limb malformations, do not have their cause in mutations within coding regions 
(Kleinjan and van Heyningen 2005) (VanderMeer and Ahituv 2011). A large amount 
of limb disorders are associated with regulatory mutations, which affect not the 
protein, but the expression pattern of the gene. This can happen either by the point 
mutations in the enhancer itself, dissociation of the enhancer by the breakpoint on the 
chromosome or modified chromatin structure. As a consequence, both loss- and gain-
of-function of genes can occur. 
Mutations within the Shh limb enhancer ZRS are probably the most 
investigated cis-regulatory mutations. As discussed earlier, Shh is a morphogen 
expressed in the proximal limb bud mesenchyme called ZPA and is extremely 
important for limb outgrowth and patterning along anterior-posterior axis. The 
expression of the Shh in the ZPA is guided by the limb specific enhancer, the ZPA 
regulatory sequence (ZRS), located 1 Mb away from the gene (Lettice, Heaney et al. 
2003). This sequence is both necessary and sufficient for the Shh expression in the 
limb. Multiple point mutations have been identified within ZRS, as well as 
duplications encompassing it. Point mutations cause gain-of-function of Shh in the 
anterior limb mesenchyme and lead to its ectopic misexpression, causing preaxial 
polydactyly (PPD) (Lettice, Heaney et al. 2003). Duplications result in more complex 
cases, including triphalangeal thumb and polysyndactyly (fusion of fingers/toes) 
(Klopocki, Ott et al. 2008). 
Another example of cis-regulatory mutations includes Brachydactyly type A2 
(Dathe, Kjaer et al. 2009). This is an autosomal-dominant disease characterized by 
shortened second and fifth digit due to improperly developed middle phalanges. 
Dathe et al. have investigated ~5.5 kb duplication located more than 110 kb 
downstream of BMP2 on chromosome 20p12 and found a conserved noncoding 
region. A study in transgenic mice showed the activity of this region in developing 
limb bud, suggesting its role as a BMP2 limb enhancer. They have postulated that the 
duplication of a potential regulatory element increases BMP2 expression. Since 
signaling by BMP2 is dose-dependent, changes in the amount of the transcript could 
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lead to a shift in signaling pathway and consequently impaired development of 
skeletal parts of the limb.  
Split hand – split foot malformations 
One group of human limb disorders is split hand – split foot malformations or 
ectrodactyly (Duijf 2003). These malformations are characterized by the absence of 
central digits on both hand and feet. The disease is usually inherited in the dominant 
manner and can be isolated or a part of a syndrome. Symptoms / severity vary among 
different individuals but also between different autopods of the same individual. 
There are five types of isolated SHFM in humans (SHFM1 to 5) and only SHFM4 has 
been related to the mutations in the coding region of a gene (p63). The others are 
caused by chromosomal rearrangements or potentially mutations in distal cis-
regulatory elements. The cause of the phenotype is premature termination of medial 
AER, which leads to truncated limbs and undeveloped digits. 
SHFM1 was linked to 1.5 Mb region on human chromosome 7q21. Seven 
breakpoints that lead to deletions, translocations or inversions have been mapped 
within 700 kb interval including genes Dlx5, Dlx6 and Dss1 (Crackower, Scherer et 
al. 1996). These three genes are expressed during limb development in the AER. 
Combined Dlx5/6 knockout mice show SHFM phenotype (Crackower, Scherer et al. 
1996) (Robledo, Rajan et al. 2002); however, no point mutations were found within 
any of the three genes. Additionally, Dlx5 and Dlx6 were not affected by the mapped 
breakpoints. Crackower et al. thus suggested that the breakpoint could remove an 
enhancer shared by Dlx5 and Dlx6, causing the disruption of a long-range control of 
gene expression. 
Only one family so far has been reported to express SHFM phenotype linked 
to X-chromosome. SHFM2 was mapped to region Xq26. No mutations in 19 genes 
within ~5 Mb region were found, again suggesting possible regulatory mutations as a 
cause (Faiyaz-Ul-Haque, Zaidi et al. 2005).  
SHFM4 is the only ectrodactyly with identified causative gene. It was mapped 
to chromosome 3q27 and multiple point mutations were identified within the gene 
p63 (Ianakiev, Kilpatrick et al. 2000; van Bokhoven, Hamel et al. 2001). Unlike its 
homologue p53 that is tumor suppressor, p63 is involved in developmental processes 
including limb development (Mills, Zheng et al. 1999). It was also shown to act 
upstream of Dlx5/6 and specifically associates with Dlx5 and Dlx6 promoters in vivo 
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(Lo Iacono, Mantero et al. 2008), suggesting altered activation of these genes as a 
cause of the disease. 
SHFM5 was mapped to a critical interval on chromosome 2q24-q31. HoxD 
cluster is located on the telomeric side, whereas Dlx1 and Dlx2 are more centromeric. 
The roles of genes in HoxD cluster and Dlx1/2 in limb development are well 
established. Surprisingly, Dlx1/2 knockouts, both individual and combined, show no 
limb phenotype in mice (Qiu, Bulfone et al. 1997). Deletions within q24 and q31 
cause various forms of limb malformation and the region between Dlx1/2 and Evx2, a 
gene centromeric to HoxD cluster, was suggested to be responsible for the SHFM 
phenotype (Goodman, Majewski et al. 2002). However, it is yet unclear. 
SHFM3 is the most interesting for us since it is mapped to chromosome 10q24 
where our studied region including Fgf8 is located (Nunes, Schutt et al. 1995). No 
mutations in coding regions of any gene were found, but ~500 kb tandem duplication 
between Lbx1 and Fbxw4 (de Mollerat, Gurrieri et al. 2003) (Figure 4). While the 
telomeric breakpoint within Fbxw4 is found in the majority of patients, the 
centromeric one is more variable, with Lbx1 not always included in the duplication 
(Lyle, Radhakrishna et al. 2006). The genes within the region code for proteins of 
various functions: Tlx1 (previously known as Hox11) is a transcription factor involved 
in spleen development and lies centromeric to the breakpoint (Roberts, Shutter et al. 
1994; Brendolan, Rosado et al. 2007); Lbx1 is a homeobox protein necessary for the 
migration of limb myoblasts (muscle precursor cells) and is homologous to 
Drosophila ladybird gene (Jagla, Dolle et al. 1995; Schafer and Braun 1999); βTrC is 
a part of ubiquitin ligase complex (Peifer and Polakis 2000); a DNA polymerase 
lambda (Polλ); Dpcd is yet uncharacterized, but possibly involved in function of 
ciliated cells (Zariwala, O'Neal et al. 2004); Fbxw4 is a member of F-box/WD40 gene 
family involved in ubiquitin-mediated degradation of proteins (Ianakiev, Kilpatrick et 
al. 1999; Sidow, Bulotsky et al. 1999).  
Fgf8 is telomeric to the breakpoint and it is outside the duplicated region. 
βTrC and SUFU (gene further from Fgf8 to the telomeric side) are both involved in 
Wnt/β-catenin signaling cascade. Wnt is required for the AER maintenance and the 
loss of β-catenin in the limb bud leads to termination of AER (Meng, Poon et al. 
2001; Barrow, Thomas et al. 2003). Lyle et al. analyzed their expression profiles in 
lymphoblastoid cells of SHFM3 patients and noticed the up-regulation of both (Lyle, 
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Radhakrishna et al. 2006). However, it still remains to be investigated how significant 
these results are, since lymphoblastoid cells are not obviously relevant for the limb 
development. 
 
 
 
 
 
Figure 4. Phenotype of SHFM3 and genomic region with duplication breakpoints 
Photos show clinical variability of phenotypes, with different penetrance among patients or even 
between different limbs of the same patient. Below, a region on human chromosome 10q24 where the 
duplication is mapped is shown, as well as duplications mapped in different individuals. 
Adapted from (Duijf 2003) and (Lyle, Radhakrishna et al. 2006). 
 
Interestingly, a partial mouse model exists for SHFM3. Dactylaplasia 
spontaneous mutations were identified in Jackson Laboratory (Bar Harbor, Maine) 
and bear striking similarity to human phenotype: Dac mice have missing central digits 
on both fore- and hind limbs and severity of the phenotype is higher in the 
homozygous form (Chai 1981). Both alleles, Dac1j and Dac2j were mapped to the 
mouse chromosome 19, to the locus syntenic to human 10q24. Interestingly, no 
Figure 1. The ectrodactyly phenotype and underlying AER defect. (A) Clinical variability of ectrodactyly. (B) Normal development of the autopod (top) and ectro-
dactyly malformation (bottom). Ectrodactyly is caused by a failure to maintain median AER activity (red) in the developing limb bud (left), leading to the absence
of the central rays (right). (Future) positions of digits 1–5 are indicated. AER, apical ectodermal ridge; PZ, progress zone; ZPA, zone of polarizing activity.
R52 Human Molecular Genetics, 2003, Vol. 12, Review Issue 1
?
?
?
? ?
? ?
?
?
?
?
?
? ?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
? ?
? ?
?
? ?
?
?
?
?
?
? ?? ?? ??
?
?
?
?
?
?
?
? ?
? ? ?
? ?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
? ?? ?? ??
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
? ?
?
? ?
? ?
?
?
?
?
?
?
?
? ?? ?? ??
?
? ?
? ?
?
?
? ? ?
?
?
? ?
?
?
?
?
?
?
? ?
?
?
? ? ?
? ? ? ? ?
? ? ? ?
?
?
?
? ?
?
?
?
? ? ?
? ? ?
? ?
?
?
? ?
?
?
?
?
?
?
?
?
? ? ? ?
? ? ? ?
? ?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
? ?
? ? ?
?
?
?
?
?
?
?
? ?
?
?
?
? ?
? ? ?
?
?
? ?
?
?
?
? ? ? ?
?
?
? ?
? ?
? ? ? ?
?
?
?
?
?
?
?
?
???
???
???
???
???
? ?
? ? ? ?
? ? ? ? ?
? ? ?
?
? ?
?
?
?
???
???
???
???
???
?
?
?
?
?
? ?
?
? ?
?
?
?
?
?
?
?
?
?
? ? ? ?
?
?
?
?
? ? ?
?
? ?
?
?
? ? ?
?
?
? ?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
? ? ?
? ?
?
?
?
?
?
?
? ? ?
?
?
?
?
?
?
?
?
?
? ? ?
?
? ?
?
?
?
?
?
?
? ?
? ?
? ?
?
? ? ?
?
?
?
? ?
?
? ?
?
?
?
?
?
?
?
? ? ?
? ?
?
? ?
?
?
?
? ?
?
?
?
? ?
? ?
?
? ?
? ?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
? ? ? ?
?
?
? ? ?
???
???
???
???
???
?
?
?
?
?
?
?
? ? ?
?
?
?
?
?
? ?? ?? ??? ?? ?? ?? ? ?? ?? ??? ?? ?? ??
?????
?
??
?
??
??
??
???
??
???
??
??
??
??
??
??
?
???
???
???
???
???
??? ???
????
???? ???? ???? ????
?????
????
??????
???????
??????
???????????????
????????????
?
?
?
? ? ? ? ? ? ? ? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
??????????? ?????????? ??????????? ??????????? ??????????? ????? ?????
?? ??????????????? ?????? ????????????? ????????????? ????????????? ????????????
????????????? ??????? ??????? ?? ??????????? ??????????? ????????
?? ?? ?????????????? ????????? ?? ?? ??
???????????
???????????
???????????
????????????
???????????
???????????
??
??
??
??
??
??
?
?
?
? ?
? ?
?
?
?
?
?
? ?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
? ?
? ?
?
? ?
?
?
?
?
?
? ?? ?? ??
?
?
?
?
?
?
?
? ?
? ? ?
? ?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
? ?? ?? ??
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
? ?
?
? ?
? ?
?
?
?
?
?
?
?
? ?? ?? ??
?
? ?
? ?
?
?
? ? ?
?
?
? ?
?
?
?
?
?
?
? ?
?
?
? ? ?
? ? ? ? ?
? ? ? ?
?
?
?
? ?
?
?
?
? ? ?
? ? ?
? ?
?
?
? ?
?
?
?
?
?
?
?
?
? ? ? ?
? ? ? ?
? ?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
? ?
? ? ?
?
?
?
?
?
?
?
? ?
?
?
?
? ?
? ? ?
?
?
? ?
?
?
?
? ? ? ?
?
?
? ?
? ?
? ? ? ?
?
?
?
?
?
?
?
?
???
???
???
???
???
? ?
? ? ? ?
? ? ? ? ?
? ? ?
?
? ?
?
?
?
???
???
???
???
???
?
?
?
?
?
? ?
?
? ?
?
?
?
?
?
?
?
?
?
? ? ? ?
?
?
?
?
? ? ?
?
? ?
?
?
? ? ?
?
?
? ?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
? ? ?
? ?
?
?
?
?
?
?
? ? ?
?
?
?
?
?
?
?
?
?
? ? ?
?
? ?
?
?
?
?
?
?
? ?
? ?
? ?
?
? ? ?
?
?
?
? ?
?
? ?
?
?
?
?
?
?
?
? ? ?
? ?
?
? ?
?
?
?
? ?
?
?
?
? ?
? ?
?
? ?
? ?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
? ? ?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
?
?
? ?
?
?
?
?
?
? ? ? ?
?
?
? ? ?
???
???
???
???
???
?
?
?
?
?
?
?
? ? ?
?
?
?
?
?
? ?? ?? ??? ?? ?? ?? ? ?? ?? ??? ?? ?? ??
?????
?
??
?
??
??
??
???
??
???
??
??
??
??
??
??
?
?
???
???
???
???
??? ???
????
???? ???? ???? ????
?????
????
??????
???????
??????
???????????????
????????????
?
?
?
? ? ? ? ? ? ? ? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
??????????? ?????????? ??????????? ??????????? ??????????? ????? ?????
?? ??????????????? ?????? ????????????? ????????????? ????????????? ????????????
????????????? ??????? ??????? ?? ??????????? ??????????? ????????
?? ?? ?????????????? ????????? ?? ?? ??
???????????
???????????
???????????
????????????
???????????
???????????
??
??
??
??
??
??
 46 
duplications or point mutations of the coding regions of the genes were detected; 
instead, a retrotransposon insertion was located either within or upstream of Fbxw4 
(Sidow, Bulotsky et al. 1999). Fbxw4 was even initially named Dactylin, for being a 
potential causative gene for the phenotype. However, sheer insertion of the 
retrotransposon within Fbxw4 is not enough to explain the phenotype since one 
insertion is in intergenic region. Also, in humans situation is different due to the 
presence of duplication, not transposon insertion. In humans, the duplication is 
unlikely to give rise Fbxw4 downregulation and therefore other causes would need to 
be evoked to explain SHFM3. 
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3. Aims and Objectives 
Advances in whole genome sequencing and gene annotation, as well as 
comparisons of whole genomes of different species, revealed that different organisms 
do not have significantly different number of genes. For example, Caenorhabditis 
elegans has around 20 000 genes, whereas in humans the estimation is around 30 000. 
Number of genes also cannot explain the complexities of different organisms – 
Drosophila melanogaster has fewer genes than C. elegans (around 14 000), but 
possesses broader range of cell types and tissues (1998; Consortium 1998; Adams, 
Celniker et al. 2000; Lander, Linton et al. 2001). In the last several decades it has 
become clear that bigger size of the whole genomes in more advanced organisms 
correlates with greater variety of cis-regulatory elements (Levine and Tjian 2003). It 
has also been noticed that various organisms use more or less the same “toolkit” 
genes during development. Their complex spatio-temporal patterns are achieved by 
multiplicity of tissue-specific cis-regulatory elements. However, their apparent 
random distribution makes it difficult to investigate the full repertoire of regulatory 
elements acting on one gene. Additionally, there are more and more indications that 
the regulatory architecture itself plays a significant role in these processes. 
Fgf8 gene is coding for signaling molecule involved in development of 
multiple embryonic tissues over defined period of time. Obviously, complex 
expression pattern requires coordinated regulation by multiple enhancers. Unlike gene 
deserts or clusters loci where neighboring genes are either far apart on a linear 
chromosome or share evolutionary origin and most probably similar function, Fgf8 is 
located in a gene-rich region surrounded with functionally unrelated genes. Proximity 
to other heterologous genes suggests that the enhancers are scattered in intergenic and 
intronic regions. This means there is a need for mechanism(s) that ensure activation of 
target promoter and not the heterologous ones. Additionally, the organization of the 
enhancers within the locus may also play an important role in driving the proper 
expression of Fgf8. 
The genomic interval where Fgf8 is located represents better normal genomic 
environment for a developmental gene than gene deserts or cluster loci, making it an 
ideal model system to study complex gene regulation. The aim of this study was to 
determine the regulatory region needed for proper Fgf8 expression. Within this region 
we preselected enhancer candidates based on conservation of noncoding sequences. I 
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determined the regulatory activities of individual candidates and their combined 
action utilizing BAC transgenesis. I took advantage of loxP sites within mouse Fgf8 
locus to introduce chromosomal rearrangements and examined the role of enhancer 
candidates in vivo.  
Results from these experiments led us to propose a novel concept: a holo-
enhancer. This concept involves complex interactions of various regulatory elements 
in the region, filtering of their regulatory potential and position-dependent promoter 
activation. The model highlights that, although a regulatory region could be divided 
into individual modules, the important part of its activity (cell specificity / regulation 
of the target gene) is holistically determined, with the overall structure of the region 
playing the key role in this process. 
In humans, the condition called Split Hand-Foot Malformation Type 3 
(SHFM3) is caused by 0.5 Mb duplication of the region downstream of Fgf8. 
Although the gene itself is not affected by the rearrangement, we proposed that the 
duplication disrupts its regulatory region, leading to the premature termination of the 
AER. However, the exact molecular mechanism is still not known. We used 
chromosomal rearrangements in mice mimicking duplication in human patients to 
investigate gene expression in limb buds of mouse embryos. The results gave us the 
insight into molecular background of the disease. 
Additionally, observation of syntenyc loci in multiple organisms allowed us to 
tackle possible mechanisms acting during evolution. The conserved gene linkage 
between Fgf8 and a neighboring gene Fbxw4 suggested the presence of evolutionary 
constraints acting along the locus. Since these two genes are not functionally related, 
it seems that the observed linkage is due to the need for the regulatory scaffold to be 
preserved in order for proper gene expression to take place.  
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4. Materials and Methods 
4.1. Materials 
4.1.1. Instruments  
 
Centrifuges  
Name  Supplier 
Microcentrifuge 5424  Eppendorf  
Multifuge 3SR+  Thermo Scientific  
Sorvall RC6T+ Thermo Scientific  
 
Thermo cyclers  
Name  Supplier 
PTC-200 DNA Engine Cycler  BIO-RAD  
PTC-200G DNA Engine Cycler  BIO-RAD  
DNA Engine Tetrad2  BIO-RAD  
 
Microscopes  
Name  Supplier 
Leica MZ16F  Leica  
Leica MZ16  Leica  
Leica M125 Leica 
Leica DM IL  Leica 
 
Other  
Name  Supplier 
Unimax 2010 Shaker Heidolph 
Polymax 1040 Shaker Heidolph 
Vortex-Genie2  Scientific Industries  
Thermomixer Compact  Eppendorf 
Hyban Shake’n’Stack  Thermo Electron Corporation  
Block Heater SBH130D  Stuart 
Mulitron Standard  INFORS HT  
GenePulser Xcell  BIO-RAD  
 
4.1.2. Chemicals  
 Unless indicated otherwise, all chemicals were supplied by Merck (Darmstadt) 
and Sigma-Aldrich (Steinheim).  
 
 50 
4.1.3. Buffers  
 Unless specified otherwise, all solutions were prepared according to (Sambrook 
and Russell: The condensed protocols from Molecular cloning: a laboratory manual 
2006).   
 
4.1.4. Kits  
Name  Supplier 
QIAquick PCR Purification Kit (Cat.No. 28104)  QIAGEN  
QIAEXII Gel extraction Kit (Cat.No. 20021)  QIAGEN  
QuickLyse Miniprep Kit (Cat.No. 27405) QIAGEN  
RNeasy Mini Kit (Cat.No. 74104) QIAGEN  
NucleoBond_XtraMidi / Maxi Prep (Cat.No. 
740410.10/740416.10) 
MACHEREY-NAGEL  
pGEM-T Easy Vector System I (Cat.No. A1360)  Promega  
Expand Long Template PCR System (Cat.No. 
11681834001) 
Roche 
 
4.1.5. Enzymes  
 Restriction enzymes were purchased from MBI Fermentas (St. Leon-Roth) or 
NEB.  DNA polymerase for genotyping was expressed from the construct provided by 
EMBL Protein Expression and Purification Core Facility. Other DNA polymerases 
used are: LA Taq (TaKaRa BIO Inc.), Long Range Expand (Roche) and Phusion 
(Finnzymes-Thermo Fisher Scientific). Ligases and phosphatases were purchased 
from NEB. 
 
4.1.6. Bacterial Strains  
Name  
DH5α  
DH10B  
Pir1 
EL250 
 
4.1.7. Oligos  
 All oligos were purchased from Sigma-Aldrich.  
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4.1.8. Sanger Sequencing  
 Sequencing of plasmids or PCR products were performed by GATC Biotech. 
  
4.1.9. Animal services  
 Breeding and crossings were performed by Silke Feller and Andrea Schulz in 
the animal facility (LAR) of EMBL.  
 Pronuclear injections of individual CNEs were performed by Cyagen 
Biosciences Guangzhou Inc., Guangzhou, China and Christian Klasen from EMBL 
Heidelberg Transgenic service.  
 Pronuclear injections of BAC clones were performed by Christian Klasen and 
Yvonne Petersen from EMBL Heidelberg Transgenic service.  
 Injections of targeted embryonic stem cells into mouse blastocysts were 
performed by Christian Klasen from EMBL Heidelberg Transgenic service.   
 
4.1.10. Software  
Program  Producer Application 
MacVector 11.0.2  MacVector Inc.  Sequence analysis, comparison  
ApplicationSuiteV3  Leica  Photos acquiring  
 
4.1.11. Internet Resources  
Resource  Address 
UCSC Genome Browser  http://genome.ucsc.edu/ 
Ensembl Genome Browser http://www.ensembl.org/index.html/ 
Mouse Genome Informatics 
(MGI, Jackson Lab)  
http://www.informatics.jax.org/ 
 
National Center of 
Biotechnology Information 
(NCBI)  
http://www.ncbi.nlm.nih.gov/ 
  
BiSearch Primer Design Tool  http://bisearch.enzim.hu/ 
Simple Modular Architecture 
Research Tool (SMART)  
http://smart.embl-heidelberg.de/ 
 
Oligo Calc: Oligonucleotide 
Properties Calculator 
http://www.basic.northwestern.edu/biotools/oligocal
c.html 
Galaxy http://main.g2.bx.psu.edu/ 
Embrys http://embrys.jp/embrys/html/MainMenu.html 
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4.2. Methods 
4.2.1. DNA Isolation   
Plasmid or BAC DNA Isolation  
 Plasmid-DNA was isolated using a QuickLyse Miniprep Kit (for small scale) or 
the Nucleobond Xtra Midi/Maxi (for medium / maxi scale) according to the 
manufacturerʼs specifications. BAC DNA was isolatated using Nucleobond Xtra 
Maxi Kit using low copy plasmid purification protocol described in user manual 
provided.  
 BAC DNA small scale was prepared from 2 mL overnight liquid culture by 
pelleting the cells at 3000 rpm for 10 minutes at room temperature. Pellet was gently 
resuspended in 250µL of P1 buffer, lysed in additional 250µL of P2 buffer for 5 
minutes at room temperature and incubated in additional 250µL of P3 buffer for 30 
minutes on ice. The lysate was centrifuged at 10000 rpm for 10 minutes at room 
temperature and supernatant was transferred into 750µL ice cold isopropanol. After 
mixing by inverting the tube, the mixture was incubated for 2 hours at -20°C. 
Precipitated BAC DNA was collected by centrifuging at 10000 rpm at 4°C for 15 
minutes and pellet was washed in 500µL of 70% ethanol for 5 minutes at room 
temperature. Dried pellet was resuspended in 40µL TE buffer.   
Genomic DNA Isolation  
 Low Purity Isolation (from tail tips or yolk sacs for genotyping PCR): Tails or 
yolk sacs were lysed in 150-200µL of tail lysis buffer-ProteinaseK mix (ProteinaseK 
was diluted 1:100 from 10mg/mL stock solution) overnight at 56ºC. Tail Lysis buffer: 
50mM KCl, 5mM Tris pH8.0, 2mM MgCl2, 0.1%w/v Gelatin, 0.45% v/v NP40 and 
Tween-20.  
 
4.2.2. Genotyping PCR  
 DNA amplification was performed with Taq-polymerase produced from the 
construct provided by the Protein Expression Purification Core Facility at EMBL 
Heidelberg. The reaction was prepared in 20µL total volume as follows: 20-100ng of 
genomic DNA as a template, 2µL of 10X PCR buffer, 0.16µL of 25mM dNTP mix, 
0.5µL of 10µM both forward and reverse primer (1µL total), 0.3µL of Taq 
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Polymerase. Below is the used program. This PCR setup was used for all the 
genotyping performed. 
 
Phase  Temperature Time (min:sec) Cycles 
Initial denaturation 94ºC  4:00   
Denaturation 94ºC  0:45  
Primer annealing  59-63ºC, mainly 60ºC  0:45   
Elongation  72ºC  0:45-1:00  30  
Final elongation  72ºC  7:00   
Hold  20ºC  ∞   
 
4.2.3. Preparation of individual CNE constructs 
Cloning strategies  
a) Majority of CNE sequences were PCR amplified from appropriate BAC template 
using primers listed in Appendix 8.1. and LA Taq or Phusion polymerase 
following manufacturer’s protocol. PCR products were purified, digested with 
Acc65I+Xho1 (or Hind3+Xho1 for CE7, 8 and 72; Acc65I+Hind3 for CE39, 62 
and 63) and cloned into pRS13 vector upstream of LacZ reporter gene coupled 
with minimal promoter. Vector contains the gene for Ampicillin resistance (AmpR) 
so resistant colonies were screened for the correct clone by the restriction digest of 
the isolated plasmids. Correct sequence of the insert was confirmed by Sanger 
sequencing using primes T7 (taatacgactcactataggg) and #94 
(cgttgtaaaacgacgggatc). 
b) CE67: purified PCR product was cloned into pGEM-Teasy following 
manufacturer’s protocol and transformed into DH5α bacterial cells. Positive 
colonies were selected based on blue-white selection. The insert was released 
from the plasmid using Acc65I+EcoRI sites, EcoRI site was blunt using Klenow 
enzyme and insert was cloned into pRS13 between Acc65I and Hind3 blunt sites. 
Colonies were screened for the correct clone by restriction digest of isolated 
plasmids and insert was confirmed by sequencing using primes T7 and #94. 
c) CE38 and CE49: BAC RP11-1126B16 was digested with Kpn1 and Hind3 
respectively and ~5 kb DNA fragments were isolated from the gel. Fragments 
were subsequently ligated into pRS13 vector and colonies were screened for the 
correct clone by restriction digest of isolated plasmids. 
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d) CEs 55, 56, 58, 73: primers with homology arms flanking corresponding elements 
were used to amplify over AmpR gene in plasmid pRS41. Purified PCR product 
was electroporated into EL250 bacterial cells harboring BAC RP11-958B14 
where these CEs are located. Prior to electroporation cells were treated at 42°C for 
15 minutes to transiently induce heat sensitive recombinase. Recombination 
between homology arms in the primers and flanking regions of the CEs on the 
BAC occurs, bringing CE sequence into pRS41 plasmid. After plasmid isolation 
from EL250 cells, wanted fragment was released from the plasmid using 
Acc65I+Xho1 restriction enzymes and subcloned into pRS13. Colonies were 
screened for the correct clone by restriction digest of isolated plasmids and insert 
was confirmed by sequencing using primes T7 and #94.  
e) CE64 was cloned and tested by Alice Young, a former lab member. 
 
PCR templates for CEs were human BACs as follows:  
• RP11-349G14: CE1 
• RP11-119O18: CEs 5-22  
• RP11-112B16: CEs 24-48  
• RP11-958B14: CEs 50-80 
  
Some CEs are relatively big and are composed of several smaller peaks in the 
genome. Therefore, for some CEs smaller peaks were cloned and tested separately, as 
well as the full region. These are: CE38 = CE37, CE39 and CE40; CE58 = CE58L 
and CE58R; CE68 = CE66 and CE69. 
Preparation the constructs for the pronuclear injection 
For the purpose of the pronuclear injections all CE fragments were released 
from pRS13 using Acc65I+Not1 restriction enzymes, except for: CE1, 11, 52 
(Acc65I+Xba1); CE38 (Stu1+Not1). CE58R was released from CE58 using 
Stu1+Not1. Digested fragments were separated on the agarose (SybrSafe stained) gel 
and desired fragments were purified and eluted in the injection buffer (10 mM Tris-Cl 
pH 7.5, 0.1 mM EDTA). 
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4.2.4. Preparation of BAC targeting constructs 
Cloning strategies for the targeting constructs 
 
a) Insertion of LacZ-Kanamycin cassette 
After defining the sequence to be deleted from the BAC RP11-958B14, 50 bp on 
each side will serve as recombination arms for the targeting cassette. To target the 
cassette containing LacZ reporter gene and Kanamycin resistance gene as a 
selection marker into the BAC, we first defined the exact position on the BAC 
where the cassette will be inserted. 50 bp on each side will serve as recombination 
arms for the targeting cassette. Primers are designed as follows: 
5’ primer: Bsp120I cloning site – 50 bp from BAC 5’ flanking sequence in reverse 
and complement orientation – Sca1 cloning site – 20 bp plasmid sequence to 
prime amplification 
3’ primer: Acc65I cloning site – 50 bp from BAC 3’ flanking sequence in direct 
orientation – Sca1 cloning site – 20 bp plasmid sequence to prime amplification 
Primers were used to perform PCR over plasmid pGPS1 backbone and the origin 
of replication that is exclusively recognized by the π protein from Pir1 bacterial 
cells. Product was purified and digested with Acc65I+Bsp120I. LacZ-Kanamycin 
cassette was released from the plasmid pRS16 using Acc65I+Not1. PCR product 
and the LacZ-Kanamycin cassette were ligated and transformed into Pir1 bacterial 
cells. Colonies resistant to Kanamycin were screened for the positive clones by 
restriction digest of the isolated plasmid. Targeting cassette containing LacZ, gene 
for Kanamycin resistance and homology arms was released from the plasmid 
using Sca1 restriction enzyme. Purified cassette was electroporated into EL250 
containing human BAC RP11-958B14. Colonies resistant to Kanamycin were 
screened for the positive clones by restriction digest of the isolated BAC with 
Hind3 and by PCR. Table in Appendix 8.2. lists primers used for the creation of 
the targeting construct and for the testing of the recombinant BACs. 
b) Targeting constructs for deletions on BAC  
After defining the sequence to be deleted from the BAC RP11-958B14 already 
targeted with LacZ-Kanamycin cassette, 50 bp on each side will serve as 
recombination arms for the targeting cassette. Primers are designed as follows: 
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5’ primer: 50 bp from BAC 5’ from the sequence in direct orientation – 20 bp 
from 5’ of the selection marker 
3’ primer: 50 bp from BAC 3’ sequence in reverse and complement orientation – 
20 bp from 3’ of the selection marker 
Primers were used to perform PCR on the plasmid having gene for the selection 
marker (Kanamycin or Zeocyn). Purified PCR product was electroporated into 
EL250 harboring BAC. Colonies resistant to Kanamycin or Zeocyn were screened 
for the positive clones by restriction digest with Hind3 of the isolated BAC and 
PCR. Table in Appendix 8.2. lists primers used for the creation of the targeting 
construct and for the testing of the recombinant BACs. 
BAC targeting  
 The targeting construct was electroporated into EL250 bacterial strain 
containing BAC RP11-958B14 and heat inducible recombinase. Before 
transformation recombinase was transiently induced by the heat shock of EL250 cells 
at 42°C for 15 minutes. The competent cells were made freshly for each 
transformation.  
Preparation for pronuclear injection  
Before the pronuclear injection BACs were linearized for 4 hours at 37°C 
using PI-Sce1 restriction enzyme and dialyzed against injection buffer (10 mM Tris-
Cl pH 7.5, 100 mM NaCl, 0.1 mM EDTA) for 1 hours. For each round of injections 
BACs were prepared fresh. Prior to injection, 30µM spermin and 70µM spermidin 
was added to the injection buffer. 0.5-1 ng of BAC DNA was injected per embryo. 
 
4.2.5. Beta-galactosidase staining and testing for the specific transgene 
Both individual CEs and BACs were tested in the mouse embryos of E10.5 for 
the expression of LacZ reporter gene. After pronuclear injection gestating mice were 
sacrificed at stage E10.5 and the uteri were removed. Embryos were collected in PBS 
on ice and then fixed in 4% PFA for 30 minutes on ice. If necessary, the yolk sacs 
were collected and processed for genotyping. After fixation step followed by two 
washing steps of 10 minutes in PBS on ice and one at room temperature embryos 
were stained in humidified chamber at 37ºC overnight in the preheated staining 
solution (500 uL NP4O 2%, 250 ul Na-Deoxycholate 2%, 100 ul MgCl2 and 13.3 mg 
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Spermidine in 50 mL PBS with 165 mg/ml K3Fe(CN)6, 210 mg/ml K4Fe(CN)6 and 
40 mg/ml Xgal). The next day embryos were washed in PBS and LacZ expression 
pattern was observed.  
Isolated genomic DNA from yolk sacs was tested for the presence of LacZ 
reporter gene using primer pair #598 (GATCCCGTCGTTTTACAACG) and #367 
(AATGTGAGCGAGTAACAACCCG). Additionally, to test the transgenic embryos 
for the specific CE inserted in the genome, primer pairs used for the cloning of the 
particular CE was used. Primers are listed in Table 2 in Appendix 1. Embryos 
transgenic for different BACs were tested for the specific modification with the 
primers from Tables 4 and 5 from Appendix 2. Full length of the BAC in the genome 
was assayed by 16 different primer pairs used to clone individual CE: 50, 54, 56, 60, 
61, 62, 63, 66, 69, 71, 72, 75, 77, 78, 79, 80 (also listed in the Table 2 in Appendix 1). 
 
4.2.6. Generation of transgenic mice 
Cloning of the targeting construct 
Targeting construct containing gene for Neomycin resistance flanked by FRT 
sites, insulator sequence HS4 from chicken β-globin locus flanked by loxP and 
lox2272 sites and LacZ gene flanked by lox2272 and loxP sites was created by 
subcloning from p139 plasmid already containing all the parts and using three 
different restriction digestion enzyme combinations (EcoRI+Bgl2, Bgl2+Bsp120I and 
Bsp120I+EcoRI) followed by triple ligation of the fragments. 
The ligation product was released from the plasmid by Pme1 restriction 
enzyme and inserted between ‘Sleeping Beauty’ transposon arms using blunted Hind3 
restriction enzyme site. Newly made fragment was released from the plasmid using 
Sal1 and Sac2 restriction enzymes and inserted between homology arms matching to 
the mouse genomic sequence within the second intron of Fbxw4 gene. This final 
fragment containing the initial cassette, ‘Sleeping Beauty’ transposon arms and 
homology arms used for the homologous recombination in the ES cells was released 
from the plasmid using Sgs1 restriction enzyme and used for targeting of the E14 
mouse embryonic stem cells (ES cells). 
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Cell culture for E14 and electroporation of the targeting construct 
Active DR3 feeders were grown on 10cm culture dishes in 10mL DMEM 
medium. On the day of inactivation medium was replaced with feeder medium with 
mytomycin C (50ng per 10cm dish). Cells were incubated for 2 hours at 37°C, 5% 
CO2. After inactivation cells were washed 2-3 times in PBS, trypsinised, concentrated 
by centrifugation at 1300 rpm for 5 minutes, resuspended in freezing medium 
(MEF+SS+DMSO) and aliquots of 1 ml were frozen in liquid nitrogen. 
 For the expansion of the ES E14 cells, inactivated DR3 feeders were plated on 
10cm culture dish (4x106 per dish) in ES cell medium: DMEM (Gibco, 
Cat.No.41965) with 15% FBS (PAN Biotech GmBH, Cat.No.2602), 1% L-glutamine 
(Gibco, Cat.No.25030-081), 1% penicillin / streptavidin (Gibco, Cat.No.15070-063), 
1% Non-essential amino acids (Gibco, Cat.No.11140-050)), 1% Sodium Pyruvate 
(Gibco, Cat.No. 11360-070), 1% 2-mercaptoethanol (diluted 1:100 from the stock 
solution which was made using 35µL of Sigma-Aldrich M7522 in 50mL water stock 
solution) and 1000U/ml of Leukaemia inhibitory factor (LIF, Chemicon, ESG1107). 
Dishes were previously gelatinized in 0.1% gelatine. After approximately 4 hours 
when the feeders settled down, E14 embryonic stem cells were plated. In all the 
upcoming steps E14 were always plated on DR3 inactivated feeder cells plated on the 
gelatinized culture dishes. E14 were fed every day with fresh medium. When 
appropriate confluence was reached (70-80%), E14 were trypsinized, concentrated by 
centrifugation and resuspended in the electroporation buffer. Cell number was 
determined by Neubauer-chamber.  
13x106 cells were incubated at room temperature with approximately 12mg of 
DNA for 5 minutes and electroporated (240V, 500µF, 4mm cuvette). Cells were 
plated in two different concentrations: 8x106 and 4x106. Cells were grown in ES cell 
medium for 3 days when selection was added: 200µg/mL of gentamycin for 2 days, 
then 250µg/mL till the end of selection (8 days). After the selection 300 individual 
colonies were picked into 96 well plates on inactivated DR3 feeder cells. Plates were 
expanded to triplicates; duplicates were frozen for backup and one expanded further 
to 24-well plates without feeders. For all the steps after the picking of colonies cells 
were grown in ES cell medium without selection antibiotic.  
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Preparation of genomic DNA from isolated E14 clones and testing for the 
transgene 
Medium was removed and E14 cells were washed two times in PBS. Cell lysis 
buffer with addition of proteinase K was added (500µl per well) and cells were 
incubated over night at 55°C. The next day the lysate was collected into 500µl 
isopropanol, shook well for DNA precipitate to become visible and spun down ay 
14000 rpm for 15 minutes the pellet was washed in 500µl 70% ethanol, air-dried and 
resususpended in 80µl EB buffer.  
DNA was tested by long range PCR using Expand Long Range kit from 
Roche, following the manufacturer’s protocol. PCR program is listed below.  Primer 
pair was: #9 (GTTGGGTAACGCCAGGGTTTTCC) 
               #820 (CAGTCCTCTACATTCACTACTTTACAAATC) 
 
Phase  Temperature Time (min:sec) Cycles 
Initial denaturation 92ºC  2:00   
Denaturation 92ºC  0:10  
Primer annealing  60ºC  0:15   
Elongation  68ºC  7:00    10  
Denaturation 92ºC  0:10  
Primer annealing  58ºC  0:15   
Elongation  68ºC  7:00 + 0:20 each cycle    120  
Final elongation  68ºC  7:00   
Hold  20ºC  ∞   
 
Positive clones were expanded from the frozen 96-well plates and grown on 
DR3 inactivated feeders. From one batch DNA was isolated and tested by Southern 
blot. 
Selected clone was injected into mouse blastocysts and chimeric mice were 
subsequently bred to Black 6 to obtain germ line transmittion (GLT). DNA of 
transgenic animals was obtained from tail pieces and GLT was confirmed by 
Southern blot and PRC with different primer pairs, including long range PCR as 
described above. 
 
4.2.7. Southern Blot 
 5-10µg of genomic DNA was digested overnight at 37ºC with Nhe1 restriction 
enzyme in the reaction volume of 25µL. The next day digested fragments were 
 60 
separated on 1% Agarose gel stained with ethidium bromide for at least 5 hours at 100 
V. Gel was then denatured in the denaturation solution (0.5N NaOH, 1.5M NaCl) for 
30 minutes and neutralized in the neutralization buffer (0.5M Tris-Base, 1.5M NaCl, 
pH7.2-7.4) until pH strips showed a value around 7.0-7.5 exchanging the solution 
every 30 minutes. Capillary transfer was set on a nitrocellulose membrane 
(Amersham Hybond+) overnight using 10X SSC, pH7.0 (diluted 1:2 from 20X SSC 
stock: 3M NaCl, 1M Sodium citrate). 
 The next day membrane was washed in 50mM NaPi, pH7.2 for 5 minutes, then 
baked / fixed for 2 hours at 80ºC. Pre-hybridization was performed in the 
hybridization buffer (0.5M NaPi pH7.2, 7% SDS, 1mM EDTA pH8.0) for at least 30 
minutes at 65ºC. The membrane was then hybridized in the hybridization buffer 
containing 5ng/mL of the probe overnight at 65ºC with constant rotating. 
 After overnight hybridization the membrane was washed 2 times in the Church 
wash buffer (0.08M NaPi pH7.2, 1%SDS) for 10 minutes at room temperature, then 
washed in 1xDIG1+0.3% Tween 20 buffer for 5 min at RT and in DIG2 blocking 
buffer (1xDIG1 buffer (0.1M Maleic acid, 0.15M NaCl) with Roche Blocking reagent 
(Cat.No.11096176001)) for 30 minutes at room temperature. The membrane was then 
blocked in the blocking buffer DIG2 with DIG antibody (Roche Cat.No. 
11093274910, used 1:20000 dilution) for 30 minutes more. After antibody incubation 
the membrane was washed 2 times in 1xDIG1+0.3% Tween 20 buffer for 20 minutes. 
Once the unbound antibody was removed, the membrane was washed in DIG3 buffer 
(0.1M Tris pH9.5, 0.1M NaCl) for 5 minutes and the signal was detected by 6µL/mL 
CDP-star reagent (Tropix Cat.No.T2306-0705036 MSC050) in DIG3. The exposure 
to the X-Ray film varied from 1 hour to overnight. 
 
4.2.8. Generation of multiple transgenic mouse lines 
The mice generated from the original targeting construct were named SHFM3-
SB0-NeoInsLac to indicate targeting into a region involved in SHFM3 (second intron 
of Fbxw4), that the transgene is within the ‘Sleeping Beauty’ transposon and that it 
contains Neomycin resistance gene, LacZ reporter gene and chicken insulator 
sequence HS4. Distribution of loxP, lox2272 and FRT sites in the original targeting 
construct was designed in such a way that it offers several possibilities to create new 
alleles. NeoInsLac mice were bred to mice positive for FLPe- or Cre-recombinase. 
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These enzymes specifically recognize FRT or loxp/lox2272 sites in the genome, 
respectively, and facilitate homologous recombination between the two. This 
subsequently led to new allelic combinations: InsLac, Lac, Neo or LoxP (Figure 1). 
 
 
 
Figure 1. Different allelic combinations obtained from the original NeoInsLac allele 
By breeding it with FLPe- or Hprt-Cre-positive mice, one can generate four more allelic combinations 
from the original allele NeoInsLac, namely InsLac, Lac, Lox and Neo. Triangles represent loxP, 
lox2272 and FLPe sites as indicated in the figure. White, beige and blue rectangles represent Neomycin 
resistance gene, HS4 insulator sequence and LacZ reporter gene, respectively.  
 
Additionally, several other groups have generated mouse alleles with the loxP 
sites within Lbx1 (Vasyutina, Stebler et al. 2005), Polλ (Bertocci, De Smet et al. 
2002) and Fgf8 (Meyers, Lewandoski et al. 1998). I bred mice with Lac allele and 
Hprt-Cre recombinase (Wu, Ying et al. 2007) with all of the other described alleles to 
obtain pups with loxP sites at two positions in the studied region in trans. Triple 
positive transloxers were founders for six new allelic combinations (see Figure 2), 
generating duplications and deletions of the regions between Fbxw4 and an 
appropriate other loxP site (Lbx1, Polλ or Fgf8), since these sites were of the same 
orientation. The efficiency of the recombination was as reported before (Wu, Ying et 
al. 2007), generating on average one newborn with the duplication or deletion in each 
new litter. 
Although the original construct and its derivatives are contained within the 
‘Sleeping Beauty’ transposon that can jump to other positions in the genome by 
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cut&paste mechanism and the system is extensively used in the lab (Ruf, Symmons et 
al. 2011), this option of the construct is beyond the scope of this thesis. 
All the lines produced in the lab and the ones used to obtain wanted allelic 
combinations and genotyping primer pairs are listed in Table 7 in Appendix 8.3. 
 
4.2.9. RNA in situ hybridization (ISH)  
Embryo dissection  
 Gestating mice were sacrificed at stage E10.5 and the uteri were removed. 
Embryos for in situ hybridization were dissected and placed in 4% PFA for overnight 
fixation at 4°C. If necessary, the embryonic amnions were collected and processed for 
genotyping. The next day embryos were washed in PBS containing 0.1% Tween-20 
(PBS-T) 3 times for 5 minutes and gradually dehydrated in 30%, 50%, 70% and 
100% methanol containing PBS-T. Dehydrated embryos were stored at -20ºC.  
Generation of DIG-labeled probes  
 Probe sequences from the appropriate ESTs were cloned into pSKII(+) vector 
containing either T7 or T3 recognition sequence at each side of the insertion. 
Depending on the probe orientation in the vector, either T3- or T7-RNA polymerase 
was used for the in vitro transcription (on linearized plasmids) for digoxygenin-
labelled complementary probe synthesis, which was conducted with DIG RNA 
Labelling Kit (Roche) according to the manufacturerʼs protocol. After the reaction 
was stopped, RNA was cleaned with RNeasy Mini Kit (QIAGEN) following the 
manufacturer’s protocol and eluted in ~50 µL RNase-free water. The success of the 
reaction was tested on an agarose gel and the probes were stored at -20°C until further 
use.   
Whole mount ISH  
 Embryos were re-hydrated in 70%, 50% and 30% methanol containing PBS-T 
and washed 3 times in PBS-T for 5 minutes. After washing, the embryos were 
bleached for 45 minutes to 1 hour in 6% H2O2 (diluted from 30% stock in PBS-T) 
and washed 3 times in PBS-T for 5 minutes. Bleached embryos were permeabilized 
by Proteinase-K treatment at room temperature for 5 minutes. The treatment was 
stopped by washing in 2mg/mL Glycine solution in PBS-T 2 times for 3 minutes on 
ice and then 3 times in PBS-T for 5 minutes. The embryos are post-fixed in 4% PFA 
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for 20 minutes at room temperature and washed 5 times in PBS-T for 5 minutes. 
Embryos are then washed once in W1 (5X SSC pH4.5, 50% ionized Formamide, 1% 
SDS, 0.1% Tween-20) for 10 minutes at 65ºC and W1 was replaced by H2 (W1+ 
5mg/mL Torula yeast RNA and 25µL of 100mg/mL Heparin) in order to pre-
hybridize for at least 2 hours at 65ºC. Embryos were incubated overnight in H2 
containing the RNA probe by gentle rocking at 65ºC.  
 The next day embryos were washed in pre-heated W1 and W2 (2X SSC pH4.5, 
50% ionized Formamide, 0.1% Tween-20) 3 times for 30 minutes and in W3 (2X 
SSC pH4.5, 0.1% Tween-20) once for 15 minutes at 65ºC. After equilibration at room 
temperature for 15 minutes, embryos were washed 3 times in TBS (137mM NaCl, 
20mM Tris) containing 1% Tween-20 and blocked in the blocking solution (TBS-T 
with 20µL fetal calf serum and 20µL of 100mg/mL BSA) for at least 2 hours. After 
the blocking, embryos were incubated with DIG antibody (1:3000 dilution in blocking 
solution) overnight at 4ºC. 
 On the third day, embryos were washed in TBS-T initially 3 times for 5 minutes 
and then 5 times for 90 minutes. The last day embryos were washed in NTMT 
(100mM Tris pH9.5, 100mM NaCl, 1% Tween-20) 3 times for 10 minutes and then 
stained in the staining solution (3.4µL/mL of 100mg/mL NBT and 3.5µL of 
100mg/mL BCIP in NTMT) in the dark chamber. Staining reaction was stopped by 
washing in PBS after the required pattern / staining is obtained. The time of staining 
depends on the probe and the gene pattern. 
 
4.2.10. Skeletal and organ preparation 
Skin was removed from the embryos of E18.5 (by dipping them in 70°C water 
for 30 seconds) and were fixed in >95% ethanol for 4 days and in acetone for 3 days. 
Then they were transferred to freshly prepared staining solution (1 vol 0.3% alcian 
blue, 1 vol 0.1 alizarin red, 1 vol acetic acid and 17 vol 70% etahnol) and stained for 3 
days at 37C. After washing in ddH2O embryos were cleared in 1% KOH for 2-3 days 
and then in 1:4 vol, 1:1 vol and 4:1 vol glycerol:1% KOH. Embryos were stored in 
100% glycerol.  
Urogenital system and the brains were dissected out from the embryos of 
E18.5, fixed overnight in 4% PFA and washed in PBS the next day.  
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5. Results 
5.1. Systematic analysis of potential regulatory elements along Tlx1-
Fgf8 interval 
5.1.1. Description of the studied locus 
FGF8 is located on human chromosome 10q24 and on mouse chromosome 19. 
The interval we focused on in this study is extending from 600 kb centromeric / 
downstream of FGF8 to FGF8 promoter region including six more genes, namely: 
TLX1, LBX1, βTrC, POLλ, DPCD and FBXW4. The structure of the locus shows 
extensive synteny between animal species, from fish to mammals, with Slc2a5 gene 
lost in mammals. Despite conservation of organization, different genes present in this 
gene-rich interval are not evolutionary related, encode different types of proteins and 
perform different functions. 
The expression pattern of Fgf8 during mouse development is well known 
(Crossley and Martin 1995) and has been investigated by many groups in its different 
expression domains and organs. We focused our study on embryonic day E10.5 when 
Fgf8 expression could be detected in multiple specific domains. At this stage, in situ 
hybridization with antisense RNA probe shows that Fgf8 is expressed in discrete 
domains, including midbrain-hindbrain boundary (MHB), commissural plate (CP) in 
the forebrain, ectoderm of branchial arches, limb apical ectodermal ridge (AER), 
somites and tail bud (Figure 1). 
We also investigated the expression patterns of other flanking genes in mouse 
embryos of the same stage, again using in situ hybridization with appropriate mRNA 
probes. Amongst these, Lbx1 showed the expression in muscle precursor cells that are 
migrating into the limb buds. In contrast, the rest of the genes did not show any 
specific pattern but relatively widespread signal throughout the embryo at the basal 
level (Figure 1). By qPCR we were able to detect the expression of these genes at 
substantial levels – for example, housekeeping gene Polλ has an equivalent 
expression level to Fgf8 in the limb tissue even though it is not expressed in the 
restricted domain like Fgf8 (Tugce Aktas, unpublished observation). Thus, while Fgf8 
(and Lbx1) showed restricted and very specific expression domains, other genes 
localized between them show relatively ubiquitous expression, suggesting they are not 
affected or responding to cis-regulatory elements that control Fgf8. 
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5.1.2. Characterization of potential regulatory elements within the studied 
interval 
To identify these regulatory elements and where they lie, we decided to pursue 
a large characterization of the region and to test potential enhancer activity of 
individual regulatory elements within 600 kb region by transgenesis. Previous works 
from other groups have indicated these elements could be located away from Fgf8 
(Beermann, Kaloulis et al. 2006). Furthermore, conservation of the synteny suggested 
that some elements could be quite far away, and this organization could act as a 
constraint to keep neighboring but otherwise unrelated genes clustered during 
evolution. For this purpose we used multi-sequence alignment in UCSC genome 
browser and we determined ~80 conserved noncoding elements (CNEs) located in 
intergenic and intronic regions from Tlx1 to Fgf8. We applied relatively relaxed 
criteria, considering four categories: elements highly conserved from fish to 
mammals, conserved only in tetrapods, only in amniotes or only in mammals (Figure 
2 and see Appendix 1 for the details about each CNE). 
 
 
Figure 2. Distribution of CNEs within 200 kb region downstream of FGF8  
Level of evolutionary conservation of each CNE is depicted by the height of the bar and a label to the 
left: 1 – conserved only in mammals; 2 – conserved only in amniotes; 3 – conserved only in tetrapods; 
4 – highly conserved from fish to mammals. Gray rectangles represent genes. 
 
Each element has on average conserved core sequence of about 1 kb long. To 
test each element, we amplified conserved core sequence with approximately 200 bp 
of flanking region on each side (depending on the sequence composition) by PCR or 
subcloned from BAC templates (cloning details are described in Materials and 
Methods 4.2.3.). When several small conserved peaks were clustered closely together, 
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we cloned them together as an individual CNE. In few cases (CE38, CE58, CE68), if 
two or three large conserved peaks were in the close proximity to each other, we 
generated constructs for individual peaks as well as combined, including the sequence 
separating them. In particular, CE38 is composed of CE 37, CE39 and CE40; two 
peaks within CE58 were tested as CE58L and CE58R and CE68 comprises of CE66 
and CE69.  
We cloned each individual or combined CNE upstream of LacZ reporter gene 
coupled with the minimal promoter from human β-globin gene. After linearization 
and purification each construct was injected into pronuclei of fertilized mouse oocytes 
and embryos were transferred into pseudo-pregnant foster females. Embryos were 
dissected at E10.5. Transgenic embryos were detected by PCR on DNA template 
from the yolk sack and we performed β-galactosidase staining to test for LacZ 
expression pattern.  
After pro-nuclear injection, the transgene is usually inserted as a tandem array 
of multiple copies of the linear construct at a random place in the mouse genome. 
Therefore, the expression of the reporter gene can be influenced not only by the 
regulatory sequence cloned upstream but also by the endogenous regulatory elements 
surrounding the transgene insertion site. Following the standard rule, we considered 
as genuine regulatory activity for each CNE the expression pattern that was 
reproducibly observed in three or more independent embryos. Considering that, out of 
47 tested CNEs 24 showed very reproducible enhancer activity (see Figure 3A and B 
and Table 1). Other elements did not show reproducible pattern (i.e. they only 
respond to the endogenous enhancer), even when multiple transgenic embryos (>5) 
were obtained. Some CNEs were even more negative, since all transgenic embryos 
failed to show any pattern of expression. 
Figure 3 shows one representative embryo for each CNE that reproducibly 
guided the expression of the LacZ reporter gene. In the Table 1 only the regions 
where reproducible expression pattern was detected are indicated for each CNE. The 
more detailed description of both reproducible and ectopic expression patterns for 
each CNE, including negative ones, as well as the efficiency of transgenesis are 
indicated in the photos and tables in the Appendix 1. 
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Table 1. Expression patterns of individual CNEs 
The first column indicates individual CNEs; the first row lists domains of expression. For each 
individual CNE only expression domains where reproducible staining was obtained are indicated in 
blue. FB = forebrain; MB = midbrain; HB = hindbrain; BA = branchial arches; NP = nasal pits; EY = 
eyes; OV = otic vesicle; NT = neural tube; SO = somites; TB = tail bud; AER = apical ectodermal 
ridge; L = limb; H = heart; SP = spleen; K = kidney. 
 
Domains of expression CNE 
FB MB HB BA NP EY OV NT SO TB AER L H SP K 
1                
14                
38                
46                
49                
54                
58R                
59                
60                
61                
62                
63                
64                
66                
68                
69                
71                
73                
75                
76                
77                
78                
79                
80                
 
Importantly, many CNEs drove the expression in very specific patterns that 
overlapped with some of discrete domains of Fgf8. For example, five CNEs drove the 
expression in the AER (CE58R, CE59, CE61, CE66 and CE80). Elements CE64, 
CE79 and CE80 showed the expression in the midbrain, although CE64 and CE80 in 
the domain broader than MHB. Similarly, broad expression domain of CE64 
overlapped with the restricted Fgf8 expression in the commissural plate. Additionally, 
CE64 and CE80 guided the expression in the tail bud whereas CE73 and CE77 were 
active in the somites. 
CNEs that have expression pattern overlapping with endogenous Fgf8 pattern 
are indicated in the Figure 4. Most of them are located downstream of Fgf8 to the 
gene Polλ, especially in the introns of Fbxw4 (see Figure 3B). Other elements showed 
expression patterns that were not related to Fgf8. For example, CE1 drove the 
expression in spleeno-pancreatic mesenchyme and CE38 in the limb mesenchyme 
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(Figure 3A). Both of these elements are on the other side of the interval, very distant 
from Fgf8. Based on their proximity to other genes and their specific activity, we 
propose they are most probably involved in the regulation of Tlx1 (Brendolan, Rosado 
et al. 2007) and Lbx1 respectively (Schafer and Braun 1999), which are known to be 
specifically expressed in these tissues. 
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Amongst Fgf8 expression domains, we recovered CNEs showing activities in 
most of them with two exceptions. We failed to obtain restricted expression in the 
commissural plate of the forebrain domain, but identified several CNEs driving the 
expression it broader domains (see further for the discussion of this point). We also 
did not identify any CNE that could reproducibly drive the expression in the ectoderm 
of branchial arches. There were several CNE transgenic embryos with LacZ staining 
in this domain, but never in a highly reproducible manner.  
It may be that the enhancers for branchial arches are not present in our tested 
subset of CNEs because they are located outside of tested interval. However, this 
seems unlikely, since BAC covering 200 kb downstream of Fgf8 with the same 
reporter gene inserted can fully recapitulate Fgf8 expression pattern in mouse 
embryos, including branchial arch ectoderm, when integrated in their genome (see 
later). Other option is that the enhancer(s) are not conserved or that the activity 
requires synergy from multiple independent elements. 
 
5.2. Defining necessary and sufficient Fgf8 regulatory region 
5.2.1. Combination of the elements localized within 200 kb centromeric to Fgf8 is 
sufficient for the proper Fgf8 expression 
The striking overlap between the activities of observed with these CNEs and Fgf8 
expression domains suggests that a large number of Fgf8 regulatory elements is 
located in a region ~200 kb downstream of Fgf8. To prove that they indeed contribute 
to Fgf8 regulation, we wanted to further investigate if this interval was both necessary 
and sufficient for proper Fgf8 expression in the developing embryo. For these 
purposes we performed transgenic assay with Bacterial Artificial Chromosome (BAC) 
covering the entire region (to test for the sufficiency) and targeted chromosomal 
rearrangements to delete these elements from the mouse genome.  
To identify the regulatory activities in this large region, we first had to introduce a 
reporter gene into the BAC through ET-mediated recombination in E. coli cells (Liu, 
Jenkins et al. 2003). For this, we constructed the targeting cassette consisting of the 
same LacZ reporter gene and minimal β-globin promoter as used for testing the 
individual CNEs and 50 bp of homology arms on each side. Using homologous 
recombination we targeted the cassette into BAC RP11-958B14. This BAC covers 
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200 kb of human genomic region downstream of Fgf8 and comprises elements CE49 
to CE80. It includes genes Polλ, Dpcd, Fbxw4 and the 3’ of βTrC, but it is important 
to mention there is no Fgf8 gene or its promoter present on this BAC, thus not 
interfering with the assay. 
Targeting cassette was inserted between CE79 and CE80 and we named the 
construct BAC5. To ensure that the BAC5 was integrated in the mouse genome in a 
way that maintains the normal structure of the locus, we injected linearized BAC5 
into fertilized mouse oocytes. For each obtained embryo, we used extensive PCR 
genotyping using 16 primer pairs detecting individual CNEs. The primers amplify 
only human BAC sequences, not the mouse ones. Detailed primer list is in the 
Appendix 8.1, Table 2. LacZ expression was assayed the same way as for individual 
CNEs at stage E10.5, but we only considered embryos with full length BAC (~30-
50% of embryos had only a partial fragment of the BAC inserted). 
LacZ expression in the embryos with inserted BAC5 in the genome revealed 
several interesting features. First, the pattern of expression fully recapitulated most of 
the endogenous domains observed for Fgf8 (Figure 5). Interestingly, we observed the 
activity of LacZ in the ectoderm of branchial arches, whereas we did not manage to 
detect reproducible activity in this domain with any of the individual CNEs. Thus, the 
sequences required for this expression are present in this region, even though no 
evolutionary conserved element we tested was sufficient to reproduce this expression 
domain. Second, BAC was more efficient in driving the expression irrespectively of 
its insertion site. Almost all BAC positive embryos showed the expression pattern, 
whereas individual elements were more susceptible to be silenced depending on their 
insertion site (see tables and photos in Appendix 1 and 2). Importantly, this very 
faithful expression was observed with a reporter gene driven by a heterologous 
promoter and in the absence of Fgf8 promoter proximal sequences. This suggested 
that these sequences are not playing a major role in tissue-specific expression of Fgf8, 
since all the regulatory activity was directed to the minimal promoter. Finally, 
expression pattern was much more restricted than with individual CNEs. This 
experiment revealed to us that the region 200 kb downstream of Fgf8 harbors all the 
sufficient regulatory elements needed for proper Fgf8 expression.   
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Figure 5. Expression pattern of BAC5 transgene 
Schematic representation of BAC5 the with insertion position of LacZ reporter gene: gray rectangles 
represent genes and BAC boundaries are depicted by square brackets. Blue ovals represent individual 
CNEs. Above, expression pattern of the transgene is shown. To the left is the endogenous Fgf8 
expression pattern for the comparison.  
 
5.2.2. Remote enhancers are required for Fgf8 expression and function 
Next, we wanted to determine whether the whole 600 kb region is necessary 
for the Fgf8 expression. For this purpose we created deletions on mouse chromosome 
19 taking advantage of loxP sites and TAMERE technique (Herault, Rassoulzadegan 
et al. 1998). Targeted meiotic recombination (TAMERE) is a technique that enables 
creation of different chromosomal rearrangements between loxP sites positioned in 
trans on homologous chromosomes (Herault, Rassoulzadegan et al. 1998). Breeding 
those mice with Cre-positive ones provides Cre recombinase, a protein that will 
recognize loxP sites and facilitate homologous recombination between the two. This 
way the region between two loxP sites can be deleted or duplicated. 
Figure 6 shows the collection of loxP sites distributed along chromosome 19 
between Lbx1 and Fgf8 that we have in the lab. Some of these sites are byproducts of 
gene targeting generated by other groups (Lbx1 from (Vasyutina, Stebler et al. 2005), 
Polλ from (Bertocci, De Smet et al. 2002); Fgf8 from (Meyers, Lewandoski et al. 
1998)). We have targeted an additional loxP site within the second intron of Fbxw4. 
Targeting was done by homologous recombination in mouse embryonic stem cells, as 
described in Materials and Methods 4.2.6. The place of the insertion was selected to 
reflect chromosomal breakpoint in the patients suffering from SHFM3 and to allow us 
to create similar duplication in mice (see later). To produce deletions and 
duplications, we used all pairwise combinations of loxP with the same orientation 
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using the efficient Hprt-Cre driver (Wu, Ying et al. 2007). For all the rearrangements 
we aimed for, we obtained both deletion and duplication configurations successfully, 
with an efficiency of around 12%, even for loxP sites separated by several hundreds 
kilobases. Almost all the litters had at least one animal with a new allelic 
combination. 
 
 
Figure 6. Distribution of loxP sites within the studied interval 
Schematic representation of 600 kb interval and the distribution of loxP sites within. Gray boxes 
represent genes. Red triangles depict positions of loxP sites. 
 
With loxP sites inserted within genes Polλ and Fbxw4 we could generate a 
deletion between these two sites. Within this region we previously characterized 
potential regulatory elements that guided the expression in multiple Fgf8 expression 
domains, notably CE58, CE59, CE61 and CE66 in the AER, CE64 in mid- and 
forebrain, CE66 and CE69 in the kidney (see Figure 3B). To test the consequences of 
this deletion on Fgf8 gene, we bred this allele to mice heterozygous for an Fgf8 null 
allele to generate mice carrying both alleles (in trans). In such embryos the only 
functional copy of Fgf8 was on the chromosome carrying Polλ-Fbxw4 deletion.  
 It is known that Fgf8KO embryos do not live longer than E8.0 because Fgf8 is 
needed for proper gastrulation (Sun, Meyers et al. 1999). Our DEL(Polλ-Fbxw4) / 
Fgf8KO embryos bypassed early lethality and survived almost till birth, indicating 
that the deletion does not lead to complete Fgf8 silencing. However, upon 
examination at E18.5 we have noticed severe malformations and defects affecting 
multiple organs and tissues (Figures 7 and 9). Embryos showed craniofacial defects 
with the absence / aplasia of the nose and maxillary region. The brain was extremely 
severely affected: the olfactory bulbs were missing and the whole forebrain was of 
smaller size, while the midbrain and the cerebellum were extremely reduced (Figure 
7). Some of these phenotypes (the absence of olfactory bulbs, smaller forebrain 
vesicles, deletion of midbrain and the anterior hindbrain) have been reported earlier in 
hypomorphic compound Fgf8neo / Fgf8null mice (Meyers, Lewandoski et al. 1998).  
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I further characterized the brain malformation by looking at some specific 
regional markers of brain development by in situ hybridization on earlier stages 
(Figure 8). Pax6 is a transcription factor expressed in the developing embryos in the 
eyes, neural tube and the forebrain with the sharp boundary at the midbrain. In 
DEL(Polλ-Fbxw4) / Fgf8KO the expression in all these domains is preserved. 
However, the defined boundary at the midbrain is shifted more posterior, which goes 
with the observation of the missing midbrain. Accordingly, the midbrain expression 
of the direct Fgf8 downstream target En2 is lost (Figure 8). This showed to us that 
indeed the deleted interval phenocopies the loss of function of Fgf8 in many brain 
domains and thus that the regulatory elements located within play a significant role in 
directly guiding this expression. 
 
 
 
Figure 8. Expression of midbrain markers Pax6 and En2 in DEL(Polλ-Fbxw4) / Fgf8KO mutants 
Schematic representation of deletion between Polλ and Fbxw4: gray rectangles represent genes. Lighter 
gray parts with dashed line show deleted region. Blue ovals represent individual CNEs. Below, in situ 
hybridization on WT and DEL(Polλ-Fgf8) / Fgf8KO embryos of E10.5 using mPax6 and mEn2 probes. 
Notice Pax6 domain shifted posterior (white arrows) and the absence of En2 expression in the 
midbrain (red arrow) in the mutant embryos. 
 
In addition, compound DEL(Polλ-Fbxw4) / Fgf8KO embryos showed very 
strong aplasia of the kidney (stronger than Fgf8neo/null (Grieshammer 2005)). 
Furthermore, while Fgf8neo mice have mostly normal limbs and kidneys, compound 
DEL(Polλ-Fbxw4) / Fgf8KO have vey small limbs, most similar to the embryos with 
limb-specific deletion of Fgf8 (Moon and Capecchi 2000) (Figure 9). However, 
DEL(Polλ-Fbxw4) / Fgf8KO animals were not showing failure of posterior 
development, which has frequently been observed in the compound hypomorphic 
alleles. 
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We further analyzed gene expression patterns in DEL(Polλ-Fbxw4) embryos 
by whole mount in situ hybridization. I wanted to investigate how Fgf8 expression 
pattern changes upon deletion of distal part of its regulatory domain. Fgf8KO allele 
we introduced in trans to observe the phenotype is constructed by the deletion of 
exons 2 and 3 of Fgf8 gene (Meyers, Lewandoski et al. 1998). Our mRNA probe 
however binds to 3’ UTR and therefore could hybridize to the potential transcripts 
from this allele. To avoid this during examination of Fgf8 expression pattern in 
malformed embryos, we introduced deletion between Lbx1 and Fgf8 or Polλ and Fgf8 
in trans. These two deletions were generated by utilizing loxP sites within Lbx1, Polλ 
and Fgf8. Observed phenotype was the same and, due to the position of loxP site 
within Fgf8, 3’ UTR is also deleted. This allowed us to investigate malformed 
embryos for Fgf8 expression without potential hybridization to the truncated Fgf8 
transcript. 
In situ hybridization on embryos E10.5 revealed complete loss of Fgf8 in all 
of the characteristic regions and notably, MHB, forebrain, olfactory and optic 
placodes and limbs. However, the expression in the tail bud and the somites was not 
visible in the wild type control. This is sometimes the case, most probably due to the 
size of the embryos. It will be necessary to repeat the experiment with younger 
embryos (E9.5) where the probe penetration is easier. Since identified CNEs that 
guide the expression of the reporter gene in the somites (CE73 and CE77) and tail bud 
(CE80) are not deleted, this experiment is needed to determine if deletion of the distal 
Fgf8 regulatory region affects its overall expression or only in the domains whose 
enhancers are deleted. 
The observed phenotype correlated well with the expression patterns of 
individual CNEs located in the deleted interval. Notably, these are CE64 that guides 
the expression of LacZ in fore- and midbrain, CE66 and CE69 showing the activity in 
the kidney, four CNEs (CE58, CE59, CE61 and CE66) that revealed the activity in the 
AER. This led us to the conclusion that those CNEs are indeed enhancers necessary 
for the proper regulation of the gene. Regarding limb development, the data show that 
four deleted AER enhancers are needed for the proper gene regulation. It is not 
possible to say which of them is completely necessary, but it is clear that CE80 is not 
enough to obtain normal limb phenotype. Similarly, it seems that CE64 is the one 
responsible for the proper midbrain development and that CE79, despite its regulatory 
activity highly similar to endogenous Fgf8, is not sufficient to initiate or maintain 
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Fgf8 expression in this domain. With this experiment we showed the necessity of 
regulatory elements located within the deleted interval. 
Finally, Sandra Ruf in the lab obtained another deletion extending from Lbx1 
to Polλ. These mice were again bred over Fgf8KO. Interestingly, the pups were born 
alive without any gross anomalies. Additionally, I have generated homozygous 
embryos carrying this deletion and performed in situ hybridization with Fgf8 mRNA 
probe. The experiment showed full Fgf8 expression pattern with no difference to the 
wild type (Figure 11). Thus, it appears that this region does not contribute importantly 
to Fgf8 expression, at least at the stages and for the organs we examined. 
 
 
 
Figure 11. Expression of Fgf8 in DEL(Lbx1-Polλ) homozygous mutants 
Schematic representation of deletion between Lbx1 and Polλ: gray rectangles represent genes. Lighter 
gray parts with dashed line show deleted region. Below, in situ hybridization on WT and DEL(Lbx1-
Polλ) homozygous embryos of E10.5 using mFgf8 probe. Fgf8 domains of expression are indicated by 
white arrows.  
 
In summary, the analysis of different chromosomal rearrangements within the 
studied region combined with BAC transgenesis allowed us to define a critical Fgf8 
regulatory interval located 0-200 kb downstream of the gene. All the necessary and 
sufficient regulatory elements for the proper gene expression are between Polλ and 
Fgf8 gene, mainly within the introns of Fbxw4. The deletion of the distal half of this 
region (Polλ-Fbxw4) is sufficient to cause the complete loss of expression / function 
of Fgf8 in multiple domains. Therefore, these experiments confirmed the functional 
role of the individual CNEs characterized before in controlling Fgf8 expression 
during embryogenesis. 
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5.3. Modularity and redundancy of regulatory potential 
The analysis of individual CNEs revealed the modular nature of Fgf8 
regulatory system: it appears to be achieved by individual elements that have the 
activity in discrete domains. Not only those different domains can be attributed to 
distinct enhancers, but also for several specific domains I identified more than one 
potential enhancer with overlapping or identical activities. It seems that Fgf8 
regulation, apart from appearing modular, involves a large number of elements with 
redundant activity.   
 
5.3.1. Modularity and hierarchy in MHB region 
For example, CE79 activity is restricted to MHB, matching precisely with the 
endogenous Fgf8 at E10.5 (see Figure 4). However, other elements, CE64 and CE80 
are also able to direct reporter gene expression in the midbrain: CE80 at midbrain-
hindbrain boundary, but towards the hindbrain, while CE64 domain spreads from the 
boundary into both mid- and hindbrain. It is interesting to mention that both elements 
are conserved in sequence and the position from teleost fish to mammals, suggesting 
that this modularity and redundancy in activity is ancestral and does not correspond to 
evolutionary recent gain of shadow enhancers. A proof fot this is work by 
Komisarczuk et al. They have investigated conserved regulatory blocks within ~200 
kb region around zebrafish fgf8 gene. Two of these elements, fgf.dr 1/8 and 10, 
correspond to our CE79 and 64, respectively. Interestingly, they drove the expression 
of the GFP reporter gene in the midbrain and otic vesicle (like our CE79) and mid-, 
hindbrain and tail bud, corresponding to the observed pattern of expression of CE64 
(Komisarczuk, Kawakami et al. 2009). These results suggested conserved role of 
these regulatory elements from fish to mammals.  
However, although both CE64 and CE79 are both evolutionary conserved, the 
deletion of CE64 causes midbrain not to develop. While CE79 and CE80 can 
autonomously drive the reporter gene expression, they are not sufficient to drive Fgf8 
expression in the midbrain in the absence of CE64, underlying the importance of this 
element at least for initiating Fgf8 expression in the brain and establishing it as a key 
node in the MHB gene regulatory network. 
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5.3.2. Modularity in AER expression 
Similarly, in total five CNEs showed reproducible staining in the AER: CE58, 
CE59, CE61, CE66 and CE80. Out of those, only CE80 is preserved after deletion of 
the region between Polλ and Fbxw4. However, the observed undeveloped limbs and 
the absence of Fgf8 signal in the AER indicated that CE80 is not sufficient for the 
proper Fgf8 expression in the limbs. Therefore, we wanted to address the question if 
all of the rest four CNEs are necessary. 
For this purpose we took advantage of another modified BAC. The procedure 
was as described before: the only difference was that the targeting cassette (LacZ 
reporter gene coupled with minimal β-globin promoter) was inserted between CE76 
and CE77. BAC4 was then injected in the fertilized mouse oocytes and the embryos 
were stained for LacZ expression. The pattern of expression again recapitulated the 
endogenous Fgf8 expression (including strong signal in the AER), with high 
penetrance with respect to the random integration site (5/5 embryos).   
We further modified this BAC, deleting sequentially CE61 and CE66. This 
was again done by homologous recombination, substituting two CNEs with the 
cassette containing homology arms and sequences of Kanamycin or Zeocyn genes, 
respectively. BAC4 with deleted CE61 and CE66 was then linearized and tested as 
described. 
In total five transgenic embryos were obtained where the BAC4_Δ61/66 was 
integrated in full length. Out of those, only two showed full BAC4 expression pattern 
with strong staining in the AER. However, the other three embryos revealed very 
weak overall staining with AER domain faintly visible or completely missing (Figure 
12).  
Clearly, the observations from this experiment suggest that the deletion of 
CE61 and CE66 does not affect the potential to regulate the expression in the AER 
and that they are most probably dispensable for the AER expression of Fgf8. This 
could indicate that they play equivalent role in regulating the expression of the gene.  
However, with this deletion we obtained three transgenic embryos with only 
weak staining. As it was the case for BAC5, all the embryos transgenic for BAC4 had 
very clear expression pattern. This highly penetrant expression was somehow reduced 
when two CNEs were deleted. Because we only generated relatively small numbers of 
embryos for each construct, the difference is not statistically significant. Thus, it 
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could be only due to random integration, with the modified BAC falling unluckily 
within the repressive regions of the genome. 
 
 
 
Figure 12. Expression pattern of BAC4_Δ61/66  transgene 
Schematic representation of BAC4_Δ61/66 the with insertion position of LacZ reporter gene: gray 
rectangles represent genes and BAC boundaries are depicted by square brackets. Blue ovals represent 
individual CNEs. White rectangles with diagonal lines depict deleted CE61 and CE66 Above, three 
individual transgenic embryos with distinct expression patterns are shown. Notice the difference in the 
expression of LacZ in the AER: strong and weak staining (left and middle, white arrows) and no AER 
(right, red arrow). Leftmost embryo shows the expression pattern of BAC4 without deletions for the 
comparison.  
 
5.4. Filtering some of the regulatory potential of the enhancers 
present in the region 
As described in the previous section, we have observed vast regulatory 
potential within the defined Fgf8 regulatory region. Multiple enhancers are active in 
the overlapping domains. Additionally, several CNEs guided the expression of the 
reporter gene reproducibly in broad domains that could not be related to neighboring 
gene expression patterns. For example, CE63 drove broad reporter gene expression in 
almost all forebrain and in posterior limb mesenchyme, CE64 showed broad activity 
in fore- and midbrain, as well as trunk whereas CE62 is active in the optic stalk and 
mesenchyme of branchyal arches. CE71 guides reproducible expression in the heart. 
In contrast, Fgf8 expression at E10.5 is detected in much more restricted domains in 
the brain and is never detected in limb and branchyal arches mesenchyme, as well as 
eye and heart, and none of the surrounding genes showed the expression in any of 
these regions (see Figures 1 and 3B).  
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One has to keep in mind though the stability of LacZ protein. Once translated, 
LacZ persists in the tissue for two to three days. During that time cells undergo 
divisions and migration within the developing embryo. This results in carryover of the 
protein to daughter cells and / or to different parts of the embryo. For example, 
although Fgf8 activity is not detected in the heart at E10.5, it is well established that 
Fgf8 is expressed in the cells of pharyngeal region. These cells will migrate towards 
the heart and contribute to its development (Ilagan, Abu-Issa et al. 2006). The 
observed expression of CE71 could simply reflect cell lineage expressing Fgf8 earlier. 
The contribution of Fgf8 is in this case very limited: cells expressing Fgf8 contribute 
to the development of the outflow tract. Similarly, CE64 could reflect earlier time 
point of Fgf8 expression, before it is restricted to midbrain-hindbrain boundary. 
However, not all the observed regulatory potential can be explained by the stability of 
LacZ and cell lineage tracking.  
Importantly, we used the same reporter gene (i.e. the same “stable” LacZ 
reporter under the control of the same minimal heterologous promoter) for transgenic 
test of individual elements or BAC injected embryos. Strikingly, embryos with BAC4 
or BAC5 integrated in the genome all have much more restricted pattern, similar to 
the endogenous Fgf8, despite the presence of all the CNEs showing broad domains of 
activity. This discrepancy suggests that these activities were silenced or filtered out by 
sequences or features that are present in the natural context reproduced by the BACs. 
To further analyze this phenomenon and mechanisms in more details, we 
targeted LacZ-β-globin promoter cassette to several positions along the same BAC 
RP11-958B14 to address the question on how the input from multiple enhancers 
could be integrated to build a complex expression profile (Figure 13). 
In the BAC2 construct LacZ reporter is in the close proximity to the element 
CE64. Contrary to the result of the single element test, we did not observe any of the 
broad CE64 pattern. Instead, the pattern of expression was restricted to Fgf8 domains, 
with the additional activity in the heart (likely from CE71) and the eye (similar to 
CE62-mediated activity). The insertion of the reporter gene in BAC0 next to the 
element CE62 recapitulated the expression in the eye driven by this element, but not 
in the mesenchyme of branchial arches (Figure 13). 
Thus, all the insertions we tested and which spanned most of the BAC 
containing large number of enhancers showed very restricted expression patterns, 
regardless on the insertion point of the reporter gene (Figure 13 and see later Figure 
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14). These patterns resembled endogenous Fgf8 to a great extent, with extra domains 
(eye, heart) present in some BACs.  
 
 
 
Figure 13. Expression patterns of BAC0 and BAC2 transgenes 
Schematic representation of BAC0 and BAC2 the with insertion positions of LacZ reporter gene: gray 
rectangles represent genes and BAC boundaries are depicted by square brackets. Blue ovals represent 
individual CNEs. Above, the expression patterns of each of the transgene are shown. Below, the 
expression patterns of individual CNEs located in the proximity of LacZ insertion positions are shown. 
 
The comparison of the BACs and individually tested elements revealed 
striking differences. As mentioned before, BAC transgenesis showed more 
reproducible activity – close to 100% independently of the insertion site – compared 
to what we obtained with individual CNEs (for details, see Appendix 1 and 2, tables 
and figures). We propose that this observation is not only due to a simple shielding of 
the reporter gene from position effects because of the larger size of the transgene, but 
also reveals synergistic activities between different elements. Indeed, if we consider 
AER enhancer elements, we observed few embryos with variegated AER LacZ 
staining. Two embryos transgenic for CE61 had strong AER expression whereas in 
two others the pattern was patchy, with some AER cells showing strong expression 
while others were negative. This phenomenon is unlikely due to mosaic integration of 
the transgene, but is more indicative that, even if sufficient, a single element is not 
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fully functional. It also suggests that the efficient AER expression of Fgf8 may 
require the integration of multiple inputs, some being more important than the others. 
In this respect, the observation that the deletion of CE61 and CE66 only moderately 
alters AER expression in the context of the BAC suggests that the remaining elements 
(CE58 and CE59) could have a major role.  
The synergistic activation in some domains is also associated with silencing of 
several other activities observed with the individual elements. Importantly, this 
filtering is not active along the whole BAC, but seems to be resulting from the limited 
range of action of individual CNEs. For instance, CE71 is active in heart but it seems 
to be only able to activate the reporter gene inserted in the limited domain 
corresponding to insertions in BACs 2 and 3. The eye expression was visible from 
BAC1 to BAC3 while MHB region was detected from BAC2 to BAC5 with staining 
in BAC5 being the strongest and most reproducible. AER expression was detected in 
all the tested BACs (Figure 14).  
When compared to Fgf8 expression patterns, we can see that this filtering 
mostly operated on enhancer activities which could be considered as ectopic, either 
because they are detected earlier with the reporter gene than the known expression of 
the endogenous one (e.g. CE69 in the future kidney in E10.5), or are much too broad 
to correspond to endogenous gene expression domains. This comparison showed that 
individual CNEs, when taken outside their natural context, could have a much larger 
and diverse regulatory activity than what they contribute in their natural location. It 
clearly indicated presence of the filtering mechanisms that act across the region and 
fine-tune an abundant intrinsic regulatory potential of individual enhancers that is not 
equivalent to their function. This filtering could be achieved by silencer elements. For 
example, we never saw the staining in the first branchial arch mesenchime from the 
BAC, even when the reporter gene was close to CE62, the enhancer with the 
corresponding regulatory potential. However, the observation that the overall output 
varies according to the position of the reporter gene suggests that the structure of the 
locus itself could play an important role by restricting the range of action of enhancers 
to some regions in a tissue-specific manner. The result is the effective filtering of 
some of their intrinsic potential. 
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Intriguingly, this output varies quite dramatically over 200 kb of the BAC. Its 
similarity to Fgf8 pattern correlated to the insertion point of the reporter gene: the 
closer LacZ is to the position where Fgf8 gene is normally present the more of its 
expression pattern is recapitulated (Figure 14). It seems that regulatory elements have 
a certain tendency to act to one side of the region and not the other. Although we 
cannot exclude some preference to the target promoter in the endogenous situation, 
our results suggest that the promoter sequence is not crucial for obtaining the 
specificity of gene expression. Rather, it is the relative position of the promoter 
towards the regulatory region that plays a role in achieving a particular expression 
pattern.  
 
5.5. Specificity of the enhancer activity towards the target promoter 
These observations prompted us to examine if the same mechanism could 
contribute to enhancer-gene specificity and explain why only Fgf8 is responsive to 
many enhancers spread next to or within other genes. The results of the experiments 
with different modified BACs showed already that the enhancers were not only 
working exclusively with the promoter of Fgf8, since they could faithfully activate 
minimal β-globin promoter reduced to its TATA box. Interestingly too, the 
preferential activation associated with the Fgf8 location was observed even though 
BAC did not contain Fgf8 promoter region. 
 
5.5.1. Fgf8 enhancers can activate heterologous endogenous promoter 
Another set of experiments showed that regulatory elements controlling Fgf8 
were promiscuous and could act on other gene promoters. In the lab we generated two 
independent stable lines (c53D13-A and c53D13-E) with chicken BAC CH261-
53D13 integrated in the genome. This BAC covers the interval from Mgea5 to middle 
of βTrC gene and includes Fgf8. The absence of extensive repetitive regions in the 
chicken genome in comparison to human or mouse makes is shorter and easier to 
manipulate. Also, it was possible to generate chicken specific mRNA probes for in 
situ hybridization that did not cross-hybridize with endogenous mouse mRNA, which 
would not be possible with human Fgf8 probes. In this experiment the chicken BAC 
was injected into fertilized mouse oocytes in the circular form; consequently, the 
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integration of the BAC in the genome was most likely accompanied by the change in 
the relative structure and gene order in the genome. 
We wanted to first examine the expression profile of the orthologous chicken 
genes. For this purpose we performed whole mount in situ hybridization on chicken 
embryos of stage 24 (Hamburger and Hamilton 1992) comparable to E10.5 in mouse. 
Using chicken Fgf8 and Fbxw4 mRNA probes we confirmed that chicken specific 
Fgf8 has the same expression pattern as the mouse one. Similarly to its murine 
counterpart, chicken Fbxw4 revealed the similar basal level of expression throughout 
the whole embryo with some specific expression in the otic vesicle. Importantly, 
neither of chicken probes cross-hybridized with endogenous mouse Fgf8 or Fbxw4 in 
wild type embryos (Figure 15). 
 
 
 
Figure 15. Expression patterns of chFgf8 and chFbxw4 in CH261-53D13 transgenic mutants 
Schematic representation of the chicken BAC CH261-53D13: gray rectangles represent genes. BAC 
boundaries are depicted by square brackets. Below, in situ hybridization with chicken mRNA probes 
for Fgf8 and Fbxw4 on mouse embryos E10.5 from two independent mouse lines (A and E) and WT 
chick embryos stage 24. Chick-specific probes do not cross-hybridize with mouse Fgf8 mRNA (WT 
mouse embryos). Chick Fgf8 probe gives specific signal in WT chick embryos. In transgenic mouse 
embryos chFgf8 probe gives Fgf8 signal. Surprisingly, chFbxw4 can also recapitulate Fgf8 expression 
pattern.  
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We therefore could use these probes to define the expression of the chicken 
Fgf8 and Fbxw4 on transgenic embryos from both A and E lines. Chicken Fgf8 was 
normally expressed from the integrated BAC in most of its domains, with albeit 
relatively weak expression in the AER. Surprisingly however, we found that chicken 
Fbxw4 was also co-expressed in all chicken Fgf8 domains (Figure 15). 
This clearly showed that other promoters in the region could also respond to 
heterologous enhancers when the context is changed. Since initially chicken BAC was 
injected into mouse oocytes in the circular form, there was no control on how exactly 
BAC integrated in the genome. Changed geometry of the regulatory region could 
position Fgf8 enhancers in such a way that they now activate Fbxw4. The results of 
this experiment pointed to the importance of the structure and geometry of the 
regulatory region. 
 
5.5.2. Fgf8 enhancers act in position-dependent and promoter-independent way 
Multiple lines of evidence from the experiments with human and chicken 
BACs integrated in the mouse genome highlighted that the structure of the whole 
regulatory region defines very precise expression pattern of Fgf8, both by filtering 
“ectopic” regulatory potential and directing enhancer activities towards the telomeric 
end of the region where Fgf8 is located. 
To further teat this hypothesis, we took advantage of different mouse strains 
with loxP sites across the mouse locus to investigate how its structure contributed to 
the specificity of the regulatory interval towards the target promoter. Using loxP sites 
located within Lbx1, Fbxw4 and Fgf8 we created additional alleles: duplications 
between Lbx1 and Fbxw4 or Lbx1 and Fgf8. The interesting feature was that the loxP 
site in Lbx1 was associated with the substitution of second exon of Lbx1 with the gene 
for green fluorescent protein (GFP) (Vasyutina, Stebler et al. 2005). Targeted loxP 
site is positioned in such a way that upon duplication the region telomeric to Lbx1 and 
corresponding 5’ flanking region including its promoter now driving GFP was moved 
to the position of the breakpoint. The breakpoints in DUP(Lbx1-Fgf8) and DUP(Lbx1-
Fbxw4) are within Fgf8 regulatory region, either immediately downstream of Fgf8 or 
more distally, within the second intron of Fbxw4. The presence of the GFP reporter 
gene allows direct monitoring of the expression from the realocated Lbx1 gene 
promoter in the embryos. Embryos with the GFP-tagged Lbx1 gene promoter in the 
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wild-type configuration showed the fluorescence in the proximal limb mesenchyme, 
marking the migrating myoblasts where Lbx1 is normally expressed. This expression 
was preserved in all the rearrangements serving as an internal control and showing 
that the corresponding regulatory elements were most likely telomeric to Lbx1. 
Surprisingly, duplication between Lbx1 and Fgf8 led to the GFP expression in 
the Fgf8 domains: fore- and midbrain, branchial arches, AER and tail bud (Figure 16). 
This result supported earlier observation that enhancers act in rather promiscuous 
manner to any promoter that is at the certain position relative to them. It suggested 
that gene regulation is position- rather than promoter-dependant. 
 
 
 
 
Figure 16. Expression patterns of GFP in DUP(Lbx1-Fgf8) and DUP(Lbx1-Fbxw4) mutants 
Schematic representation of the DUP(Lbx1-Fgf8) and DUP(Lbx1-Fbxw4) regions: gray rectangles 
represent genes. Genes in the duplicated regions are depicted by brown rectangles. Below each 
configuration embryos of E10.5 with Fgf8 characteristic expression pattern are shown. Notice how 
GFP is expressed in more Fgf8 domains and with stronger intensity if the whole downstream region is 
duplicated (white arrows), as is the case in DUP(Lbx1-Fgf8). Migrating limb myoblasts (white 
arrowhead) show the fluorescence in the Lbx1::GFP in WT configuration and serve as an internal 
control. 
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Additionally, smaller duplication that brings Lbx1::GFP to the 2nd intron of 
Fbxw4 only partially recapitulates Fgf8 expression pattern – the expression in the 
forebrain, AER and BA is weaker or barely visible whereas midbrain and tail bud 
expression is missing (Figure 16). Thus, both the extent and the strength of the new 
expression of Lbx1 depend on the number of duplicated enhancers and are maximal 
when the entire and complex regulatory region normally controlling Fgf8 is 
preserved. This additionally confirmed the need of the promoter to be at the optimal 
distance from the enhancers for the gene to be expressed properly. The type of the 
promoter did not seem to be crucial, since the activity of the enhancers can be 
transferred to the heterologous one, as long as the promoter is at the appropriate 
position from them. 
We further expanded this analysis in collaboration with Tugce Aktas from the 
lab to examine the expression levels of the other genes in the forelimb and brain 
tissues dissected from E10.5 homozygous embryos. We compared the duplications 
between Lbx1 and Fgf8 (DUP(Lbx1-Fgf8)) and yet another one created, DUP(Polλ-
Fgf8). Total RNA was isolated from whole forelimbs and brain and used as a template 
for the first strand complementary DNA preparation. The changes in gene expression 
levels of DUP configurations were compared to wild type situation by quantitative 
real time PCR (qPCR). 
Preliminary experiments suggested there is an up regulation of Dpcd in limbs 
of DUP(Lbx1-Fgf8) homozygous embryos. This up-regulation was over 20-fold of the 
wild type gene expression levels. For the brain tissue we did not observe such a 
significant increase. In DUP(Polλ -Fgf8) Polλ gene was up-regulated in both brain 
and limb tissues, although not so significantly (Figure 17). 
Even though these investigations are only preliminary, they offered additional 
support to the earlier observations that the gene expression levels do not solely 
depend on the promoter. Rather, relative positions of the genes and their regulatory 
elements have a significant role in the regulatory processes.  
Chromosomal rearrangements like the ones we investigated or the ones 
observed in some human disorders, including SHFM3, disrupt normal regulatory loci. 
Additionally, different positions of the breakpoints duplicate alternative sets of 
regulatory elements, bringing them to the proximity of various heterologous genes. 
Enhancers, due to their intrinsic potential, can cause up-regulation of those genes, 
which can in turn lead to the disease. Therefore, variability of observed phenotypes in 
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the patients suffering from SHFM3 could be a consequence of changed expression 
levels of different genes in the region. 
 
 
 
 
 
Figure 17. Altered gene expression levels in DUP(Lbx1-Fgf8) and DUP(Polλ-Fgf8) mutants 
Graphs show Cp values from qPCR experiments on the samples from the brain and limb tissues of WT 
and E10.5 embryos homozygous for DUP(Lbx1-Fgf8) or DUP(Polλ-Fgf8). Notice significant up-
regulation of Dpcd in limb tissue in DUP(Lbx1-Fgf8) homozygotes. Although other genes in the region 
(Polλ and Fbxw4) are also up-regulated, the difference to WT is not so significant. 
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Figure 17 (continued). Altered gene expression levels in DUP(Lbx1-Fgf8) and DUP(Polλ-Fgf8) 
mutants 
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6. Discussion 
Transcriptional regulation of developmental genes involves complex 
interactions between multiple regulatory elements and their target promoters. 
Misregulation of the expression of these genes often leads to physical malformations 
and / or different forms of mental retardation. Therefore, understanding how different 
genes are regulated and especially defining the role of regulatory elements in this 
process is a key for understanding developmental mechanisms. 
In this study we defined that ~200 kb region centromeric to Fgf8 contains the 
regulatory information necessary and sufficient to drive its expression in most of the 
embryonic expression domains. Within this region, we characterized multiple 
individual regulatory elements and investigated their role in mouse embryonic 
development. Similar studies of regulatory regions of other developmental genes have 
already been performed, also showing that they are usually controlled by multiple 
enhancers; for example chicken Sox2 and mouse Myf5 gene (Carvajal, Cox et al. 
2001; Uchikawa, Ishida et al. 2003). Also, the regulation of Hox and β-globin clusters 
has been extensively investigated (e.g. (Tolhuis, Palstra et al. 2002; Montavon, 
Soshnikova et al. 2011)). The locus I studied is a relatively gene-dense region, in 
contrast to the usual large intergenic intervals surrounding other developmental genes. 
Also, while other large regulatory intervals have associated co-expression of adjacent 
bystander genes, this locus shows remarkable specificity, since only Fg8 shows an 
expression pattern corresponding to the enhancer activities under normal conditions. 
By dissecting the extended regulatory region of Fgf8 combining mouse transgenesis 
and chromosomal engineering, we gained important insight into the full complexity of 
a regulatory region and the mechanisms that ensure its specific action with respect to 
target genes and tissues. 
 
6.1. Modularity and redundancy of regulatory potential 
The analysis of isolated CNEs revealed that they could act as independent 
modules contributing to the overall regulatory activity of the region. I found that 
multiple individual regulatory modules guide the expression in discrete domains in 
the embryo, with some being expressed in broader regions. Interestingly, several 
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CNEs showed the activity in the overlapping domains, emphasizing extensive 
modularity and potential redundancy of their activities.  
 
6.1.1. Limb enhancers 
We found five CNEs that could drive the expressed in the AER: CE58, CE59, 
CE61, CE66 and CE80. These CNEs are at least partially synergistic when we 
compare their expression individually and within a context of BACs modified by the 
insertion of the reporter gene. We observed sporadic variegation of the AER 
expression pattern in some embryos when a CNE was tested alone to drive the 
reporter gene expression. Depending on the insertion site, embryos injected with 
CE61 revealed both LacZ activity in the whole length of the AER as well as patchy 
pattern, with clusters of cells being positive for LacZ protein. On the other hand, 
expression was reproducibly stronger along the whole AER in the embryos with the 
injected BACs containing multiple modules. However, in this context we found the 
evidence of at least partial redundancy since the deletion of CE61 and CE66 from 
BAC4 did not significantly modify the AER expression of the reporter gene (in two 
out of five embryos). This suggested these elements are dispensable or redundant with 
CE58 and CE59 for Fgf8 regulation in the limb. 
Despite these observations, identified AER enhancers also act independently 
of each other. When CE61 and CE66 were deleted from the BAC4, the signal in the 
AER was still observed in two out of five embryos. Interestingly however, the overall 
efficiency of transgenesis was somehow reduced. While all the embryos with inserted 
BAC4 in their genome had strong expression pattern in the Fgf8 domains, only two 
out of five BAC4 delta61/66 positive embryos showed the same. The other three had 
a weak overall staining, with AER faintly visible in only one embryo.  
Even though CE61 and CE66 were substituted with the antibiotic resistance 
genes (Kanamycin or Zeocyn) and hence relative distances to the rest of the regulatory 
elements were more or less preserved, the transcription factor binding sites within 
CNEs were removed. This could impair the assembly of trans-acting factors that 
possibly in the unmodified BAC bring the sequences of enhancers to the physical 
proximity of the minimal promoter next to LacZ.  
However, it does not seem likely that the two relatively short sequences that 
guide very specific expression in defined domains (AER and kidney) would so 
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significantly affect the overall expression pattern, causing the loss of signal in 
multiple unrelated domains (midbrain, somites, tail bud). Moreover, the numbers of 
transgenic embryos obtained in the experiments with BAC 4 with and without 
deletion of CE61 and CE66 do not make statistically significant difference. It is 
therefore difficult to say whether the deletion impacts the overall pattern of the 
expression. Clearly, the deletion of CE61 and CE66 does not affect the expression in 
the AER, judging by the two embryos whose pattern of expression is not different 
from the unmodified BAC4. Weak overall expression pattern in the other three 
embryos could be only due to random integration in the genomic region of repressive 
chromatin. 
Also, when four out of five CNEs were deleted in mouse, embryos showed 
severe limb malformations and the loss of Fgf8 expression in the AER at E10.5. Thus, 
the remaining CE80 alone was not enough for the proper expression of Fgf8 gene in 
the limb, even though it could work autonomously in a transgenic test and is localized 
very close to Fgf8 promoter. The AER was still was formed, most probably due to the 
activity of other Fgf family members in the limb (Fgf4, Fgf9 and Fgf17), but the 
deletion of a subset of the AER enhancers was sufficient to abrogate Fgf8 expression 
and phenocopy limb-specific Fgf8 loss of function. 
This functional redundancy does not necessarily mean that the enhancers are 
functionally equivalent and that their “synergistic” action is only due to additive 
effects. The regulatory logic of the enhancers can be flexible (Brown, Johnson et al. 
2007; Zinzen, Girardot et al. 2009). Contrary to the initial in vitro observations, in the 
natural context stable multi-protein complexes are not formed on the cis-regulating 
elements. Rather, binding of transcription factors seems to be highly dynamic, with 
individual factors transiently contacting the binding site within the enhancer (Voss, 
Schiltz et al. 2011). Initial binding of so-called pioneering factors causes remodeling 
of the local chromatin and facilitates binding of other transcription factors in the 
process named assisted loading. Relatively fast dissociation rate induces chromatin 
remodeling, but allows only limited time frame for the binding of secondary 
regulators. This suggests that identical regulatory activities of functionally redundant 
enhancers could be achieved with distinct combinations of different transcription 
factors. Thus, multiple enhancers active in the same domain could serve to transfer 
inputs from different regulatory pathways that control gene expression. 
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Indeed, a closer look at multi-sequence alignment of CE61 and CE66 among 
several mammalian and bird species revealed interesting differences. This 
“phylogenetic footprinting” is pretty successful approach for identifying putative 
transcription factor binding sites. We found two TAAT motifs within CE61, 
suggesting regulation by transcription factors with homeobox domain expressed in the 
AER, for example Dlx5 or Msx2 (Pan, Kronenberg et al. 2002). On the other hand, 
CE66 harbors two motifs characteristic for Lef1 transcription factor (Atcha, Syed et 
al. 2007). Lef1 mediates Wnt signaling pathway and is needed for the activation of 
Wnt target genes (Kengaku 1998; Galceran, Farinas et al. 1999). Although this was a 
relatively simple and crude analysis, it points to the possibility that these two 
enhancers bring cues from alternative regulatory pathways in the cell to Fgf8 to guide 
its expression in the same structure. Further experimental validation will be needed to 
confirm this hypothesis, but it suggests that the different enhancers are not mere 
duplicates (or shadow enhancers). They rather contribute to independently integrate 
multiple inputs (spatial regulation, feedback loops through signaling pathways) that 
collectively participate to establish and maintain robust expression of Fgf8 in the 
AER.    
 
6.1.2. Brain enhancers 
Similarly to the five elements active in the AER, we found three CNEs driving 
the expression in MHB: CE64, CE79 and CE80. Although CE79 shows striking 
similarity to the endogenous pattern of Fgf8, functional analysis revealed that deletion 
of CE64 causes failure of the midbrain development. However, in the embryos E10.5 
CE64 drove the expressed in much broader domain than Fgf8 at the same stage. As 
explained in the introduction, Fgf8 starts to be expressed in the brain in similarly 
broad domain earlier during development, but then the activity of Otx2 and Gbx2 
narrows it down to MHB. We propose that CE64 acts as an initiator element needed 
for the activation of Fgf8 expression in the midbrain. Later on, CE79 could serve to 
maintain the expression in the narrow region of isthmus.  
The broad expression elicited by CE64 around the MHB is reminiscent of 
earlier broad Fgf8 expression. As LacZ protein is stable over few days, this domain 
observed at E10.5 could be a temporal persistence of an earlier activity. While the 
turnover of the transcribed Fgf8 mRNA in the endogenous situation is relatively fast 
 100 
causing the loss of the signal in the midbrain, this cannot be the case with LacZ 
protein. 
However, this extensive expression was only detected when CE64 was tested 
individually. In any of the tested BACs, even for the one with LacZ reporter gene in 
the close proximity to CE64 (BAC2), we did not detect broad domain of expression in 
the midbrain. This difference suggested that LacZ stability is not the only factor 
explaining the expansion of the LacZ domain around the MHB, but that the broad 
MHB activity of CE64 is actively repressed, either by negative element(s) present 
within or by the reduced range of action, at E10.5 in the natural context. 
To regulate Fgf8 expression in the brain multiple enhancers may receive 
different inputs from several signaling pathways and play various roles in a temporal 
sequence of events. Thus, our findings suggest a model involving three elements: an 
early initiator (CE64), whose expression is both repressed by the currently unknown 
element and maintained in the sharp midbrain region with CE79. 
Interestingly, in their work with zebrafish embryos Inoue et al. defined several 
regulatory regions located between Fgf8 and hagoromo, a zebrafish orthologue of 
Fbxw4 (Inoue, Nagayoshi et al. 2006). One of them, S4.2 drove the expression of the 
reporter gene GFP in zebrafish MHB, otic vesicle, olfactory placodes and optic stalks. 
The sequence is conserved to amniotes and corresponds to our element CE79, which 
is also active in MHB and otic vesicle. 
Because S4.2 does not recapitulate early Fgf8 expression in the anterior 
hindbrain, Inoue et al. concluded this is late Fgf8 midbrain regulatory element (Inoue, 
Parvin et al. 2008). In their work from 2006 they did not characterize any enhancer 
that would be active earlier. Thus, they hypothesized that the potential early enhancer 
could not be conserved up to amniotes (Inoue, Nagayoshi et al. 2006). However, they 
did not extend their search further away from Fgf8 as we did. CE64 is located in the 
fifth intron of hagoromo orthologue gene Fbxw4 and is conserved from fish to 
mammals, suggesting that it may correspond both in mammals and fish to the early 
MHB enhancer.  
Inoue et al. conducted an additional detail analysis of S4.2. They found two 
binding sites for transcription factor Pax2 and confirm its binding in vitro and in vivo. 
Pax2 is known to be involved in the genetic cascade during midbrain development 
(Lun and Brand 1998). No isthmus (noi) allelic series comprises of five mutant alleles 
of Pax2.1 gene in the zebrafish. Midbrain development is affect in these mutants, 
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ranging from null (with complete absence of midbrain, MHB and cerebellum) to weak 
one (with some midbrain still formed). In noi-/- mutants the expression of early 
midbrain markers Wnt1 and Fgf8 is initiated, but disappears from MHB by 9-somite 
stage. This suggests Pax2 acts as a maintenance factor during midbrain development 
(Lun and Brand 1998). In the genetic background of noi mutant (lacking functional 
Pax2) GFP fluorescence driven by S4.2 was absent in MHB and optic stalk, 
emphasizing the role of pax2 in the function of this regulatory element in the 
development of these domains and its role during maintenance phase (Inoue, Parvin et 
al. 2008). 
The conserved core of CE64 sequence in fish also harbors two Pax2 consensus 
binding sites. This observation, in addition to detected activity in the midbrain could 
suggest that Pax2 could participate in the initiation of Fgf8 expression through this 
enhancer.  
Interestingly, further analysis revealed three subregions within the core S4.2 
sequence: #3 and #4 were active in broad region from midbrain to rhombomere 5 
whereas #2 repressed the ectopic activity of #3 and #4 in midbrain and from r2 to r5 
(Inoue, Parvin et al. 2008). They showed that within only 342 bp of the core S4.2 both 
enhancer and repressor activities were located. Initially characterized as a midbrain 
enhancer, S4.2 possesses a complex structure and enhancer activity is internally finely 
tuned for the proper activity in MHB. With respect to our proposed model, it could be 
possible that the activity which is restricting CE64 activity to the strict MHB in the 
BAC and natural context is encoded within CE79. This enhancer could therefore have 
a dual role as a silencer of CE64 outside MHB and cooperative enhancer in the MHB. 
 
6.1.3. Integration of redundant activities: a recurrent theme in gene expression 
control 
The integration of multiple cis-acting elements is emerging as an important 
feature of gene regulation. The earlier transgenic approaches have usually focused on 
elements that were sufficient to reproduce (with more or less accuracy) the 
endogenous expression patterns of the gene of interest, without necessarily 
considering the contribution of additional elements. This has been realized with the 
large scale ChIPs or with characterization of large intervals.  
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One of the examples is ChIP-chip analysis of genome-wide binding of Dorsal, 
Twist and Snail, determinants of Drosophila dorso-ventral patterning (Zeitlinger, 
Zinzen et al. 2007). As expected, the binding profile accurately predicted known 
enhancers. Surprisingly, it also revealed several hundreds of additional potential 
regulators for many more target genes than initially thought. Some of the potential 
enhancers were tested in transgenic assay and shown to be functional. Interestingly, 
the target genes were not only the ones involved in dorso-ventral, but also in anterior-
posterior patterning, indicating interconnections of the two networks during 
Drosophila development. 
ChIP-chip experiments additionally revealed that many genes have two 
enhancers: one relatively close to the gene and a secondary one sometimes located far 
away (Zeitlinger, Zinzen et al. 2007; Hong, Hendrix et al. 2008). Both enhancers are 
able to guide an almost identical expression pattern of the reporter gene when tested 
in the transgenic assay. Based on the observations by Zeitlinger et al. and their own, 
Hong et al. proposed the term “shadow enhancer” for the remote secondary one and 
suggested they provide robustness to the gene regulation and are important for the 
fitness (Hong, Hendrix et al. 2008).  
Further analysis revealed that indeed, shadow enhancers play a significant role 
in providing an additional input for the gene regulation (Perry, Boettiger et al. 2010). 
Under normal conditions there are no differences in the gene activity guided by both 
enhancers or only one of the two. However, under suboptimal conditions (for 
example, higher temperature for Drosophila embryos) gene expression was impaired 
in the absence of the shadow enhancer. These results suggested the role of shadow 
enhancers in providing the robustness of gene regulation under perturbing 
environmental conditions (Perry, Boettiger et al. 2010).  
Although both above-mentioned studies hinted to the possibility of similar 
mechanisms in other animal species, several studies of regulatory complexity in 
vertebrates clearly show that developmental genes in those species often have more 
than two enhancers, sometimes with overlapping functions. One of the first examples 
of the diversity of gene regulatory elements targeting single cell-type came from the 
analysis of Myf5 enhancers (Carvajal, Cox et al. 2001), which revealed an extensive 
number of skeletal muscle enhancers. However, most of them are being specific for a 
different type of muscles (head, back, limb). 
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The study of Sox2 enhancers provided another example of additivity and 
apparent redundancy. Extensive study of 50 kb around chicken Sox2 gene revealed 
eleven discrete regions with regulatory activities (Uchikawa, Ishida et al. 2003). 
These enhancers have precise spatio-temporal specificities, despite apparent uniform 
expression of Sox2 throughout developing nervous system. Five of them, labeled N-1 
to N-5, are early neural enhancers; L, NOP-1 and -2 drive the expression in sensory 
placodes, whereas NC-1, SC-1 and -2 are active later during development in neural 
crest and spinal cord. N-1 to N-5 are enough to recapitulate full Sox2 expression in 
the whole CNS at stage 12 of embryonic development. The authors propose N-1 to be 
the initiator element and the rest are autoregulated by Sox2 itself (Uchikawa, 
Takemoto et al. 2004). In agreement to this, the authors found multiple SOX binding 
sites within those enhancers. They do point out that this is probably only part of the 
input, since precise spatial regulation is achieved for each of these elements, probably 
through additional signals from the tissue surrounding particular parts of the CNS. 
As we proposed for the different AER and MHB enhancers, these regulatory 
elements may not only provide robustness by adding backup copies with the same 
specificities, but have to be considered in the developing context as a way to integrate 
spatially restricted input, feedback and feedforward systems in a dynamic temporal 
progression. Their deletion may help to precise their individual and specific 
contribution, particularly if combined with other perturbations.  
 
6.2. Filtering and specificity of regulatory potential 
6.2.1. Filtering of enhancer potential within natural genomic context 
When compared to the endogenous expression of Fgf8, it becomes clear that 
the studied interval harbors much more intrinsic regulatory potential within individual 
elements than what is eventually utilized. This situation departs significantly from the 
traditional models that present enhancers as separate modules, each having very 
specific and restricted activities and acting independently.  
In the study published in 2009, Visel et al. compared the individual activities 
mediated by several enhancers with distinct tissue specificities with the one obtained 
by a compound multi-enhancer construct, where these different enhancers have been 
cloned in tandem (Visel, Blow et al. 2009). Compound multi-enhancer transgene 
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displayed expression in each of the discrete domains of activity of its individual 
modules. No novel expression sites or inhibitory effect were detected. Their 
conclusion was that the enhancer modules were functionally autonomous and act 
additively. They have also suggested that combining individual tissue specific 
modules custom-made complex expression patterns could be generated. 
Our analysis of modified BACs clearly demonstrated that within the natural 
locus the activity of individual elements is not only additive, but that the substantial 
amount of their regulatory potential is masked. In other words, tissue-specificity 
results from an intersection strategy between enhancing and silencing activities. This 
raises the question how the activity of multiple modules is filtered in the regulatory 
region and what are the potential negative elements or structural features of the locus 
that contribute to achieve proper gene expression. 
 
6.2.2. No strict specificity of enhancer activity to target gene promoter 
Fgf8 is within a relatively gene-rich region, with more than ten genes in 600 
kb window around. 200 kb regulatory interval downstream of Fgf8 trespasses Fbxw4, 
Dpcd and Polλ. Therefore, the enhancers need to distinguish between heterologous 
promoters and act upon Fgf8. Apart from restricting broad regulatory potential, 
filtering of enhancer activity also plays an important role in achieving the specificity 
towards the promoter of the target gene. 
Our study showed that this specificity is not exclusively embedded in the 
sequence of the promoter. Different enhancers could act equally well on the minimal 
beta globin promoter used in the single CNEs and BAC transgenic experiments. More 
importantly, chicken BAC transgenic embryos showed that Fbxw4 promoter could 
also respond accurately to these inputs in some genomic context, while in its normal 
position it could not. Although we do not know precisely how the BAC got integrated 
into the mouse genome and therefore how exactly the relative positions of enhancers 
changed, it is obvious that they can activate non-cognate promoter, depending on the 
genomic context. This raises the possibility that specificity could lie within the 
structure of the locus itself. 
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6.2.3. The role of the genomic structure in filtering and specifying regulatory 
input  
Another interesting characteristic emerging from our transgenic BAC studies 
is the dependence of the expression pattern on the position of the reporter gene used 
to monitor the output of the combined action of the regulatory elements. These results 
from BAC transgenic assay do not support additive behavior of enhancers. 
Importantly, the expression in some domain appears to be limited to a short region 
surrounding the corresponding elements (compare the expression in the heart and the 
position of CE71), while other activities are distributed along most of the interval. 
This observation argues against the presence of simple silencer elements that would 
counteract enhancer intrinsic potential, but suggests that the tissue-specificity and the 
filtering are resulting from spatial organization of the locus. Importantly, the closer 
the reporter gene is to the natural position of Fgf8, the more of its regulatory pattern is 
accurately recapitulated. It seems that all the elements acting together have a certain 
tropism to the promoter on one side of the region, which argues that the same 
structural logic filtering enhancer activities may also contribute to gene specificity.  
The observation that reshuffling the region leads to the ectopic recruitment of 
Lbx1 promoter by the Fgf8 regulatory elements strongly supports this model. By 
comparing duplications between genes Lbx1 and Fgf8 or Fbxw4 we have observed 
recapitulation of Fgf8 expression pattern in both cases. However, more domains were 
recapitulated and with higher intensity when heterologous promoter with the reporter 
gene was brought into Fgf8 regulatory region closer to endogenous gene position. 
This led to the conclusion that regulatory elements are relatively promiscuous and are 
able to act upon different promoters. Although we cannot exclude some preference of 
enhancers to the certain target promoters, it seems that there is no exclusive activation 
of it. Rather, the position of the promoter has a significant influence in filtering the 
regulatory input.  
This is nicely exemplified by the responsiveness of different genes in different 
duplications. In the parallel study in the lab on duplications between Lbx1 and Fgf8 or 
Polλ and Fgf8 gene expression levels were investigated by qPCR (Tugce Aktas, 
unpublished observation). Initial experiments showed up regulation of Dpcd or Polλ, 
respectively. Possible explanation to changed expression levels of various genes could 
be because of the different positions of breakpoints. Duplications of various sets of 
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regulatory elements could bring them to the position where they either have to bridge 
bigger distance to their target gene or could have another gene positioned in between. 
In the first case the efficiency of gene activation could be just reduced whereas in the 
other, since this is not natural surrounding for the enhancers, and because of their 
intrinsic promiscuity, activation of heterologous gene(s) could occur. It will be 
therefore interesting to investigate two other duplications created in the lab, between 
Fbxw4 and Fgf8 or Polλ and Fgf8. These rearrangements offer the possibility to study 
both scenarios (Figure 1).  
. 
 
Figure 1. Modulation of enhancer activity in different chromosomal rearrangements 
Schematic representation of WT locus and two different chromosomal rearrangements: gray rectangles 
and blue ovals represent genes and individual CNEs located in the introns, respectively. Duplicated 
genes and corresponding CNEs are indicated in brown and orange, respectively. 
In the normal situation, enhancers activate their target gene Fgf8. Activation is depicted by graded red 
arrow.  
In DUP(Fbxw4-Fgf8), proximal Fgf8 regulatory region is duplicated, moving distal part of the region 
further downstream. In this case, enhancers have to bridge bigger distances to activate their target 
promoter, potentially with lesser efficiency (longer but thinner faint red line). Additionally, proximal 
truncated regulatory set may also be insufficient for the proper activation. 
When distal Fgf8 regulatory region is duplicated in DUP(Polλ-Fgf8), one full set of regulatory 
elements is brought to the proximity of the heterologous promoters (Polλ or Dpcd) that can now be 
activated due to enhancer inner promiscuity and position-dependent mode of action.  
 
In DUP(Fbxw4-Fgf8) the position of the breakpoints causes the phusion of 3’ 
Fgf8 gene and 5’ of Fbxw4. Duplication moves away the distal part of Fgf8 regulatory 
!"#$%%%%%%%%%%%%%%%%%%%%&'()%%%%%%%%%%%%%%*+,-%%%%%%%%%%%%%%%%%%%%%./012%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%.345%%
DUP(Polλ-Fgf8)
!"#$%%%%%%%%%%%%%%%%%%&'()%%%%%%%%%%%%%%%*+,-%%%%%%%%%%%%%%%%%%%%%%%./012%%%%%%%%%%%%%%%%%%%%%%%%.345%67%%&'()%87%%%%%%%*+,-%%%%%%%%%%%%%%%%%%%%%./012%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%.345%%
DUP(Fbxw4-Fgf8)
!"#$%%%%%%%%%%%%%%%%%%%&'()%%%%%%%%%%%%%%%%%*+,-%%%%%%%%%%%%%%%%%%%%%./012%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%.345%67%./012%87%%%%%%%%%%.345%%
WT
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region, leaving the truncated proximal part next to the gene. The relative position of 
the enhancers within this truncated regulatory set to the target Fgf8 promoter remains 
as in the non-perturbed locus. In this situation the truncated set could activate Fgf8, 
but possibly with lesser efficiency. Similarly, the complete but reallocated set now 
needs to bridge bigger distance (additional 100 kb), having potentially similar 
outcome.  
On the other hand, in DUP(Polλ-Fgf8) the breakpoints cause the phusion of 3’ 
Fgf8 with 5’ of Polλ. In this case the only functional copy of Fgf8 has a full 
regulatory region located downstream. However, the second Fgf8 regulatory region 
centromeric to the breakpoint is brought to the proximity of two heterologous 
promoters: from Dpcd and truncated Polλ. These promoters are located in the position 
of the endogenous Fgf8 promoter in the natural situation; therefore, their activation 
could take place 
The analysis of individual regulatory elements combined with chromosomal 
rearrangements can give us the insight to different kinds of regulatory elements acting 
within the regulatory locus. Besides reallocated autonomous enhancers, breakpoints 
can change the position of the potential insulators, allowing activation of the 
promoters that are normally protected by their activity. Additionally, tethering 
elements may exist, like the one in Drosophila Antennapedia gene complex (Calhoun, 
Stathopoulos et al. 2002). A tethering element located next to scr gene directs the 
activity of T1 enhancer positioned further upstream to the target scr promoter. At the 
same time, ftz gene located between T1 and scr is not activated. In the complex 
genomic loci some elements may have a tethering function, directing multiple 
enhancers towards the target promoter. If the structure of the region is perturbed, a 
tethering element may be brought into the proximity of heterologous promoter, now 
directing the enhancers to it and causing the activation of the non-target gene. 
 
6.3. A holo-enhancer concept 
As presented above, we observed that the individual enhancers within the Fgf8 
regulatory locus do not act additively, but regulatory potential of the region is filtered 
to finely tune their activity. In addition to that, the structure of the locus itself and the 
position to the target promoter, and not exclusively its sequence, carry important cues 
on how to achieve precise expression pattern and gene specificity.  
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Figure 2. A holo-enhancer concept 
Within a gene-dense region multiple regulatory elements (ovals) for a developmental gene (red 
rectangle) are distributed in the intergenic intervals and the introns of the bystander genes (gray 
rectangles). Individual enhancers can act independently (orange; activity in the somites and otic 
vesicle) or synergistically / cooperatively (red; activity in the AER). Some elements have broad activity 
(dark blue; midbrain region), but it can be filtered by the silencers (white ovals and brackets). Others 
can have limited range of activity (small pink oval; heart) and part of the activity can be restricted or 
finely tuned. Some elements can have both enhancer and silencer functions (blue-white oval). 
Regulatory potential of some enhancers is completely blocked (purple; eye, branchial arches and limb 
mesenchyme). As indicated by the colored regions on the embryo to the left, individual enhancers have 
vast regulatory potential. However, this activity is refined by their complex interactions within the 
holo-enhancer. The whole set of regulatory elements acts holistically in a polar manner to the target 
promoter located on one side of the region and the structure of the locus plays an important role in the 
specificity of gene expression (red graded arrow pointing to the right). The result is restricted and 
highly specific expression pattern, as indicated on the embryo to the right. 
 
Therefore, in light of the evidence presented in this thesis, we propose a novel 
concept for regulatory regions: a holo-enhancer (see Figure 2). This concept explains 
complex regulatory processes within the large regions of the genome where tissue-
specific regulatory elements of (developmental) genes need to discriminate between 
relatively closely positioned heterologous promoters. Regulatory activities in discrete 
domains in the developing embryo are not achieved by the additive behavior of single 
modules (for example, we did not characterize single CNE that would guide the 
expression in the ectoderm of branchial arches or in the narrow region of commissural 
plate). Rather, it includes cooperative activity of various cis-acting elements present 
in a regulatory locus and their positional activation of a target promoter. The full 
output of gene-rich regions includes repression of the vast regulatory potential by the 
presence of negative regulatory elements and their interaction with putative 
enhancers. These interactions contribute to the enhancer specificity towards the target 
promoter, which is tightly connected to the structure of the locus itself. Once the 
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regulatory region is broken down to individual elements their full potential is 
revealed, possibly reflecting acquired activities over the evolution. However, to 
understand the full scope of the regulatory region of a certain gene simply considering 
individual elements in the additive manner is not enough. From presented and 
findings of the others (see later) it is becoming more obvious that the additional level 
of regulation is encoded within the structure of the locus and respective associations 
within the locus need to be taken into consideration. This regulatory scaffold is the 
basis upon which coding regions are transcribed to perform their function. Our 
findings of complex regulatory activity within the Fgf8 downstream region open the 
questions of what are the various mechanisms involved in the gene regulation within 
different loci and how should they be studied.  
Our findings differ from the ones for the extensively studied human β-globin gene 
cluster. There, multiple genes active in erythroid cell line are organized in a cluster 
and their linear organization on the chromosome reflects timing of activation (from 
embryonic and fetal to adult stage). 5’ from the cluster there is a LCR, a complex 
regulatory element crucial for the proper expression of the genes within. In erythroid 
cell line, insulator elements located within LCR (HS5) and 3’ from the cluster (3’HS) 
are crucial for the formation of a loop that separates the genes into an active 
chromatin hub (ACH). The rest of the enhancers within LCR can then contact 
appropriate globin genes (Tolhuis, Palstra et al. 2002). 
Different times of activation of globin genes require precise regulation of their 
activation. However, linear organization and relative proximity in the cluster 
combined with exclusive activity in erythroid cell line make their regulation employ 
relatively simple mechanisms. Separating the whole cluster into a loop by insulator 
elements located on both sides, specific enhancer-promoter interactions can take place 
without the interference of the regulatory elements outside the loop. Also, globin 
enhancers are prevented from activating olfactory receptor genes outside the ACH.  
Situation is not so simple in gene-dense intervals like the one where Fgf8 is 
located. There, enhancers spread over longer chromosomal interval need to activate 
appropriate promoter, avoiding the ones located in between. The specificity of 
interactions cannot be achieved by simply separating the appropriate gene(s) inside 
the loop, since multiple genes in these loci perform various functions and are not co-
regulated. 
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Montavon et al. recently reported somehow similar observations. The authors 
performed functional and structural studies on HoxD genes during digit development 
(Montavon, Soshnikova et al. 2011) and discovered that the gene desert located 
centromeric to HoxD13 gene harbors multiple regulatory regions involved in HoxD 
expression in the digits. They also showed that these sequences physically contact 
genes within the cluster. Deletions or inversions of relatively large regions had 
minimal impact, suggesting highly redundant system and shared regulation. Authors 
compare these regulatory sequences to the islands within gene desert and propose a 
novel concept for regulatory region: a regulatory archipelago. They propose these 
sequences provide flexibility in the digit patterning, with some acting as enhancers 
while the others playing a structural role in bringing them together. This could have 
had the impact during digit evolution. Within the gene-free interval the addition of 
new modules and their fine-tuning could have been selected for the optimal gene 
expression. Complementary and redundant nature of regulatory elements could then 
allow modifications of gene regulation, without deleterious effect to the overall 
output.  
However, the situation within and around HoxD cluster is somehow different 
than in our studied region. It is well known that the genes within the cluster originated 
by duplication of the ancestral copy and are also often expressed in the same structure 
or cell type (as exemplified by β-globin cluster described above). Therefore, they are 
likely to share regulatory sequences. Additionally, the presence of the gene desert 
centromeric to the cluster opens a possibility to safely evolve multiple regulatory 
elements without a need for the restriction towards heterologous promoters. The 
exception is two genes located 5’ to the cluster, Evx2 and Lnp – they are both 
coexpressed in the digits, due to bystander effect (Spitz, Gonzalez et al. 2003).  
On the other hand, within the region where Fgf8 is located, multiple enhancers 
are scattered between relatively closely positioned genes and within their introns. 
Since these genes do not perform similar functions nor did they originate from the 
common ancestral copy, there is a strong need for the enhancers to recognize and act 
upon their target promoter. Indeed, in situ hybridization of all the genes downstream 
of Fgf8 did not show any bystander effect. Within a holo-enhancer, redundancy exists 
at the level of individual modules, visible when they are tested alone. However, 
delicate balance of their regulatory potential is needed within the endogenous locus. 
Rather than binary interactions guiding the specificity of promoter activation, the 
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overall structure of the locus with all the individual regulators create an appropriate 
input from the target promoter, activating it at the right time in specific structures. 
 
6.4. Implications of disrupted regulatory regions in human diseases 
6.4.1. SHFM3 / Dactylaplasia 
In line with that, disruption of the holo-enhancer can cause misexpression of 
genes leading to different diseases. As described in the introduction, duplication in the 
region on human chromosome 10 where Fgf8 is located is involved in split hand-foot 
malformation type 3 (SHFM3). Even thought Fgf8 is the only gene in the region 
playing a crucial role in limb development, it is outside the duplicated interval. Also, 
conditional knockout of Fgf8 causes reduction of stylopod, hypoplasia of zeugopod 
and absence of digit I in hindlimbs and digit II or III in the forelimbs; however, it 
does not lead to SHFM phenotype (Lewandoski, Sun et al. 2000).   
Parallel study in the lab on a set of duplications generated in the mice 
comprising the extended region from Pax2 to Pitx3 gene did not reveal any limb 
malformations, even in the homozygous form, ruling out the possibility that altered 
dosage of some other gene(s) in the region causes this malformation (Namita Tripathi, 
unpublished observations). The alternative cause could be impaired regulation of Fgf8 
by disruption of its regulatory domain.  
In their study of six patients suffering from SHFM3 Dimitrov et al. reported 
different range of phenotypes, from relatively mild ones with only affected limbs to 
syndromic ones involving micrognathia, renal hypoplasia, myopia and hearing 
problems combined with various levels of mental retardation (Dimitrov, de Ravel et 
al. 2010). These additional syndromes were present in patients with the breakpoint 
closer to Fgf8. Other reported cases with breakpoints between LBX1 and βTRC had 
triphalangeal thumb or preaxial polydactyly (Elliott, Reed et al. 2005). Interestingly, 
overexpression of Lbx1 in the AER performed in our lab resulted in duplicated thumb 
(PhD thesis, Aktas T. 2011 Ruperto-Carola University, Heidelberg). This breakpoint 
might change the regulatory architecture causing misexpression of Lbx1 in the AER. 
Therefore, we hypothesize that duplication of Fgf8 holo-enhancer in patients 
suffering from SHFM3 leads to reallocation of part of it further from the target gene 
(Figure 3). Because individual enhancers have regulatory potential broader than 
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eventually utilized in the normal situation and are intrinsically promiscuous, 
reallocation can release this potential (possibly due to dissociation from the negative 
elements) and lead to the activation of other promoter(s) positioned at an appropriate 
distance. This can cause gain of function of other genes in the region. Variable 
positions of breakpoints cause duplication of different regulatory elements and 
activation of possibly different genes. This way observed continuum of phenotypes 
could arise.  
 
 
Figure 3. A model for SHFM3 
In the patients suffering from SHFM3 ~0.5 Mb duplication downstream of Fgf8 disrupts the holo-
enhancer region. Reallocated set of regulatory elements is now brought into the proximity of 
heterologous genes. Due to the promiscuous nature of individual enhancers and position-dependent 
mode of action, they are now free to act on the heterologous genes that are properly positioned from 
them. Upregulation of other gene(s) could ultimately lead to downregulation of Fgf8 expression in the 
AER, its premature termination and impaired limb development.  
 
Accepted mouse model for SHFM3 is Dactylaplasia (Dac), due to striking 
similarity of the limb phenotype to the one observed in human patients and 
involvement of the syntenic locus on mouse chromosome 19. It is known from the 
study of Dac mouse embryos that the down regulation of Fgf8 in the AER leads to its 
premature termination and causes characteristic limb phenotype (Crackower, 
Motoyama et al. 1998). Intriguingly, no duplication was detected in Dac mice, but the 
insertion of the retrotransposon element within or upstream of Fbxw4 has been 
associated with the phenotype.  
In her PhD thesis, Tugce Aktas investigated the barrier role of MusD element 
(PhD thesis, Aktas T. 2011 Ruperto-Carola University, Heidelberg). When inserted 
downstream of Fgf8 MusD blocks the activity of distally positioned enhancers, not 
allowing them to activate the gene. Again, within the disrupted holo-enhancer region 
now isolated set of enhancers potentially redirects its activity to the other genes 
nearby. Besides already mentioned forced expression of Lbx1 in the AER, the same 
experiment was performed with βTrC, but no limb malformations were observed. 
However, this experimental setup might not completely correspond to the situation in 
!!"#$%!!!!!!!!!!!!!!!!!&'()!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!*+,-!!!./01!!!!234#$56!!!!!!"#$%!!!!!!!!!!!!!!!!!!!!!!&'()!!!!!!!!!!!!!!!!!!!!!!!!*+,-!!!./01!!!!!!!4#$56!!!!!!!!!!!!!4789!!
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the disease. Alternatively, other gene or the combination of several could be activated 
instead the tested ones.    
Although characterization of candidate genes goes beyond the scope of this 
thesis, evidence presented here and in PhD thesis from Tugce Aktas provides a solid 
ground for future experiments. Even though different in the nature of mutation, both 
SHFM3 patients and Dac mice offer an insight on how the regulatory region functions 
as a whole to drive the proper Fgf8 expression and how rearrangements of various 
types within it can lead to the same developmental malformations.  
 
6.4.2. Application of holo-enhancer concept to other human malformations 
In addition to the described human malformation, there are more and more 
emerging examples of other developmental defects where mutations of coding regions 
were not found (Kleinjan and van Heyningen 2005; Klopocki and Mundlos 2011). 
Sometimes, point mutations in the cis-regulatory elements are shown to be causative 
for the disease. The best studied example is Shh limb enhancer ZRS. Point mutations 
cause misexpression of Shh in anterior part of the developing limb bud resulting in 
polydactylous phenotype. Lettice et al. demonstrated variety of outputs depending on 
the position of the point mutations (Lettice, Hill et al. 2008). 
Besides point mutations in the defined enhancers, structural variations in the 
form of duplications, deletions or inversions were detected in the noncoding regions 
of the genome where multiple conserved sequences are found. Relative proximity of 
these variations to the important developmental genes strongly suggests altered 
regulatory landscape as a causative for the disease. For many of these cases an 
enhancer responsible for the expression of the disease gene (usually the one affected 
by the breakpoint) in a particular structure has been characterized. However, this is 
often not so obvious because of the existence of multiple regulatory elements possibly 
involved in the regulation of a gene. 
Alternatively, structural change can modify regulatory landscape altering 
relative distances between different enhancers and / or their target genes. While 
deletions of potential regulatory elements most probably cause loss-of-function 
mutations, the consequence of duplications are not so straightforward and multiple 
mechanism could be involved (Klopocki and Mundlos 2011). 
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Duplication of an enhancer could increase the amount of transcription factor 
binding, which can in turn lead to gain-of-function mutation. This mechanism was 
proposed for Brachydactyly type 2A where duplication of potential limb-specific 
enhancer ~100 kb away from BMP2 gene causes the imbalance in BMP signaling 
pathway. Another possibility is that the duplication removes the enhancer from its 
target gene and brings it to the proximity of another one. Lettice et al. recently 
proposed a case of “enhancer-adoption”: chromosomal rearrangement brings an 
enhancer of one gene to the close proximity of the other unrelated one and causes its 
activation and ectopic expression (Lettice, Daniels et al. 2011). 
Still, in light of the results obtained in this study, it is conceivable that not 
even a single element would be the sole cause. The observed effects of described 
duplications to the gene regulation go beyond simple one-enhancer-one-promoter 
interactions within the duplicated interval. Based on what we saw with Fgf8 locus, it 
is possible that disruption of the full holo-enhancer is causing misexpression of the 
target gene.  
Reallocated enhancers could be necessary in combination with the others to 
obtain full expression pattern of Fgf8. Additionally, once removed from their natural 
position, they may be released from structural and functional constrains in the form of 
negative regulators. Broader activity observed for individual enhancers, which is not 
necessarily used at their normal position and their intrinsic promiscuity could now 
allow ectopic activity, bringing it to the other gene(s) in the region.  
Within various human diseases caused by structural variations chromosomal 
breakpoints were mapped to slightly different positions. Individual patients often 
display a variety of malformations, ranging from mild to severe ones. A spectrum of 
observed phenotypes within one type of malformations when a single locus is 
involved could be because of variable positions of breakpoints that reallocate different 
parts of a holo-enhancer to the other genes in the region. Activated heterologous 
genes can then indirectly, via different signaling pathways, cause changes in the 
expression of the gene actually involved in the developmental process.   
Therefore, to understand the full scope of regulatory changes taking place in 
various human malformations we need to appreciate the complexity of regulatory 
regions of developmental genes and multiplicity of interactions acting within. 
Interplay of individual regulatory elements needs to be seen in the combination with 
the structure of the locus and structural changes taking place when the region is 
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altered. While the dissection of these regions provides an important insight into the 
individual players, one has to keep in mind their interdependence and should apply 
holistic approach when analyzing the readout in form of gene expression. 
 
6.5. Evolutionary implications 
6.5.1. Evolutionary constraints  
Results of our study of interval around Fgf8 raised several points with 
interesting evolutionary implications. First, linkage of the genes in the whole region is 
extremely conserved throughout the evolution with preserved gene number and order 
in all the tetrapods. The exception is the loss of Slc2a5 gene in mammals. 
Additionally, due to whole genome duplication in the teleost lineage (Panopoulou and 
Poustka 2005), fish have two syntenic loci split between the two chromosomes. There 
are two orthologs of Fgf8, fgf8a and fgf8b, and their expression overlaps to a great 
extent, with some spatial and temporal differences (Jovelin, He et al. 2007). 
Although absolute sizes of the syntenic regions are different, the orientation 
and relative distances between the genes are conserved. Also, because this is a gene-
dense region, regulatory elements of one gene are embedded in the introns of a 
neighboring one. Even more strikingly, conserved tested elements kept their relative 
positions. For example, CNEs located within the introns of Fbxw4 in humans are 
present in the orthologous introns of other tetrapods. In fish βTrC gene was lost, but 
conserved blocks can be found in the places of the former introns. Striking 
conservation of the organization of CNEs strongly suggests the existence of 
functional constrains acting over long period of time.  
Kikuta et al. recently suggested that the mechanism of maintaining synteny in 
vertebrates comes from the intricate distribution of genes and their regulatory 
elements (Kikuta, Laplante et al. 2007). Chromosomal segments where the gene 
involved in developmental processes, CNEs and functionally and evolutionary 
unrelated bystander genes are linked together in syntenic blocks in different 
organisms they termed Genomic Regulatory Blocks (GRBs). Conserved noncoding 
elements spread within GRBs most probably have a regulatory role for the 
developmental gene. Bystander genes are often ubiquitously expressed and do not 
share regulatory functions of CNEs they harbor. However, the constraints of long-
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range gene regulation keep bystander genes within GRBs. The authors also compared 
GRBs with gene deserts, with the difference that there are no bystander genes in gene 
deserts.  
One of the GRBs identified in their study is Fbxw4-Fgf8 gene pair. These two 
genes are conserved together even in ascidians. Knowing that Fbxw4 and Fgf8 did not 
originate from the common ancestral copy or have any functional overlaps, this 
ancient linkage supports the idea of overlapping regulatory regions. We compared the 
intronic sequences of human and Ciona orthologues of Fbxw4, but did not reveal any 
conservation between the two, despite strong evolutionary linkage of Fbxw4 and 
Fgf8. This may suggest that potential regulatory elements of Ciona Fgf8 orthologue 
could have evolved beyond recognition while still maintaining the relative position to 
the gene. If this were true, it could offer additional support to our observations that 
regulatory geometry needs to be preserved for the proper gene expression. Also, it 
could reinforce the suggestion that synteny is more the conservation of the regulatory 
scaffold than gene linkage (Kikuta, Laplante et al. 2007).  
In gene-rich interval like the one we investigated, there is no luxury for the 
regulatory elements to occupy gene-free region. Therefore, they are interspersed in 
the introns of the neighboring genes. Identification of multiple Fgf8 enhancers within 
the introns of the bystander Fbxw4 exemplifies the functional constrain of the gene 
linkage. Holo-enhancer concept adds the requirement for structural constraint: proper 
distances between regulatory elements and the optimal promoter position are needed 
for the precise expression pattern to be achieved. Similarly, because Fgf8 regulatory 
region does not extend into βTrC, conserved elements there could be part of the Lbx1 
regulatory region. This would explain the conservation of their relative positions in 
fish, where all the exons of βTrC are lost. Indeed, Kikuta et al. propose two adjacent 
GRBs in this interval: one with Fgf8 and Fbxw4 and another one belonging to Lbx1 
and / or Tlx1 (Kikuta, Laplante et al. 2007). βTrC could in this case be the bystander 
gene within Lbx1 GRB.  
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6.5.2. Evolutionary opportunities 
Redundancy of regulatory potential as one of the sources for evolutional tinkering 
Even though the position of the enhancers can be constrained due to the 
regulatory scaffold that they belong to, their functional redundancy opens various 
possibilities for evolutionary tinkering. In our analysis of individual CNEs we 
identified five with the activity in the AER of the developing limb bud. Further 
experiments showed that CE80 is not enough for the proper Fgf8 expression in the 
limb, whereas CE61 and CE66 were at least partially dispensable, since the 
expression of LacZ was preserved, despite the deletion of these two CNEs from the 
injected BAC. When the sequence of the chicken CE61 was analyzed, we found only 
a short overlap with the tested human one. This may suggest a relatively fast rate of 
evolution for this element in the chicken genome. Due to functional redundancy of 
other AER enhancers, the changes in CE61 did not impair limb development. Instead, 
they may have contributed to modifications of gene expression and potentially played 
a role in developing specific characteristics of the chicken limb.  
Chicken was a valuable experimental model in determining different 
molecular and morphological processes during limb development. The comparison to 
the experiments done in mice showed that the same gene players are involved in the 
genetic cascades. However, one has to keep in mind that mouse and chicken limbs are 
different. Even though the same genes contribute to their development, modulation of 
regulation by individual enhancers could eventually lead to morphologically various 
structures. The observed variations between the sequences of human and chicken 
CE61 only offer a speculation on potential differences in the role of this particular 
element. Still, similar discoveries in the regulatory repertoire of developmental genes 
could be of a potential use when considering the modulations of gene expression and 
evolution of various phenotypic forms.  
Control of filtering mechanisms: making use of pre-existing potential 
Another intriguing CNE tested in our systematic analysis is CE63. The expression 
pattern of individually tested CE63 construct is highly reproducible in broad forebrain 
domain, as well as in the limb mesenchyme. Interestingly, couple of years ago 
Weatherbee et al. reported a similar mesenchymal domain of Fgf8 expression in the 
developing limb buds of the bat and proposed bats evolved new regulatory element(s) 
that may contribute to the survival of the interdigital mesenchyme in their wings 
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(Weatherbee, Behringer et al. 2006). However, identification of CE63 offers the 
possibility that bats may have just recruited an already existing additional activity 
from our common ancestral genome that other mammals do not use (Figure 4).  
Rather than evolving a new regulatory element, CE63 offers a ground for the 
speculation how evolutionary selection might have acted to fine-tune regulatory 
elements. The strategy may include modulating the activity of the existing enhancer, 
either by expanding / restricting its region of activity or changing the timing of action. 
Since CE63 is driving the expression in two separate domains, limbs and brain, the 
deletion of the enhancer in tetrapods that do not express Fgf8 the limb mesenchyme 
could have been deleterious for its activity in the brain. Instead, mesenchymal activity 
could be masked in the limb tissue, leaving the function in the brain intact. Enhancer 
modulating mechanisms could include negative regulatory elements that selectively 
block one aspect of the activity, different timing or tissue-specific activation by 
selected set of transcription factors or changes in the affinity of transcription factor 
binding by point mutations in the binding motifs.  
 
Figure 4. Comparison of CE63 and bat Fgf8 expression pattern in the limb 
In addition to the Fgf8 expression in the AER, bats express Fgf8 in the posterior mesenchyme (black 
and red arrow, respectively). Although mice do not show the expression of the endogenous Fgf8 in this 
domain, they harbor in their genome a CNE that can reproducibly guide the expression in the posterior 
limb. This finding suggests alternative usage of the common set of regulatory elements among different 
species. 
 
Although mutations in regulatory sequences can lead to diseases in humans, just 
as mutations in exons, not many examples are known so far. This is mainly due to the 
experimental focus on exons. Another reason may be lesser sensitivity of enhancers to 
single base changes. Unlike in proteins, where point mutation can alter the amino acid 
and severely impair their function, similar changes in enhancer sequences are more 
likely to modulate affinity of transcription factor binding, subsequently altering 
patterns of expression. In this way the function of the enhancer is only modified, not 
CE63
bat forelimb
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diminished. This offers a fertile ground for vast array of intraspecies variations, as 
well as evolutionary divergence, to occur. 
In their work on the regulation of gene expression in Ciona muscle cells Brown et 
al. developed a technique to quantitatively and qualitatively measure the activity of 
motifs within cis-acting elements (Brown, Johnson et al. 2007). They discovered that 
individual cis-elements present diverse functional architecture: each one has different 
combinations and arrangements of motifs of various activities. Although cis-elements 
are different from each other and within paralogues genes, there is much more 
evolutionary constraint between orthologues elements acting on the same gene in 
different organisms.  
Higher flexibility in the architecture of cis-elements regulating multiple genes 
within the cluster (paralogues) could come from the fact that the change in the 
expression of one gene in the cluster will not necessarily affect the overall 
transcriptional output. Conversely, enhancers regulating single-copy orthologous 
genes in different organisms are under strong evolutionary constraint because changes 
in those elements could severely impact function of a particular gene.  
This work nicely demonstrates both constraints and flexibility of regulatory 
elements. Genes can have a variety of regulatory elements that respond to different 
transcriptional factor inputs. The combination of binding motifs and the strength of 
their activity within multiple enhancers offers possibilities for modulating 
transcriptional output of the gene. However, once a function of a regulatory element is 
established, it is quite resistant to further changes, suggesting that similar functional 
modules are reused in different organisms to perform similar functions.  
Our work supports these observations, showing how important developmental 
genes have multiple different regulatory elements. Their evolutionary conservation 
suggests established role in maintaining the function of the same target gene in 
various organisms. However, their individual regulatory potential opens different 
possibilities for evolutionary tinkering, by modulating timing or a tissue where they 
are active. This way the same set of developmental regulators could give rise to 
multiple morphological forms without the need to evolve new structures with 
complex functions like genes.    
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7. Conclusions and Outlook 
The region on human chromosome 10q24 between TLX1 and FGF8 genes 
proved to be an excellent model to study gene regulation. Majority of the genes are 
housekeeping ones, expressed ubiquitously in all the cells. This is most probably 
achieved by the activity of their promoters and they do not need additional enhancers. 
Only the product of FGF8 gene plays important roles during development of multiple 
tissues and organs in the embryo. This complex spatio-temporal expression requires 
coordinated action of multiple enhancers. 
In this work we demonstrated that Fgf8 regulatory region spreads 200 kb 
downstream of the gene. There, all the necessary elements needed for the proper Fgf8 
expression are located. Within it, I characterized multiple individual enhancers and 
discovered striking difference between redundancy in their regulatory potential and 
very restricted activity when located in the normal genomic context. Further analyses 
showed extensive filtering of this potential, possibly via negative regulatory elements.  
However, synteny conservation of this and also other studied loci in different 
organisms pointed to the presence of additional level of regulation embedded in the 
structure of the locus itself. Indeed, BAC transgenesis revealed position-dependent 
mode of action of the enhancers. This was further confirmed by generated 
chromosomal rearrangements within the locus, which also showed that enhancers are 
able to activated heterologous gene, if it is in the proper position from them on the 
chromosome.  
Discovered contrast between redundancy of the regulatory potential and 
filtering of activity through negative elements and the structure of the locus led us to 
propose a novel concept of gene regulation. A holo-enhancer concept unifies different 
aspects of gene regulation in complex genomic locus where multiple enhancers need 
to make a difference between the target promoter and heterologous ones positioned 
close by. 
It remains to be investigated whether this holds true for similar other loci. 
However, our study indicates that regulation of a gene is much more than the sum of 
individual enhancer activities. It also emphasizes the importance of taking all these 
aspects into account when studying regulation of developmental genes within gene-
rich regions and can offer mechanistic explanation on what goes wrong in human 
conditions caused by the rearrangements of the potential other holo-enhancers. 
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Additionally, we also showed that the structure of the locus plays extremely 
important role in achieving proper gene expression patterns. This holds true for linear 
structure – the position of genes and their enhancers along the chromosome – but as 
well as for the tridimensional one. It has been shown that promoters and enhancers 
come into physical contact by loop formation. However, the studies so far mainly 
addressed one-on-one interactions. It will be interesting to investigate how all the 
regulatory elements within holo-enhancers form 3D structure and act upon the target 
gene. 
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8. Appendices 
8.1. Individual CNEs 
Table 1. Conserved noncoding element within TLX1-FGF8 interval 
All the CNEs are located on human chromosome 10q24. Precise coordinates, intergenic / intronic 
locations and depth of conservation are indicated. 
 
CE Chromosomal Location Gene Position Conservation 
1 chr10:102,968,700-102,969,700 TLX1-LBX1 Fish to Mammals 
2 chr10:102,973,850-102,975,300 TLX1-LBX1 Fish to Mammals 
3 chr10:102,985,900-102,986,599 LBX1-BTRC Amniotes 
4 chr10:102,987,900-102,989,000 LBX1-BTRC Amniotes 
5 chr10:102,991,300-102,992,600 LBX1-BTRC Tetrapods 
6 chr10:102,998,700-102,999,800 LBX1-BTRC Amniotes 
7 chr10:103,010,600-103,011,800 LBX1-BTRC Tetrapods 
8 chr10:103,011,000-103,012,700 LBX1-BTRC Tetrapods 
9 chr10:103,012,000-103,012,900 LBX1-BTRC Tetrapods 
10 chr10:103,039,874-103,040,411 LBX1-BTRC Tetrapods 
11 chr10:103,041,905-103,043,500 LBX1-BTRC Fish to Mammals 
12 chr10:103,054,000-103,054,999 LBX1-BTRC Tetrapods 
13 chr10:103,060,288-103,060,999 LBX1-BTRC Fish to Mammals 
14 chr10:103,072,196-103,073,100 LBX1-BTRC Fish to Mammals 
16 chr10:103,082,308-103,083,200 LBX1-BTRC Amniotes 
17 chr10:103,079,827-103,081,230 LBX1-BTRC Tetrapods 
18 chr10:103,078,983-103,086,315 LBX1-BTRC Tetrapods 
19 chr10:103,084,710-103,085,453 LBX1-BTRC Amniotes 
20 chr10:103,129,000-103,130,050 BTRC (intragenic) Tetrapods 
21 chr10:103,133,729-103,134,622 BTRC (intragenic) Amniotes 
22 chr10:103,140,400-103,141,300 BTRC (intragenic) Amniotes 
23 chr10:103,146,500-103,149,000 BTRC (intragenic) Amniotes 
24 chr10:103,151,500-103,152,400 BTRC (intragenic) Amniotes 
25 chr10:103,185,415-103,186,097 BTRC (intragenic) Amniotes 
26 chr10:103,188,150-103,189,700 BTRC (intragenic) Fish to Mammals 
27 chr10:103,191,500-103,192,500 BTRC (intragenic) Tetrapods 
28 chr10:103,193,700-103,195,000 BTRC (intragenic) Tetrapods 
29 chr10:103,193,800-103,196,700 BTRC (intragenic) Fish to Mammals 
30 chr10:103,195,000-103,196,500 BTRC (intragenic) Fish to Mammals 
31 chr10:103,198,700-103,199,600 BTRC (intragenic) Amniotes 
32 chr10:103,200,000-103,203,800 BTRC (intragenic) Fish to Mammals 
33 chr10:103,213,592-103,215,400 BTRC (intragenic) Amniotes 
34 chr10:103,215,446-103,219,516 BTRC (intragenic) Fish to Mammals 
35 chr10:103,213,000-103,219,600 BTRC (intragenic) Fish to Mammals 
36 chr10:103,230,900-103,231,800 BTRC (intragenic) Amniotes 
37 chr10:103,233,700-103,234,800 BTRC (intragenic) Tetrapods 
38 chr10:103,233,500-103,238,835 BTRC (intragenic) Fish to Mammals 
39 chr10:103,235,279-103,236,600 BTRC (intragenic) Fish to Mammals 
40 chr10:103,236,800-103,238,300 BTRC (intragenic) Fish to Mammals 
41 chr10:103,241,600-103,245,901 BTRC (intragenic) Tetrapods 
42 chr10:103,241,659-103,242,671 BTRC (intragenic) Amniotes 
43 chr10:103,243,102-103,244,114 BTRC (intragenic) Amniotes 
44 chr10:103,244,646-103,245,658 BTRC (intragenic) Amniotes 
45 chr10:103,253,675-103,254,319 BTRC (intragenic) Amniotes 
46 chr10:103,256,121-103,257,968 BTRC (intragenic) Tetrapods 
47 chr10:103,262,492-103,263,067 BTRC (intragenic) Amniotes 
48 chr10:103,279,190-103,280,300 BTRC (intragenic) Amniotes 
49 chr10:103,307,913-103,312,000 BTRC-POLL Tetrapods 
50 chr10:103,312,500-103,313,800 BTRC-POLL Tetrapods 
51 chr10:103,314,100-103,315,100 BTRC-POLL Tetrapods 
52 chr10:103,316,014-103,316,720 BTRC-POLL Fish to Mammals 
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53 chr10:103,323,288-103,324,520 BTRC-POLL Tetrapods 
54 chr10:103,330,584-103,331,500 POLL (intragenic) Tetrapods 
55 chr10:103,344,900-103,347,648 DPCD (intragenic) Mammals 
56 chr10:103,352,000-103,353,084 DPCD (intragenic) Amniotes 
57 chr10:103,356,526-103,357,742 DPCD (intragenic) Amniotes 
58 chr10:103,362,310-103,365,900 FBXW4 (intragenic) Fish to Mammals 
59 chr10:103,367,021-103,368,111 FBXW4 (intragenic) Amniotes 
60 chr10:103,369,502-103,370,511 FBXW4 (intragenic) Tetrapods 
61 chr10:103,375,742-103,376,900 FBXW4 (intragenic) Tetrapods 
62 chr10:103,379,088-103,381,246 FBXW4 (intragenic) Fish to Mammals 
63 chr10:103,393,127-103,394,316 FBXW4 (intragenic) Amniotes 
64 chr10:103,398,581-103,402,547 FBXW4 (intragenic) Fish to Mammals 
65 chr10:103,409,516-103,413,238 FBXW4 (intragenic) Tetrapods 
66 chr10:103,409,816-103,410,738 FBXW4 (intragenic) Tetrapods 
67 chr10:103,411,568-103,412,490 FBXW4 (intragenic) Amniotes 
68 chr10:103,408,414-103,410,643 FBXW4 (intragenic) Tetrapods 
69 chr10:103,408,414-103,409,400 FBXW4 (intragenic) Amniotes 
70 chr10:103,415,450-103,416,739 FBXW4 (intragenic) Fish to Mammals 
71 chr10:103,417,900-103,419,189 FBXW4 (intragenic) Tetrapods 
72 chr10:103,432,042-103,433,976 FBXW4 (intragenic) Tetrapods 
73 chr10:103,435,854-103,439,903 FBXW4 (intragenic) Tetrapods 
74 chr10:103,456,888-103,460,837 FBXW4-FGF8 Amniotes 
75 chr10:103,457,300-103,458,700 FBXW4-FGF8 Amniotes 
76 chr10:103,459,366-103,460,766 FBXW4-FGF8 Amniotes 
77 chr10:103,474,661-103,476,270 FBXW4-FGF8 Amniotes 
78 chr10:103,482,100-103,483,600 FBXW4-FGF8 Amniotes 
79 chr10:103,498,500-103,500,000 FBXW4-FGF8 Fish to Mammals 
80 chr10:103,517,000-103,518,700 FBXW4-FGF8 Fish to Mammals 
81 chr10:103,528,000-103,531,575 FBXW4-FGF8 Tetrapods 
82 chr10:103,528,200-103,529,575 FBXW4-FGF8 Tetrapods 
83 chr10:103,522,864-103,524,471 FBXW4-FGF8 Fish to Mammals 
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Table 2. Primer pairs used for cloning of individual CNEs 
Names, sequences and database ID are listed. Primers were designed with ttat overhang and restriction 
enzyme site. 
  
CE Primer name Sequence DB#* 
1 Elt1 Kpn1 f N ttatggtaccAGTGACAGTGACATCTCTGGG 434 
 Elt1 Xho1 r N ttatctcgaGTTTATGCAAACATGGGAGTAG 435 
5 Elt5 Kpn1 fwd ttatggtaccTGTGGAATGCCTTGAATCTC 691 
 Elt5 Xho1 rev ttatctcgagCTCCTGCTGTTTTCTCTTCT 692 
6 Elt6 Kpn1 fwd ttatggtaccGGTTTTGTTTATGACAAGGAGG 693 
 Elt6 Xho1 rev ttatctcgaGTGGCGGTGGCTAGCTTAGT 694 
7 Elt7 Hind3 rev ttataagcttGCATTCTGACCATTCCTCTC 1837 
 Elt7 Xho1 fwd ttatctcgagCTCCACGCTGCTCCTTCTCTCT 1836 
8 Elt8 Hind3 rev ttataagcttGACACCATTCTCCTAGACCA 1835 
 Elt8 Xho1 fwd ttatctcgaGTACCCCACTCATTTTCAAGC 1834 
9 Elt9 Kpn1 fwd ttatggtaccATCTTTATGGCTCCTGTGTC 695 
 Elt9 Xho1 rev ttatctcgagATCAATGGCTTGTTGGGGGT 696 
10 Elt10 Kpn1 fwd ttatggtaccGCGGAATAAAGGTTGCATCT 697 
 Elt10 Xho1 rev ttatctcgaGCATCATCCCGTGTATCACT 698 
11 Elt11 Kpn1 f N ttatggtacCACCCCCTCCCGGGCTCCC 495 
 Elt11 Xho1 r N ttatctcgagCCTCAAACTTCTCCAGTATATTTCC 496 
12 Elt12 Kpn1 fwd ttatggtaccATGGGTCAAGGGCAGTTTGG 668 
 Elt12 Xho1 rev ttatctcgagTGGAAAGTGAGAGGGTAGAG 669 
13 Elt13 Kpn1 f N ttatggtaccGGTTGGAGTCAATCTGCTCAAG 440 
 Elt13 Xho1 r N taatctcgagAAGGAAAGAGGGAGAGAAAAG 441 
14 Elt14 Kpn1 fwd ttatggtaccTTCACTCTGCTACCTTCCTC 571 
 Elt14 Xho1 rev ttatctcgagCACTCACATTCATCCTCCCA 572 
16 Elt16 Kpn1 fwd ttatggtaccTTTTGTGATGTTGACTCTGGG 648 
 Elt16 Xho1 rev ttatctcgagTTGAAAGGTGAAGTTGGGGG 649 
17 Elt17 Kpn1 fwd ttatggtacCTCACTATCATTACCAGATCAG 699 
 Elt17 Xho1 rev ttatctcgaGCCACATTAAATGCTTTCTG 700 
19 Elt19 Kpn1 fwd ttatggtaccGATTTGTCTTGGTTTCCTCT 701 
 Elt19 Xho1 rev ttatctcgagCCATTCCTCATCACTTCTCC 702 
20 Elt20 Kpn1 fwd ttatggtaccGGATTGCTTCCACTTATATC 1840 
 Elt20 Xho1 rev ttatctcgagTAAGAGACACATGATCTGGA 1841 
21 Elt21 Kpn1 fwd ttatggtaccGCAACTGGTTTTGTTAAGTC 1844 
 Elt21 Xho1 rev ttatctcgagACCTTCTATGTCTTGTCCTC 1845 
22 Elt22 Kpn1 fwd ttatggtaCCTGCCATCCCACACAACCACTTTT 703 
 Elt22 Xho1 rev ttatctcgaGAGTCTCTCCAACATACATCAGA 704 
24 Elt24 Kpn1 fwd ttatggtaccGCAGGGCAAAAAAAGAAGGA 650 
 Elt24 Xho1 rev ttatctcgagCACGAAACTTGGACTAAAGGG 651 
25 Elt25 Kpn1 fwd ttatggtaccGGCAATAAAGAAGGAGAAGC 1846 
 Elt25 Xho1 rev ttatctcgagCAACCTTTGACATGGAACCC 1847 
26 Elt26 Kpn1 fwd ttatggtaccGTCTCACACATACACATACA 652 
 Elt26 Xho1 rev ttatctcgagTCACCACTTGTTAAAGACAC 653 
27 Elt27 Kpn1 fwd ttatggtacCTGCCTAAGATTGCATATAC 705 
 Elt27 Xho1 rev ttatctcgagTCACTGAAGGACAAAATGAG 706 
28 Elt28 Kpn1 fwd ttatggtaccTGATTTATTGAGCTAGAGG 654 
 Elt28 Xho1 rev ttatctcgagTAAGATGCAGGAATGAAAAGGG 655 
30 Elt30 Kpn1 f N ttatggtacCTCAAGCCAACTGTAAGGTATAG 442 
 Elt30 Xho1 r N ttatctcgaGCTTCTTTGGGAGGAAAAG 443 
31 Elt31 Kpn1 fwd ttatggtaccAGGCAGTATCATTAGTTGGG 707 
 Elt31 Xho1 rev ttatctcgaGGACAACCATTCTTTCAGGG 708 
32 Elt32 Kpn1 fwd ttatggtaccTTACAGCATTACCAGGCCAC 557 
 Elt32 Xho1 rev ttatctcgaGGACAAAATCACTCAAACTC 558 
33 Elt33 Kpn1 fwd ttatggtacCTACTTGTGCCTTCTGACTTC 1832 
 Elt33 Xho1 rev ttatctcgagCATGCAGTAGTTATGTCCTATC 1833 
36 Elt36 Hind3 rev ttataagcttCAGTATTCTCATGCTATGGG 1843 
 Elt36 Xho1 fwd ttatctcgaGGGATACACAGTTATTTGGG 1842 
37 Elt37 Kpn1 fwd ttatggtaccTTTCCCTAATTTACCCTTACCCACACCC 709 
 Elt37 Xho1 rev ttatctcgaGTGCCCCATGTCTGTATTTT 710 
39 Elt39 Kpn1 f N ttatggtaccAGAGGTTAGGGGAAAGAGG 444 
 Elt39 Hind3 r N ttataagctTGGCATTTCTAGGCTTGTCTTG 445 
40 Elt40 Kpn1 f N taatggtaccAAGGTATAGGAGGTGAAGC 446 
 Elt40 Xho1 r N ttatctcGAGGAGAGAGGAGGCTGACAAG 447 
42 Elt42 Kpn1 fwd ttatggtaccGTGTGTATGTGTAGTTGTTG 711 
 Elt42 Xho1 rev ttatctcgaGTGTCCCAGGCTAGATGTAT 712 
43 Elt43 Kpn1 fwd ttatggtaccGGTAGATGTAGCAAATGGGG 713 
 Elt43 Xho1 rev ttatctcgaGTACTCTGGTTATGGACAAG 714 
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44 Elt44 Kpn1 fwd ttatggtaccGGATTACAGCATCACATCTA 715 
 Elt44 Xho1 rev ttatctcgagACACAGGTATGTTCACTTCG 716 
45 Elt45 Kpn1 fwd ttatggtacCATGTGCCTCTGTGTTTTGC 717 
 Elt45 Xho1 rev ttatctcgaGGTTGGTGAGAGATGGGATA 718 
46 Elt46 Kpn1 f ttatggtaCCTAGGTATGCAAGGTGGATG 369 
 Elt46 Xho1 r ttaactcgagAATGGTACATATAGAATGGGGC 370 
47 Elt47 Kpn1 fwd ttatggtaccGCAGCTTCAGAGAAATTCATGG 719 
 Elt47 Xho1 rev ttatctcgagTCCTACTGATAAATCCACTG 720 
48 Elt48 Kpn1 fwd ttatggtaccAAGTAGTTAAGAATGTGGGTGGGC 721 
 Elt48 Xho1 rev ttatctcgagCTCTGGCATGGAGATCACTT 722 
50 Elt50 Kpn1 fwd ttatggtaccAGAGGGAAGGGTGTTGGAGA 723 
 Elt50 Xho1 rev ttatctcgagCTGCCTTATGTTGAAAGAGT 724 
51 Elt51 Kpn1 fwd ttatggtaccATTGTCTTCTGTTCAATTCCTGG 656 
 Elt51 Xho1 rev ttatctcgagTCCTGATTGTTTGGCACATA 657 
52 Elt52 Kpn1 f N ttatggtaccTGACAGACGAGGCTGTTGTG 448 
 Elt52 Xho1 r N ttatctcgaGTGGTGTGTGCATGGATTTAC 449 
53 Elt53 Kpn1 fwd ttatggtacCTGAGCTGTGGGCAAGTGGA 725 
 Elt53 Xho1 rev ttatctcgaGCGTCTGTGCTGTATGTTCA 726 
54 Elt54 Kpn1 fwd ttatggtaccGGTTTGGAATATGTGAGCTGGGGT 727 
 Elt54 Xho1 rev ttatctcgaGAGTTGGGTTAGCGATTAGG 728 
55 Elt55_Fwd ACCATATTTTATAGTGTTGCCTTTGAGGCAAGCTCAGAAGCTCTGCCTCTggtaccCGCGGGGAGAGGCGGTTTGCGTAT 2157 
 Elt55_Rev ACACCCATGCACTTGTGCATAGGAAAAATAAGAAGGACTTCCCCAAAATCctcgagCTGGCCGTCGTTTTACAACGTCGT 2158 
56 Elt56_Fwd CACCACATCACCTGAGGAGATGCACAAGGAGCTGTGTCCCCATTACTGCAggtaccCGCGGGGAGAGGCGGTTTGCGTAT 2333 
 Elt56_Rev CTACCTGGAAGAATGTATTTTATACCTTTACTCCCATTAATTATATAGAActcgagCTGGCCGTCGTTTTACAACGTCGT 2334 
57 Elt57 Kpn1 fwd ttatggtaCCTATCATGGAAAAACCCTATG 731 
 Elt57 Xho1 rev ttatctcgaGAATGGCCTCCTCATCTCTA 732 
58 Elt58_Fwd CCTGAGCCCCCTTCCTTGAGTCTCATTCTAGCTGAGGAAAGAGAACATTTggtaccCGCGGGGAGAGGCGGTTTGCGTAT 2159 
 Elt58_Rev TCAGGGCCCCCTGGCCCAAACCATCCTGCTGCCCAGGTGACTCTACTGCActcgagCTGGCCGTCGTTTTACAACGTCGT 2160 
58L Elt58 Kpn1 fwd ttatggtaccTGTTCTCTTTCCTCAGCTAG             559 
 Elt58 Xho1 rev ttatctcgaGTGGCTGAATCTTGGCTGGT             560 
59 Elt59 Kpn1 fwd ttatggtaccGCACTCCCCACCTTCACAGACAAT 733 
 Elt59 Xho1 rev ttatctcgaGGCCCTTTCCACTGAACACA 734 
60 Elt60 Kpn1 fwd ttatggtaccACTGCCCCTCCATCCCTGTT 563 
 Elt60 Xho1 rev ttatctcgagCTCAGTTCTTCCTGGAGCCT 564 
61 Elt61 Kpn1 f N ttatggtaCCTGCCAGTTGCTGATGGGGGAG 430 
 Elt61 Xho1 r N ttatctcgaGGCCCTGTACAGGGTATGAAGG 431 
62 Elt62 Kpn1 f N ttatggtaccGAATGGACAAATGAACAAATG 432 
 Elt62 r N ttatGCTTTGGTCTTTACCCCTTGAAGG 433 
63 Elt63 Kpn1 fwd ttatggtaccGCATTACATCTCCACTTGTGC 573 
 Elt63 Hind3 rev ttatctcgagAAGCTTCCTGACTGAGTTGC 574 
66 Elt66 Kpn1 fwd ttatggtaccAGTGGGGTAGGTGGAAGTAT 565 
 Elt66 Xho1 rev ttatctcgagACAAGTAGAAGCAGAGGCTC 566 
67 Elt67 Kpn1 fwd ttatggtaccGCACTATAGTCATCCACCTGAG 735 
 Elt67 Hind3 rev ttataagctTAGATCTTCAGCTTTCAGGG 736 
68 Elt68 Kpn1 fwd ttatggtaccTAATCCAGCCACAACCTCA 666 
 Elt68 Xho1 rev ttatctcgagCATCTTTCTCTTCCTCCCAC 667 
69 Elt69 Kpn1 fwd ttatggtaccTACCTGTGATATGACCCCCT 737 
 Elt69 Xho1 rev ttatctcgaGTTTTGAAAAGACATCCCTGC 738 
70 Elt70 Kpn1 f ttatggtaccGAGGAGGCTGGAATAGAGAAATG 499 
 Elt70 Xho1 r ttatctcgagCCAAAGTGCTGGGATTACAGTTG 500 
71 Elt71 Kpn1 fwd ttatggtaccCTCTCCATCCTAACTACCCT 567 
 Elt71 Xho1 rev ttatctcgagGTCCTTAGTGTTTCCTCACC 568 
72 Elt72 Xho1 fwd ttatctcgaCCACCTACACTACCAGACTA 1639 
 Elt72 Hind3 rev ttataagctTAACCCTGTTTTCCCCTCCT 1640 
73 Elt73_Fwd TCATGCACATAAAGGACCCAGGGTTATGCTTAGTGCTTCTGAAACTGTTTggtaccCGCGGGGAGAGGCGGTTTGCGTAT 2161 
 Elt73_Rev AAAAATAGCTTTACATGCACAGATGTACTTTTTCTTTCCATTATTTGCGTctcgagCTGGCCGTCGTTTTACAACGTCGT 2162 
75 Elt75 Kpn1 fwd ttatggtaccTTGACAGAAGGAAACAGAAC 739 
 Elt75 Xho1 rev ttatctcgaGATGTTTTTGCCACCTATCC 740 
76 Elt76 Kpn1 fwd ttatggtaccAGTTATGTCTCGCTTTCTTG 741 
 Elt76 Xho1 rev ttatctcgagTCAGCTCCCCAACTTTCAGG 742 
77 Elt77 Kpn1 f atatggtaccAGCTGGTTCCTGAACTTCGGTC 371 
 Elt77 Xho1 r tattctcgagTGGTGGGTTTCTTGCCCTAAGG 372 
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78 Elt78 fwd GCCACTTGGTTTTTCTTCAT 743 
 Elt78 Xho1 rev ttatctcgagTGTTTGGGGTAGGAATTGAG 744 
79 Elt79 Kpn1 f atttggtaccGACATTGACAATCGTCATTTTCTC 373 
 Elt79 Xho1 r ttaactcgaGCCTGACTAAGTAACATTCATTAG 374 
80 Elt80 Kpn1 fwd ttatggtaccTAGGTGAGGAAGGAATGAGC 660 
 Elt80 Xho1 rev ttatctcgagAGTTTCCTGAGTGCAGAGCT 661 
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Table 3. The efficiency of transgenesis and expression patterns of individual CNEs 
For each CNE numbers indicate: number of transgenic embryos tested with the primers for LacZ gene 
and primers specific for the element; number of blue embryos and the ones with the reproducible 
pattern. If more than one number is written it corresponds to numbers of embryos having a specific 
pattern. These numbers correspond to the numbers in brackets next to each pattern. For the ectopic 
expression, numbers in brackets indicate if there was more than one embryo with an ectopic pattern 
and comments indicate why this was not counted as reproducible. For the photos of the embryos with 
the reproducible pattern, refer to Figure 1 of Appendix 8.1. 
 
CE LacZ 
PCR 
Spec. 
PCR 
Blue Pattern Reproducible Pattern Ectopic Pattern 
1 19 12 6 5 spleeno-pancreatic 
mesenchyme 
BA mesenchyme(2) 
limb mesenchyme(1) 
11 4 3 3 0  stomach(2) 
lateral neural tube, BA 
mesenchyme(1) 
13 7 5 1 0  Stomach(1) 
14 18 15 8 4,3 rhombic lip ectoderm(4) 
lateral neural tube(3) 
BA(3not same) 
heart(2not same) 
eye, kidney, gut, limb mesenchyme, 
nasal pit ectoderm, midbrain, 
somites(1) 
26 13 8 2 0  AER, neural tube, brain(2) 
liver, somites(1) 
27 5 5 3 0  lateral neural tube(2) 
nasal lobes, otic vesicle, midbrain 
ectoderm(1) 
28 9 6 1 0  tail tip(1) 
30 4 4 1 0  otic vesicle, posterior limb(1) 
32 5 2 0 0   
37 9 8 4 0  BA ectoderm(3not same)  
gut(1) 
38 16 NF 7 6, 3 neural tube(6) 
limb myoblasts(3) 
somites, limb mesenchyme, nasal 
pits, BA ectoderm, head ectoderm(1) 
39 10 NF 6 0  AER, BA ectoderm(2not same) 
eye, heart, kidney, midbrain, MHB, 
CP, neural tube, facial ectoderm, 
anterior limb(1) 
40 10 10 1 0  head ectoderm, forelimb 
mesenchyme, somites, gut(1) 
46 10 10 3 3 forelimb mesenchyme(3) 
dorsal ectodermal 
midline(2) 
 
47 6 NF 0 0   
49 23 21 9 9 lateral neural tube limb mesenchyme(2) 
stomach, somites, eye(1) 
50 4 4 3 0  larinx, midbrain, gut 
51 10 10 2 0  face&BA ectoderm (1) 
52 14 12 3 0  otic placoid, heart, midbrain, BA 
ectoderm(few cells) (1) 
53 4 4 1 0  neural tube, midbrain, kidney, 
posterior distal limbs(1) 
54 22 18 12 11 hindbrain AER, midbrain&facial ectoderm(1) 
55 9 9 1 0  head(whole), neural tube, forelimb 
myoblasts(1) 
56 17 16 5 0  facial ectoderm, migrating cells on 
shoulder level(2) 
distal limb mesenchyme, otic vesicle, 
gut, BA ectoderm(1) 
57 4 4 1 0  somites, BA&hindbrain ectoderm(1) 
58 8 NF 2 2 AER somites, whole brain, nasal pits 
ectoderm(1) 
58L 20 18 8 0  liver, limb mesenchyme, eye, heart, 
somites, neural tube, head ectoderm 
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58R 6 NF 4 3 AER, middle of brain heart, somites, limb mesenchyme 
59 9 9 6 5 AER(5) limb mesenchyme(3not same) 
somites, neural tube, head and BA 
ectoderm, nasal pits(1) 
60 7 7 3 3 head ectoderm, nasal pits(3) whole gut, heart(1) 
61 17 15 5 4 AER(4) BA ectoderm&mesenchyme, neural 
tube, posterior proximal limb, 
midbrain(1) 
62 18 18 12 10, 5 eye(10) 
BA mesenchyme(5) 
forebrain ectoderm,  midbrain(2) 
otic vesicle, gut(1) 
63 3 3 3 3 posterior distal forelimb 
mesenchyme, forebrain 
midbrain(2) 
tail tip(1) 
64 NA NA 4 4, 3, 2 forebrain, nasal pits, tail 
bud(4) 
neural tube, midbrain, 
hindbrain(3) 
kidney, somites(2) 
 
66 10 7 4 4, 3 AER(4) 
kidney, limb 
mesenchyme(3) 
otic vesicle, somites, neutal tube in 
tail(1) 
67 5 4 2 0  neural tube, otic pit, otic vesicle, 
rhombic lip, face/eye(1) 
68 11 NF 10 9, 6, 5, 
3 
AER(9) 
kidney, otic vesicle(6) 
limb mesenchyme(5) 
somites(3) 
MHB(1) 
69 7 7 3 3, 2 kidney 
otic vesicle(2) 
BA ectoderm(small area) 
70 11 9 4 0  liver, neural tube(2) 
BA(few cells on ectoderm), forebrain 
lobes ectoderm, proximal 
hindlimbs&forelimbs(1) 
71 7 7 3 3 heart face ectoderm (2) 
otic placoid, gut(1) 
72 11 NF 5 3 otic vesicle (3not same) neural tube, forebrain, midbrain, eye, 
rhombic lip, nasal pits ectoderm, limb 
mesenchyme(1), 
73 21 15 7 6 somites neural tube, rhombic lip ectoderm, 
brain(1) 
75 5 4 4 3 forebrain fore-, mid-, hindbrain ectoderm, 
facial, BA ectoderm, limb 
mesenchyme(1) 
76 40 32 8 4 heart BA ectoderm(4not same) 
neural tube, forebrain(2not same), 
AER(2) 
gut, somites(1) 
77 10 9 5 5 somites otic vesicle, AER(forelimbs), face, 
BA, nasal pits ectoderm, forelimb 
mesenchyme(1) 
78 4 NF 3 3 midbrain otic vesicle, midbrain, face ectoderm, 
nasal pits (ectoderm), trunk, liver(1) 
79 8 6 5 4, 5 otic vesicle(5) 
MHB(4) 
face ectoderm(2) 
heart(1) 
80 18 13 10 9,8,7,4 midbrain, neural tube,tail 
tip(9) 
AER(8) 
somites(7) 
limb&BA mesenchyme(4) 
forebrain, face ectoderm, otic 
vesicle(1) 
NA = data not available; NF = data not finalized 
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Figure 1. Triplicates of CE-transgenic embryos with reproducible expression patterns 
For each construct that guided the reproducible expression pattern three representative embryos are 
shown. For more detailed description of the patterns, refer to the Table 1. 
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8.2. BAC transgenesis 
 
 
Table 4. Primer pairs used for targeting insertions to the BAC  
Listed are the primer pairs used for the creation of the BAC targeting constructs for the insertion of 
LacZ-Kan cassette and testing obtained transgenic BACs. 
 
Primer name Sequence DB# 
 
Primers for targeting 
Region I fwd CAGGGGGGCCCAATCAGGGTCTGACCTCCATTCTTGACATCCCTCCCCATCTGCCTTAACTAGTACTCTGTGAATGCGCAAACCAACC 1010 
Region I rev ctcggggtaccTCAGACAAAGAAGTAAGCGGCATCCCTCCCTGCAGTTCTGGGACCTCCCTagtactTCTGCCTGTTCATCCGCGTC 1011 
Region II fwd CAGGGGGGCCCAAGATATCATGTGGTTTGTGCAATAATCAGAATCACATTTAATTCAGTGAGTACTCTGTGAATGCGCAAACCAACC 1012 
Region II rev ctcggggtaccGCTCCATCCGGGACTTGACAGAGACCCTTTACCTCGATGGCTTTCTGAGTagtactTCTGCCTGTTCATCCGCGTC 1013 
Region III fwd CAGGGGGGCCCTGTCTTTGTACCATTCCTTGAAAAGATTCTGGCCTAAACCTGTTATACTGAGTACTCTGTGAATGCGCAAACCAACC 1014 
Region III rev ctcggggtaccGTGACCAATCAGAAGCCTGAAGTAAGTATGAAGTAGGGTAATAGGAAGCagtactTCTGCCTGTTCATCCGCGTC 1015 
Region IV fwd CAGGGGGGCCCGATGCCCTTGAGCTGTGGTGAGAGTTGTGCCCTTTGCTGGAGGGAGTCTAGTACTCTGTGAATGCGCAAACCAACC 1016 
Region IV rev ctcggggtaccTTGGAGTACAGCTGTACACAATCCAAAAGAATCACAGGTGATTCTGATTagtactTCTGCCTGTTCATCCGCGTC 1017 
Region V fwd new CAGGGGGGCCCTGGCTTGGGACCCGAGAGTGGCAGAATAGCAAAGCCTGCAGCAGCCACAGAGTACTCTGTGAATGCGCAAACCAACC 2750 
Region V rev new ctcggggtaccGGCATCTTCCGGACCTATGGGGTCAAGGGAATGCGAGGCAGCACACTGGCagtactTCTGCCTGTTCATCCGCGTC 2751 
 
Test primers 
   
from Kanamycin side   
BAC I fwd CAAGACTCAGAAATCCCTCC 1371 
BAC II fwd GTTACCTGAAAGATGTGTTGC 1372 
BAC III fwd GGTGTCACTGAAAAGGAGGA 1373 
BAC IV fwd CTCTTTGGTGACCTTCTGTC 1374 
BAC_Vnew_test_fwd GGGGGAGGGTATAGAAAAAG 3113 
   
from Kan gene always the 
same rev primer AACACCTTCTTCACGAGGCAGAC 375 
   
from LacZ side   
BAC I rev TAGATAGGAGAGGGGCTGGGGAAA 1434 
BAC II rev TTCTTGTGAGGGATAGGCTT 1435 
BAC III rev TCCTCCCTTTACTGTTTTCT 1436 
BAC IV rev ACCAAGGAAGCTGAGAGACA 1437 
BAC_Vnew_test_rev TGTATGGAGCAGTGGGTACT 3114 
   
from LacZ gene the same 
fwd primer TGCAAGGCGATTAAGTTGGG 1376 
CE
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Table 5. Primer pairs used for targeting deletions to the BAC   
Listed are the primer pairs used for the creation of the BAC targeting constructs for deletion of CE61 
and CE66 and testing obtained transgenic BACs. 
 
Primer name Sequence DB# 
 
Primers for targeting 
Fwd_delCE61_zeo CAGAGAGGGCCCTGGAGAAGCCAGTGGCTTTGGCTGGGGTGGGGAGGTTGCACGTGTTGACAATTAATCA 1894 
Rev_delCE61_zeo AGGAGCTCAAGACCAGCCTGGGCAACATAGTGAGACCCCTGTCTCTATTTTCAGTCCTGCTCCTCGGCCA 1895 
Rev_delCE66_kan TGCACCACTCTTTCTTCCACTCTGCTCATCAGGAAGGGAAATGGGAATTTCGAAAGGGGGATGTGCTGCA 1897 
Fwd_delCE66_kan TTTGAGGAGTAACACCGACATCCTGACTATTACATCTTGTACCTCCAAAAGCACGACAGGTTTCCCGACT 1896 
 
Test primers 
BAC4delCE61left_fwd GCAGAGTCTCACTTTAAATG 2256 
BAC4delCE61left_rev GCCATGGTTTAGTTCCTCAC 2257 
BAC4delCE61right_fwd GGAGCAGGACTGAAAATAGAG 2258 
BAC4delCE61right_rev TAGTGGGGAGTAGTTGAAGG 2259 
BAC4delCE66left_fwd GCATAAAGTGTAAAGCCTGGGGTG 459 
BAC4delCE61left_rev ttatggtaccTACCTGTGATATGACCCCCT 737 
BAC4delCE66right_fwd GGAAACAGCTATGACCATG 512 
BAC4delCE66right_rev ttatctcgagACAAGTAGAAGCAGAGGCTC 566 
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Table 6. Expression patterns of different BAC constructs 
The first column indicates individual embryos obtained for each BAC construct; the first row lists 
domains of expression. CP = commissural plate; MHB = midbrain-hindbrain boundary; BA = branchial 
arches; NP = nasal pits; EY = eyes; SO = somites; TB = tail bud; AER = apical ectodermal ridge; H = 
heart; K = kidney. 
 
Domains of expression BAC 
CP MHB BA NP EY SO TB AER H K 
BAC1 
#932           
#939           
#982           
BAC2 
#1447           
#1484           
BAC3 
#1258           
#1381           
#1383           
#1390           
BAC4 
#853           
#854           
#863           
#867           
#870           
BAC5 
#1663           
#1673           
BAC4_Δ61/66 
#1195           
#1315           
#1398           
#1399           
#1401           
#1402           
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Figure 2. Triplicates of BAC-transgenic embryos with reproducible expression patterns 
For each construct that guided the reproducible expression pattern three (or two, when not more 
transgenic embryos were generated) representative embryos are shown.  
 
 
                               
BA
C 
0
BA
C 
1
BA
C 
2
BA
C 
3
BA
C 
4
BA
C 
5
 138 
 
 
8.3. Transgenic mice 
 
Table 7. Different alleles used in the experiments 
Generated alleles, as well as already existing ones in the lab, are listed with corresponding 
genotyping primer combinations. 
 
Genotype Primer pair Comments 
Original allele and its derivatives 
#153/1137  for allele itself 
#2296/2297 for wt 
#2296/678 for original location 
left 
NeoInsLac 
#472/2297 for original location 
right 
#6/123 for allele itself 
#2296/2297 for wt 
#2296/678 for original location 
left 
Neo 
#472/2297 for original location 
right 
#3/1137 for allele itself 
#2296/2297 for wt 
#772/680 for original location 
left 
InsLac 
#472/2297 for original location 
right 
#6/114 for allele itself 
#4/772 for original location 
left 
Lac 
#472/2297 for original location 
right 
Lox #19/772 for allele itself 
Additional alleles created in other labs 
Fgf8DEL #117/118  
PolλDEL #121/248  
Lbx1::GFP #44/157 
 
 
BA
C 
5
BA
C4
_Δ
61
/6
6 
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Chromosomal rearrangements generated with loxP sites in Lbx1, Polλ , Fgf8 and 
Fbxw4 
DUP(Lbx1::GFP-SHFM-Lac) #94/157  
DEL(Lbx1-SHFM) #19/44  
DUP(Polλ-SHFM-Lac) #94/121  
DEL(Polλ-SHFM) #19/248  
DUP(SHFM-Fgf8DEL) #19/118  
DEL(SHFM-Lac-Fgf8 DEL) #94/117  
Additional chromosomal rearrangements used in the lab 
DUP(Lbx1-Fgf8) #455/457  
#452/121 to test the breakpoint DEL(Lbx1-Polλ) 
#37/38 in Btrc to test for 
homozygous 
DUP(Polλ-Fgf8) #520/521  
The rest 
Hprt-Cre #189/190  
A- and E-lines (TG mice with 
chBAC in the genome) 
#131/132  
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Table 8. Genotyping primers 
Sequences and names of the primers from Table 7 are listed. 
 
Stock OligoName Sequence 
3 sb_Rir1 GTTTTGGCAAGTCAGTTAGGACATC 
4 LacZ3´_sb CGCTACCATTACCAGTTGGTCTG 
6 SB_Lir1 TTTCATCACATTCCCAGTGGGTC 
19 sb_lir2 CTTGGGTCAAACATTTCGAGTAGC 
37 Btrc_fwd ACGACGACCAGAAGATAGTCAGCG 
38 Btrc_back GCATTCCAGTGTGCTTTTATCCC 
44 Lbx1_back GACTCTCTCCCATAACTCTCCAACC 
94 LVBG3´rev cgttgtaaaacgacgggatc 
114 LacZ_5DSrev TTGAGGGGACGACGACAGTATC 
117 fgf8_5dir TTAGGGCTATCCAACCCATCCG 
118 Fgf8_6rev AGAAGACAGACACCACAGCCAGTG 
121 PolLambda_5 GCTCCATATGGTTGCTGGGC 
123 PolLambda_NEOdir CATAGCGTTGGCTACCCGTG 
131 chFgf8_fwd AGCACTCACACTGCTGAACCCC 
132 chFgf8_rev CCACTGAGGGGCACGCGTCATGG 
153 pL451-3’up CTCGACTAGAGCTTGCGGAAC 
157 EGFP-3UpTg AACCACTACCTGAGCACCCAGTC 
189 Cre_upper TGCTGTTTCACTGGTTGTGCGGCG 
190 Cre_lower TGCCTTCTCTACACCTGCGGTGCT 
248 Pol-del3rev CTGGTCCAACACAAGGGATGTC 
452 Lbx1cen1 AAGTCTAGGAGAGTCCAAGCGGAC 
455 Lbx1telgfp AAAAAACCTCCCACACCTCCCC 
456 Fgf8tel1 GGTCTTTCTTAGGGCTATCCAACC 
457 Fgf8cen1 AGAAGACAGACACCACAGCCAGTG 
472 biotin-SB-R1 CTTCTGACCCACTGGGAATGTGATG 
520 Fgf8_cen2 CCTGGGATTTCAGGAGAACAGAC 
521 Poll_tel2 TCTGGGAACCAAAGGACAAGC 
678 pPuroa cggagccggttggcgcctacc 
680 p428-ES-R GTCTGTAAACAATTGTTGGAAAAATGACTTGT 
772 p428-ES-Long-F GCGGGTAAGGCCGTCATAGGAGG 
1137 Insulator ES cell test GTCTCAGTGTAAAGCCATTCCC 
2296 SHFM_SB0_homozygous_fwd GTGACCGAGGAAAGACAAGT 
2297 SHFM_SB0_homozygous_rev GCCCATGTGAGTGATCTACA 
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